
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Dyslipidemia - Endocrine and Metabolic Disorders - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "47789936-4b59-4aec-9810-c84b2beaeb1b";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v989684";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "6b7f2ee6-1cb0-44ae-aa34-cb34ce3e55aa",
 VasontId : "v989532"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "4ea3f68c-a029-4073-a010-f26f493d2d02",
 VasontId : "v878839"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="47789936-4b59-4aec-9810-c84b2beaeb1b">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = 'eabd906a-5f07-4068-81d9-7e3e863aab56';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Dyslipidemia
 </h1>
 <h2 class="topic__section topic__header__headermodify--subtitle">(Hyperlipidemia)</h2>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/davidson-michael.html">Michael H. Davidson</a></strong>
 <p class="topic__authors--description">, MD, FACC, FNLA, University of Chicago Medicine, Pritzker School of Medicine;</p>
 <br>
 <strong class="topic__label topic__label--author"><a href="./Contributors/pradeep-pallavi.html">Pallavi Pradeep</a></strong>
 <p class="topic__authors--description">, MD, University of Chicago</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised May 2023 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="272.4;272.0;272.1;272.2;272.3" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v989699" class="topicmenu_mobile__paragraph">Classification</a>
 </li>
 <li>
 <a href="#v989769" class="topicmenu_mobile__paragraph">Etiology</a>
 </li>
 <li>
 <a href="#v990122" class="topicmenu_mobile__paragraph">Symptoms and Signs</a>
 </li>
 <li>
 <a href="#v990134" class="topicmenu_mobile__paragraph">Diagnosis</a>
 </li>
 <li>
 <a href="#v80953274" class="topicmenu_mobile__paragraph">Screening</a>
 </li>
 <li>
 <a href="#v990175" class="topicmenu_mobile__paragraph">Treatment</a>
 </li>
 <li>
 <a href="#v9009046" class="topicmenu_mobile__paragraph">Key Points</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D Models (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Calculators'); }, keypress: function() { $data.activateGroup('Calculators'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Calculators (5)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--calculator" data-group-name="calculator" title="Martin Equation for Low Density Lipoprotein (LDL-C)">
 <div class="hero__excerpt">
 <img class="hero__excerpt--image" src="./Content/Images/Redesign/calculator/icon_calculator_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Martin Equation for Low Density...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"/medical-calculators/MartinLDL.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"2fdb23a2-c0ae-411a-9e9b-9d13e4100b2d","Title":"Martin%20Equation%20for%20Low%20Density%20Lipoprotein%20%28LDL-C%29","ShareUrlTitle":"martin-equation-for-low-density-lipoprotein-ldl-c","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical%20Calculator","UniqueId":null,"Placement":null,"IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Martin%20Equation%20for%20Low%20Density%20Lipoprotein%20%28LDL-C%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Clinical%20Calculator","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--calculator" data-group-name="calculator" title="Very Low Density Lipoprotein (VLDL)">
 <div class="hero__excerpt">
 <img class="hero__excerpt--image" src="./Content/Images/Redesign/calculator/icon_calculator_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Very Low Density Lipoprotein...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"/medical-calculators/VeryLowDensityLipoprotein.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"98ed3657-d663-4369-bb10-bf55bece8504","Title":"Very%20Low%20Density%20Lipoprotein%20%28VLDL%29","ShareUrlTitle":"very-low-density-lipoprotein-vldl","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical%20Calculator","UniqueId":null,"Placement":null,"IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Very%20Low%20Density%20Lipoprotein%20%28VLDL%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Clinical%20Calculator","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--calculator" data-group-name="calculator" title="Friedewald Equation for Low Density Lipoprotein (LDL-C SI units)">
 <div class="hero__excerpt">
 <img class="hero__excerpt--image" src="./Content/Images/Redesign/calculator/icon_calculator_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Friedewald Equation for Low...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"/medical-calculators/Friedewald_SI.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"20484bf8-584c-431b-af65-3f7b7b40b17e","Title":"Friedewald%20Equation%20for%20Low%20Density%20Lipoprotein%20%28LDL-C%20SI%20units%29","ShareUrlTitle":"friedewald-equation-for-low-density-lipoprotein-ldl-c-si-units","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical%20Calculator","UniqueId":null,"Placement":null,"IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Friedewald%20Equation%20for%20Low%20Density%20Lipoprotein%20%28LDL-C%20SI%20units%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Clinical%20Calculator","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--calculator" data-group-name="calculator" title="Friedewald Equation for Low Density Lipoprotein (LDL-C)">
 <div class="hero__excerpt">
 <img class="hero__excerpt--image" src="./Content/Images/Redesign/calculator/icon_calculator_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Friedewald Equation for Low...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"/medical-calculators/Friedewald.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"4244b658-113a-4da3-803a-bf8025a55b10","Title":"Friedewald%20Equation%20for%20Low%20Density%20Lipoprotein%20%28LDL-C%29","ShareUrlTitle":"friedewald-equation-for-low-density-lipoprotein-ldl-c","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical%20Calculator","UniqueId":null,"Placement":null,"IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Friedewald%20Equation%20for%20Low%20Density%20Lipoprotein%20%28LDL-C%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Clinical%20Calculator","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--calculator" data-group-name="calculator" title="Cardiovascular Risk Assessment (10-year, Revised Pooled Cohort Equations 2018)">
 <div class="hero__excerpt">
 <img class="hero__excerpt--image" src="./Content/Images/Redesign/calculator/icon_calculator_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Cardiovascular Risk Assessment...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"/medical-calculators/CVRiskRevised2018.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"4858d1c4-e027-433d-a284-ebe26a577767","Title":"Cardiovascular%20Risk%20Assessment%20%2810-year%2C%20Revised%20Pooled%20Cohort%20Equations%202018%29","ShareUrlTitle":"cardiovascular-risk-assessment-10-year-revised-pooled-cohort-equations-2018","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical%20Calculator","UniqueId":null,"Placement":null,"IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Cardiovascular%20Risk%20Assessment%20%2810-year%2C%20Revised%20Pooled%20Cohort%20Equations%202018%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Clinical%20Calculator","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Images'); }, keypress: function() { $data.activateGroup('Images'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Images (8)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Creamy Plasma due to Severe Hypertriglyceridemia">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="750" height="1000" loading="lazy">
 </div>
 <span class="hero__description">
 Creamy Plasma due to Severe...
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Creamy Plasma due to Severe Hypertriglyceridemia","Credits":"\u003cspan id=\u0022v85654782\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Michael H. Davidson, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"4a2cf2ea-bf89-4db4-8c03-bf19a684d953","Title":"Creamy%20Plasma%20due%20to%20Severe%20Hypertriglyceridemia","ShareUrlTitle":"creamy-plasma-due-to-severe-hypertriglyceridemia","Description":"","ImageUrl":"./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v45392373","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"750","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Creamy%20Plasma%20due%20to%20Severe%20Hypertriglyceridemia","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Eruptive Xanthoma (Skin)">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/e/r/u/eruptive_xanthoma_high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="758" loading="lazy">
 </div>
 <span class="hero__description">
 Eruptive Xanthoma (Skin)
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Eruptive Xanthoma (Skin)","Credits":"\u003cspan id=\u0022v87770757\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003ePhoto provided by Thomas Habif, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"4d02fb1a-568a-4af9-8c17-07cc7a21e490","Title":"Eruptive%20Xanthoma%20%28Skin%29","ShareUrlTitle":"eruptive-xanthoma-skin","Description":"%3Cp%3EEruptive%20xanthomas%20are%20skin%20manifestations%20of%20elevated%20triglyceride%20levels.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/e/r/u/eruptive_xanthoma_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/e/r/u/eruptive_xanthoma_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v8398990","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"758","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Eruptive%20Xanthoma%20%28Skin%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Eruptive Xanthoma">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/5/3/7/537-eruptive-xanthoma-s131-springer-high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="607" loading="lazy">
 </div>
 <span class="hero__description">
 Eruptive Xanthoma
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Eruptive Xanthoma","Credits":"\u003cspan id=\u0022v85655766\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003e© Springer Science+Business Media\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"77a2adc8-cfd2-4dd4-8291-38bd947fa691","Title":"Eruptive%20Xanthoma","ShareUrlTitle":"eruptive-xanthoma","Description":"%3Cp%3EPatients%20with%20severe%20elevations%20of%20TGs%20can%20have%20eruptive%20xanthomas%20over%20the%20trunk%2C%20back%2C%20elbows%2C%20buttocks%2C%20knees%2C%20hands%2C%20and%20feet.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/5/3/7/537-eruptive-xanthoma-s131-springer-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/5/3/7/537-eruptive-xanthoma-s131-springer-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v27732326","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"607","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Eruptive%20Xanthoma","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Tuberous Xanthoma">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/6/8/x/68_xanthoma_slide_5b_springer_high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="715" height="1000" loading="lazy">
 </div>
 <span class="hero__description">
 Tuberous Xanthoma
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Tuberous Xanthoma","Credits":"\u003cspan id=\u0022v85663387\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003e© Springer Science+Business Media\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"86c5fbea-16b0-4b47-b27e-1b3f81200281","Title":"Tuberous%20Xanthoma","ShareUrlTitle":"tuberous-xanthoma","Description":"%3Cp%3ETuberous%20xanthomas%20are%20painless%2C%20firm%20nodules%20typically%20located%20over%20extensor%20surfaces%20of%20joints.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/6/8/x/68_xanthoma_slide_5b_springer_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/6/8/x/68_xanthoma_slide_5b_springer_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v21453889","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"715","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Tuberous%20Xanthoma","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Achilles Tendon Xanthomas">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/a/c/h/achilles-tendon-xanthomas-hypercholesterolemia-davidson-sized.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="750" loading="lazy">
 </div>
 <span class="hero__description">
 Achilles Tendon Xanthomas
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Achilles Tendon Xanthomas","Credits":"\u003cspan id=\u0022v85652423\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Michael H. Davidson, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"312d60f9-5296-4121-90e7-3d4e5ec6b525","Title":"Achilles%20Tendon%20Xanthomas","ShareUrlTitle":"achilles-tendon-xanthomas","Description":"%3Cp%3EAchilles%20tendon%20xanthomas%20are%20diagnostic%20of%20familial%20hypercholesterolemia.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/a/c/h/achilles-tendon-xanthomas-hypercholesterolemia-davidson-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/a/c/h/achilles-tendon-xanthomas-hypercholesterolemia-davidson-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v45392406","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"750","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Achilles%20Tendon%20Xanthomas","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Tendon Xanthomas">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/t/e/n/tendon-xanthomas-davidson-arrow-sized.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="750" loading="lazy">
 </div>
 <span class="hero__description">
 Tendon Xanthomas
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Tendon Xanthomas","Credits":"\u003cspan id=\u0022v85662926\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Michael H. Davidson, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"9bdd2dc5-5498-42c7-aaf9-ca29a6553fb4","Title":"Tendon%20Xanthomas","ShareUrlTitle":"tendon-xanthomas","Description":"%3Cp%3ETendon%20xanthomas%20%28arrow%29%20are%20diagnostic%20of%20familial%20hypercholesterolemia.%20%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/t/e/n/tendon-xanthomas-davidson-arrow-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/t/e/n/tendon-xanthomas-davidson-arrow-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v45392423","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"750","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Tendon%20Xanthomas","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Xanthelasma of the Eyelid">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/x/a/n/xanthelasma-davidson-sized.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="750" height="1000" loading="lazy">
 </div>
 <span class="hero__description">
 Xanthelasma of the Eyelid
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Xanthelasma of the Eyelid","Credits":"\u003cspan id=\u0022v85663938\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Michael H. Davidson, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"c366fe8b-b36f-4863-a859-f1ef186bc781","Title":"Xanthelasma%20of%20the%20Eyelid","ShareUrlTitle":"xanthelasma-of-the-eyelid","Description":"%3Cp%3EThis%20photo%20shows%20yellow-white%20plaques%20on%20the%20lateral%20eyelids%20and%20underneath%20the%20medial%20inner%20corner%20of%20the%20eye%20in%20a%20patient%20with%20hypercholesterolemia.%20Xanthelasma%20are%20not%20specific%20for%20familial%20hypercholesterolemia.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/x/a/n/xanthelasma-davidson-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/x/a/n/xanthelasma-davidson-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v45392389","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"750","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Xanthelasma%20of%20the%20Eyelid","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Xanthelasma of the Eyelid">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/5/3/8/538-xanthoma-eyelid-s132-springer-high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="667" loading="lazy">
 </div>
 <span class="hero__description">
 Xanthelasma of the Eyelid
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Xanthelasma of the Eyelid","Credits":"\u003cspan id=\u0022v87770647\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003e© Springer Science+Business Media\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"b48c2151-ed98-4fba-aa69-b01176485e0c","Title":"Xanthelasma%20of%20the%20Eyelid","ShareUrlTitle":"xanthelasma-of-the-eyelid","Description":"%3Cp%3EThis%20photo%20shows%20yellow-white%20plaques%20on%20the%20upper%20medial%20eyelids%20in%20a%20patient%20with%20hypercholesterolemia.%20Xanthelasma%20are%20not%20specific%20for%20familial%20hypercholesterolemia.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/5/3/8/538-xanthoma-eyelid-s132-springer-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/5/3/8/538-xanthoma-eyelid-s132-springer-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v27763713","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"667","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Xanthelasma%20of%20the%20Eyelid","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (5)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Cholesterol Levels and Cardiovascular Risk">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Cholesterol Levels and Cardiovasc...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"058cfbbb-9f9d-41e4-84af-e6b555162cf0","Title":"Cholesterol%20Levels%20and%20Cardiovascular%20Risk","ShareUrlTitle":"cholesterol-levels-and-cardiovascular-risk","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v80952898","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Cholesterol%20Levels%20and%20Cardiovascular%20Risk","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Lipoprotein Patterns (Fredrickson Phenotypes)">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Lipoprotein Patterns (Fredrickson...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"e2e4cfb9-b905-429d-8126-630459e33cab","Title":"Lipoprotein%20Patterns%20%28Fredrickson%20Phenotypes%29","ShareUrlTitle":"lipoprotein-patterns-fredrickson-phenotypes","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55564502","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Lipoprotein%20Patterns%20%28Fredrickson%20Phenotypes%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Genetic (Primary) Dyslipidemias">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Genetic (Primary) Dyslipidemias
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"e4a15865-7f8c-4cb2-b9fc-7022b2c065ef","Title":"Genetic%20%28Primary%29%20Dyslipidemias","ShareUrlTitle":"genetic-primary-dyslipidemias","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55564567","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Genetic%20%28Primary%29%20Dyslipidemias","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Statins For ASCVD Prevention">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Statins For ASCVD Prevention
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"25aa7f27-d15c-4405-b26f-e168117d5f61","Title":"Statins%20For%20ASCVD%20Prevention","ShareUrlTitle":"statins-for-ascvd-prevention","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55564932","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Statins%20For%20ASCVD%20Prevention","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Non-Statin Lipid–Lowering Drugs*">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Non-Statin Lipid–Lowering...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"e9ee36de-b7c3-4624-b0ca-3907bba2fe85","Title":"Non-Statin%20Lipid%E2%80%93Lowering%20Drugs%2A","ShareUrlTitle":"non-statin-lipidlowering-drugs","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v80953053","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Non-Statin%20Lipid%E2%80%93Lowering%20Drugs%2A","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v989695" class="anchor"></span><div class="para"> <p><div class='topic__explanation'>Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of <a href="./{2E89ECA0-4144-42F5-A042-99D82FF08250}.html" data-toggle="tooltip" title="Atherosclerosis" data-id="a5aaafe6-0fb5-42e8-b2a3-60aeb89f06cf" data-itemid="2e89eca0-4144-42f5-a042-99d82ff08250">atherosclerosis</a><span id="a5aaafe6-0fb5-42e8-b2a3-60aeb89f06cf" class="d-none xref"> <span class="tooltip-container"> <a href="./{2E89ECA0-4144-42F5-A042-99D82FF08250}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Atherosclerosis </span> Atherosclerosis is characterized by patchy intimal plaques (atheromas) that encroach on the lumen of medium-sized and large arteries. The plaques contain lipids, inflammatory cells, smooth muscle... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/7/m1750135-atherosclerotic-plaque-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Atherosclerosis" loading="lazy"> </span> </a> </span> </span>. Causes may be primary (genetic) or secondary. Diagnosis is by measuring plasma levels of total cholesterol, TGs, and individual lipoproteins. Treatment involves dietary changes, exercise, and lipid-lowering drugs.</div></p></div><span id="v37991845" class="anchor"></span><div class="para"> <p>(See also <a href="./{B0CE355F-3128-4E55-9D50-B5509467809F}.html" data-toggle="tooltip" title="Overview of Lipid Metabolism" data-id="bb16ecea-d44d-4b81-ac31-40c5a6941af7" data-itemid="b0ce355f-3128-4e55-9d50-b5509467809f">Overview of Lipid Metabolism</a><span id="bb16ecea-d44d-4b81-ac31-40c5a6941af7" class="d-none xref"> <span class="tooltip-container"> <a href="./{B0CE355F-3128-4E55-9D50-B5509467809F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Lipid Metabolism </span> Lipids are fats that are either absorbed from food or synthesized by the liver. Triglycerides (TGs) and cholesterol contribute most to disease, although all lipids are physiologically important... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>.)</p></div><span id="v989697" class="anchor"></span><div class="para"> <p>Serum lipid levels are continuous; there is no precise threshold between normal and abnormal levels. A linear relation likely exists between lipid levels and cardiovascular risk (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"058cfbbb-9f9d-41e4-84af-e6b555162cf0","Title":"Cholesterol%20Levels%20and%20Cardiovascular%20Risk","ShareUrlTitle":"cholesterol-levels-and-cardiovascular-risk","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v80952898","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ECholesterol%20Levels%20and%20Cardiovascular%20Risk%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>), so many people with “normal” cholesterol levels benefit from achieving still lower levels. Consequently, there are no numeric definitions of dyslipidemia; the term is applied to lipid levels for which treatment has proven beneficial. </p></div><span id="v80953233" class="anchor"></span><div class="para"> <p>Proof of benefit is strongest for lowering elevated low-density lipoprotein cholesterol (LDL-C) levels. In the general population, evidence is less strong for a benefit from lowering elevated TG and increasing low high-density lipoprotein cholesterol (HDL-C) levels.</p></div><span id="v989698" class="anchor"></span><div class="para"> <p>HDL-C levels do not always predict cardiovascular risk. For example, high HDL-C levels caused by some genetic disorders may not be associated with a lower risk of cardiovascular disorders, and low HDL-C levels caused by some genetic disorders may not be associated with an increased risk of cardiovascular disorders. Although HDL-C levels predict cardiovascular risk in the general population, the increased risk may be caused by other factors, such as accompanying lipid and metabolic abnormalities, such as hypertriglyceridemia, rather than the HDL-C level itself.</p></div> <span id="v80952897"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v80952899"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"058cfbbb-9f9d-41e4-84af-e6b555162cf0","Title":"Cholesterol%20Levels%20and%20Cardiovascular%20Risk","ShareUrlTitle":"cholesterol-levels-and-cardiovascular-risk","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v80952898","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Cholesterol%20Levels%20and%20Cardiovascular%20Risk","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="058cfbbb-9f9d-41e4-84af-e6b555162cf0"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '058cfbbb-9f9d-41e4-84af-e6b555162cf0' }, async: true, success: function (data) { $('#058cfbbb-9f9d-41e4-84af-e6b555162cf0').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> <section id="v989699" class="topic__section FHead"> <h2 id="Classification_v989700" class="topic__header--section" data-originaltitle="Classification"> <span id="v989700" class="anchor"></span> Classification of Dyslipidemia </h2> <div class="topic__content"> <span id="v989704" class="anchor"></span><div class="para"> <p>Dyslipidemias were traditionally classified by patterns of elevation in lipids and lipoproteins (Fredrickson phenotype—see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"e2e4cfb9-b905-429d-8126-630459e33cab","Title":"Lipoprotein%20Patterns%20%28Fredrickson%20Phenotypes%29","ShareUrlTitle":"lipoprotein-patterns-fredrickson-phenotypes","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55564502","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ELipoprotein%20Patterns%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). A more practical system categorizes dyslipidemias as primary or secondary and characterizes them by</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v21453945" class="anchor"></span><div class="para"> <p>Increases in cholesterol only: Pure or isolated hypercholesterolemia</p></div></li><li class="topic__listitem"><span id="v21453947" class="anchor"></span><div class="para"> <p>Increases in TGs only: Pure or isolated hypertriglyceridemia</p></div></li><li class="topic__listitem"><span id="v21453949" class="anchor"></span><div class="para"> <p>Increases in both cholesterol and TGs: Mixed or combined hyperlipidemias</p></div></li></ul></div><span id="v21453950" class="anchor"></span><div class="para"> <p>This system does not take into account specific lipoprotein abnormalities (eg, low HDL-C or high LDL-C) that may contribute to disease despite normal cholesterol and TG levels.</p></div> <span id="v55564501"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v989709"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"e2e4cfb9-b905-429d-8126-630459e33cab","Title":"Lipoprotein%20Patterns%20%28Fredrickson%20Phenotypes%29","ShareUrlTitle":"lipoprotein-patterns-fredrickson-phenotypes","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55564502","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Lipoprotein%20Patterns%20%28Fredrickson%20Phenotypes%29","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="e2e4cfb9-b905-429d-8126-630459e33cab"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'e2e4cfb9-b905-429d-8126-630459e33cab' }, async: true, success: function (data) { $('#e2e4cfb9-b905-429d-8126-630459e33cab').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> </div> </section> <section id="v989769" class="topic__section FHead" itemprop="cause" itemscope="" itemtype="http://schema.org/MedicalCause"> <h2 id="Etiology_v989770" class="topic__header--section" data-originaltitle="Etiology"> <span id="v989770" class="anchor"></span> Etiology of Dyslipidemia </h2> <div class="topic__content"> <span id="v989771" class="anchor"></span><div class="para"> <p>Dyslipidemias may be </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v37991852" class="anchor"></span><div class="para"> <p>Primary: Genetic</p></div></li><li class="topic__listitem"><span id="v37991854" class="anchor"></span><div class="para"> <p>Secondary: Caused by lifestyle and other factors</p></div></li></ul></div><span id="v37991855" class="anchor"></span><div class="para"> <p>Both primary and secondary causes contribute to dyslipidemias in varying degrees. For example, in familial combined hyperlipidemia, expression may occur only in the presence of significant secondary causes.</p></div> <section id="v989772" class="topic__section GHead"> <span></span> <h3 id="Etiology_v989770_v989773" class="topic__header--subsection"> <span id="v989773" class="anchor"></span> Primary causes </h3> <div class="topic__content"> <span id="v989774" class="anchor"></span><div class="para"> <p>Primary causes are single or multiple gene mutations that result either in overproduction or defective clearance of triglycerides and LDL or in underproduction or excessive clearance of HDL (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"e4a15865-7f8c-4cb2-b9fc-7022b2c065ef","Title":"Genetic%20%28Primary%29%20Dyslipidemias","ShareUrlTitle":"genetic-primary-dyslipidemias","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55564567","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EGenetic%20%28Primary%29%20Dyslipidemias%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). </p></div> <span id="v55564566"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v45392470"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"e4a15865-7f8c-4cb2-b9fc-7022b2c065ef","Title":"Genetic%20%28Primary%29%20Dyslipidemias","ShareUrlTitle":"genetic-primary-dyslipidemias","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55564567","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Genetic%20%28Primary%29%20Dyslipidemias","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="e4a15865-7f8c-4cb2-b9fc-7022b2c065ef"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'e4a15865-7f8c-4cb2-b9fc-7022b2c065ef' }, async: true, success: function (data) { $('#e4a15865-7f8c-4cb2-b9fc-7022b2c065ef').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> </div> </section> <section id="v990114" class="topic__section GHead"> <span></span> <h3 id="Etiology_v989770_v990115" class="topic__header--subsection"> <span id="v990115" class="anchor"></span> Secondary causes </h3> <div class="topic__content"> <span id="v990116" class="anchor"></span><div class="para"> <p>Secondary causes contribute to many cases of dyslipidemia in adults. </p></div><span id="v37991868" class="anchor"></span><div class="para"> <p>The <b>most important</b> secondary cause of dyslipidemia in high-resource countries is </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v21453966" class="anchor"></span><div class="para"> <p>A sedentary lifestyle with excessive dietary intake of total calories, saturated fat, cholesterol, and trans fats</p></div></li></ul></div><span id="v21453967" class="anchor"></span><div class="para"> <p>Trans fats are polyunsaturated or monounsaturated fatty acids to which hydrogen atoms have been added; they are used in some processed foods and are as atherogenic as saturated fat.</p></div><span id="v37991869" class="anchor"></span><div class="para"> <p>Other common secondary causes of dyslipidemia include </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v21453970" class="anchor"></span><div class="para"> <p> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html" data-toggle="tooltip" title="Diabetes Mellitus (DM)" data-id="dbcd5e9e-017f-4ba9-97e6-61389d26443f" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">Diabetes mellitus</a><span id="dbcd5e9e-017f-4ba9-97e6-61389d26443f" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetes Mellitus (DM) </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v21453972" class="anchor"></span><div class="para"> <p> <a href="./{291C26B0-7C10-48A8-8057-7D2D9EE60EE6}.html" data-toggle="tooltip" title="Chronic Kidney Disease" data-id="1ef93752-e10d-4e5e-83ff-18ad7e282b92" data-itemid="291c26b0-7c10-48a8-8057-7d2d9ee60ee6">Chronic kidney disease</a><span id="1ef93752-e10d-4e5e-83ff-18ad7e282b92" class="d-none xref"> <span class="tooltip-container"> <a href="./{291C26B0-7C10-48A8-8057-7D2D9EE60EE6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chronic Kidney Disease </span> Chronic kidney disease (CKD) is long-standing, progressive deterioration of renal function. Symptoms develop slowly and in advanced stages include anorexia, nausea, vomiting, stomatitis, dysgeusia... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/3/3/633-uremic-frost-springer-high-with-arrow-cropped.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Chronic Kidney Disease" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v21453978" class="anchor"></span><div class="para"> <p> <a href="./{030DDEFB-01D0-4220-86EF-BABF49674439}.html" data-toggle="tooltip" title="Primary Biliary Cholangitis (PBC)" data-id="255a3562-fbfb-4fbb-bd86-14faa6fd8c5f" data-itemid="030ddefb-01d0-4220-86ef-babf49674439">Primary biliary cirrhosis</a><span id="255a3562-fbfb-4fbb-bd86-14faa6fd8c5f" class="d-none xref"> <span class="tooltip-container"> <a href="./{030DDEFB-01D0-4220-86EF-BABF49674439}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Primary Biliary Cholangitis (PBC) </span> Primary biliary cholangitis (PBC; formerly known as primary biliary cirrhosis) is an autoimmune liver disorder characterized by the progressive destruction of intrahepatic bile ducts, leading... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and other cholestatic liver diseases</p></div></li><li class="topic__listitem"><span id="v21453976" class="anchor"></span><div class="para"> <p> <a href="./{AED9B0F6-7F08-4F38-8383-CB92A7292346}.html" data-toggle="tooltip" title="Hypothyroidism" data-id="ed075912-fcd0-4455-b279-daa2244ef514" data-itemid="aed9b0f6-7f08-4f38-8383-cb92a7292346">Hypothyroidism</a><span id="ed075912-fcd0-4455-b279-daa2244ef514" class="d-none xref"> <span class="tooltip-container"> <a href="./{AED9B0F6-7F08-4F38-8383-CB92A7292346}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypothyroidism </span> Hypothyroidism is thyroid hormone deficiency. Symptoms include cold intolerance, fatigue, and weight gain. Signs may include a typical facial appearance, hoarse slow speech, and dry skin. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/y/x/myxedema_in_hypothyroidism_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Hypothyroidism" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v21453974" class="anchor"></span><div class="para"> <p> <a href="./{566F2C28-2392-4CD0-B1C7-E90708C7E2C8}.html" data-toggle="tooltip" title="Alcohol-Related Liver Disease" data-id="d8cb0965-a169-4e6d-82ff-df20ab50f2c1" data-itemid="566f2c28-2392-4cd0-b1c7-e90708c7e2c8">Alcohol overuse</a><span id="d8cb0965-a169-4e6d-82ff-df20ab50f2c1" class="d-none xref"> <span class="tooltip-container"> <a href="./{566F2C28-2392-4CD0-B1C7-E90708C7E2C8}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Alcohol-Related Liver Disease </span> Alcohol consumption is high in most Western countries. According to a survey using the <i>Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)</i> definition of alcohol... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/4/m1400187_dupuytrens_contracture_of_little_finger_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Alcohol-Related Liver Disease" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v21453980" class="anchor"></span><div class="para"> <p>Medications, such as thiazides, beta-blockers, retinoids, highly active antiretroviral agents, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cyclosporine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tacrolimus</span>, progestins, and glucocorticoids; oral <span class="genericDrug" data-showrollover="false">estrogens</span> cause a mixed effect (decrease LDL-C and increase HDL-C, but also increase TGs)</p></div></li></ul></div><span id="v21453981" class="anchor"></span><div class="para"> <p>Secondary causes of low levels of HDL-C include cigarette smoking, anabolic steroids, <a href="./{F74E7EDD-B57E-443C-AF88-E04A1F79DA48}.html" data-toggle="tooltip" title="Human Immunodeficiency Virus (HIV) Infection" data-id="2c3b6d30-d046-4b1d-81a8-3b0f3f2a9764" data-itemid="f74e7edd-b57e-443c-af88-e04a1f79da48">HIV infection</a><span id="2c3b6d30-d046-4b1d-81a8-3b0f3f2a9764" class="d-none xref"> <span class="tooltip-container"> <a href="./{F74E7EDD-B57E-443C-AF88-E04A1F79DA48}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Human Immunodeficiency Virus (HIV) Infection </span> Human immunodeficiency virus (HIV) infection results from 1 of 2 similar retroviruses (HIV-1 and HIV-2) that destroy CD4+ lymphocytes and impair cell-mediated immunity, increasing risk of certain... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/1/3/313_hiv_slide_3_springer_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Human Immunodeficiency Virus (HIV) Infection" loading="lazy"> </span> </a> </span> </span>, and <a href="./{6F0F2AEE-EEA7-494D-9A62-A001CC0C2D33}.html" data-toggle="tooltip" title="Overview of Nephrotic Syndrome" data-id="2ebb5014-86d5-4804-bfce-723df48897f2" data-itemid="6f0f2aee-eea7-494d-9a62-a001cc0c2d33">nephrotic syndrome</a><span id="2ebb5014-86d5-4804-bfce-723df48897f2" class="d-none xref"> <span class="tooltip-container"> <a href="./{6F0F2AEE-EEA7-494D-9A62-A001CC0C2D33}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Nephrotic Syndrome </span> Nephrotic syndrome is urinary excretion of > 3 g of protein/day due to a glomerular disorder plus edema and hypoalbuminemia. It is more common among children and has both primary and secondary... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. </p></div><span id="v990119" class="anchor"></span><div class="para"> <p><b>Diabetes</b> is an especially significant secondary cause because patients tend to have an atherogenic combination of high TGs; high small, dense LDL fractions; and low HDL (diabetic dyslipidemia, hypertriglyceridemic hyperapo B). Patients with type 2 diabetes are especially at risk. The combination may be a consequence of obesity, poor control of diabetes, or both, which may increase circulating free fatty acids (FFAs), leading to increased hepatic very-low-density lipoprotein (VLDL) production. TG-rich VLDL then transfers TG and cholesterol to LDL and HDL, promoting formation of TG-rich, small, dense LDL and clearance of TG-rich HDL. Diabetic dyslipidemia is often exacerbated by the increased caloric intake and physical inactivity that characterize the lifestyle of some patients with type 2 diabetes. Women with diabetes may be at special risk of cardiac disease as a result of this form of dyslipidemia.</p></div> </div> </section> </div> </section> <section id="v990122" class="topic__section FHead" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <h2 id="SymptomsAndSigns_v990123" class="topic__header--section" data-originaltitle="Symptoms and Signs"> <span id="v990123" class="anchor"></span> Symptoms and Signs of Dyslipidemia </h2> <div class="topic__content"> <span id="v990124" class="anchor"></span><div class="para"> <p>Dyslipidemia itself usually causes no symptoms, although very high TG levels can cause paresthesias, dyspnea, and confusion. Lipid disorders can lead to symptomatic end-organ disease, including</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v80953242" class="anchor"></span><div class="para"> <p>Vascular disease (eg, <a href="./{B08A09F4-F747-4FA0-985E-90465F8128C5}.html" data-toggle="tooltip" title="Overview of Coronary Artery Disease" data-id="3fa7ca72-b68f-4667-9af0-25df6485a6ab" data-itemid="b08a09f4-f747-4fa0-985e-90465f8128c5">coronary artery disease</a><span id="3fa7ca72-b68f-4667-9af0-25df6485a6ab" class="d-none xref"> <span class="tooltip-container"> <a href="./{B08A09F4-F747-4FA0-985E-90465F8128C5}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Coronary Artery Disease </span> Coronary artery disease (CAD) involves impairment of blood flow through the coronary arteries, most commonly by atheromas. Clinical presentations include silent ischemia, angina pectoris, acute... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/a/n/g/angioplasty_stent_01_high_blausen.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Coronary Artery Disease" loading="lazy"> </span> </a> </span> </span> (CAD), <a href="./{E61C2983-3440-4F96-AA2E-B108231A4E5D}.html" data-toggle="tooltip" title="Overview of Stroke" data-id="a5123d8a-e7f4-4bba-80de-90c52955a9ea" data-itemid="e61c2983-3440-4f96-aa2e-b108231a4e5d">stroke</a><span id="a5123d8a-e7f4-4bba-80de-90c52955a9ea" class="d-none xref"> <span class="tooltip-container"> <a href="./{E61C2983-3440-4F96-AA2E-B108231A4E5D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Stroke </span> Strokes are a heterogeneous group of disorders involving sudden, focal interruption of cerebral blood flow that causes neurologic deficit. Strokes can be Ischemic (80%), typically resulting... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/u/b/subacute-mca-infarct-ctisus-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Stroke" loading="lazy"> </span> </a> </span> </span>, and <a href="./{9B1A6686-21BF-44A1-932E-124AB567A473}.html" data-toggle="tooltip" title="Peripheral Arterial Disease" data-id="d04c3d64-47bb-403e-b840-67fe663f5ac5" data-itemid="9b1a6686-21bf-44a1-932e-124ab567a473">peripheral arterial disease</a><span id="d04c3d64-47bb-403e-b840-67fe663f5ac5" class="d-none xref"> <span class="tooltip-container"> <a href="./{9B1A6686-21BF-44A1-932E-124AB567A473}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Peripheral Arterial Disease </span> Peripheral arterial disease (PAD) is atherosclerosis of the extremities (virtually always lower) causing ischemia. Mild PAD may be asymptomatic or cause intermittent claudication; severe PAD... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/7/m1750188-cyanosis-peripheral-vascular-disease-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Peripheral Arterial Disease" loading="lazy"> </span> </a> </span> </span>)</p></div></li><li class="topic__listitem"><span id="v80953247" class="anchor"></span><div class="para"> <p> <a href="./{7E47F9C7-92B2-4285-9AB0-BCB4AA41145C}.html" data-toggle="tooltip" title="Acute Pancreatitis" data-id="756cf797-9763-4613-ba77-d4ad0f12140b" data-itemid="7e47f9c7-92b2-4285-9ab0-bcb4aa41145c">Acute pancreatitis</a><span id="756cf797-9763-4613-ba77-d4ad0f12140b" class="d-none xref"> <span class="tooltip-container"> <a href="./{7E47F9C7-92B2-4285-9AB0-BCB4AA41145C}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Pancreatitis </span> Acute pancreatitis is acute inflammation of the pancreas (and, sometimes, adjacent tissues). The most common triggers are gallstones and alcohol intake. The severity of acute pancreatitis is... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/v/p/pv-pancreatits-walled-off-necrosis-arrows-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Pancreatitis" loading="lazy"> </span> </a> </span> </span> can be caused be high TG levels (<span class='symbol'>></span> 500 mg/dL [<span class='symbol'>></span> 5.65 mmol/L])</p></div></li><li class="topic__listitem"><span id="v80953250" class="anchor"></span><div class="para"> <p>Hepatosplenomegaly can be caused by very high TG levels </p></div></li></ul></div><span id="v80953251" class="anchor"></span><div class="para"> <p>Findings in patients with severe dyslipidemia may include localized lipid deposits (xanthomas) or other findings caused by high serum concentrations or accumulation of lipids.</p></div><span id="v45392823" class="anchor"></span><div class="para"> <p>High LDL-C levels can cause tendinous xanthomas at the Achilles, elbow, and knee tendons and over metacarpophalangeal joints. Other clinical findings that occur in patients with high LDL-C (eg, in familial hypercholesterolemia or dysbetalipoproteinemia) include planar or tuberous xanthomas. Planar xanthomas are flat or slightly raised yellowish patches. Tuberous xanthomas are painless, firm nodules typically located over extensor surfaces of joints. </p></div><span id="v80953252" class="anchor"></span><div class="para"> <p>Patients with high levels of LDL-C can develop arcus corneae (lipid deposits in the cornea around the iris) and xanthelasma (lipid-rich, yellow plaques on the medial eyelids). Xanthelasma can also occur in patients with <a href="./{030DDEFB-01D0-4220-86EF-BABF49674439}.html" data-toggle="tooltip" title="Primary Biliary Cholangitis (PBC)" data-id="56c0a38f-8b41-46b7-9724-29f590168ab1" data-itemid="030ddefb-01d0-4220-86ef-babf49674439">primary biliary cirrhosis</a><span id="56c0a38f-8b41-46b7-9724-29f590168ab1" class="d-none xref"> <span class="tooltip-container"> <a href="./{030DDEFB-01D0-4220-86EF-BABF49674439}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Primary Biliary Cholangitis (PBC) </span> Primary biliary cholangitis (PBC; formerly known as primary biliary cirrhosis) is an autoimmune liver disorder characterized by the progressive destruction of intrahepatic bile ducts, leading... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and normal lipid levels. </p></div><span id="v80953254" class="anchor"></span><div class="para"> <p>Extremely high total cholesterol levels give a lactescent (milky) appearance to blood plasma. </p></div><span id="v45392824" class="anchor"></span><div class="para"> <p>Severe elevations of TGs can cause eruptive xanthomas over the trunk, back, elbows, buttocks, knees, hands, and feet. Severe hypertriglyceridemia (<span class='symbol'>></span> 2000 mg/dL [<span class='symbol'>></span> 22.6 mmol/L]) can also give retinal arteries and veins a creamy white appearance (lipemia retinalis). </p></div> <div class="inlinemedia-component " data-ko-rebind="v45392373" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Creamy Plasma due to Severe Hypertriglyceridemia","Credits":"\u003cspan id=\u0022v85654782\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Michael H. Davidson, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"4a2cf2ea-bf89-4db4-8c03-bf19a684d953","Title":"Creamy Plasma due to Severe Hypertriglyceridemia","ShareUrlTitle":"creamy-plasma-due-to-severe-hypertriglyceridemia","Description":"","ImageUrl":"./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v45392373","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"750","ImageHeight":"1000","IframeSrc":null,"Target":null}'> </div> <div class="inlinebox__clear"></div> <div class="inlinemedia inlinemedia--full inlinemedia--slider" data-slide-count="5"> <div class="inlinemedia__wrapper"> <div class="inlinemedia__header"> <div class="inlinemedia__title">Xanthoma Manifestations</div> <div class="inlinemedia__open"> <i class="inlinemedia__icon--open"></i> </div> </div> <div class="tablebox inlinemedia__container"> <div class="tablebox__cell slidernav__previous" role="button" tabindex="0" aria-label="Previous"></div> <div class="tablebox__cell inlinemedia__content"> <div class="inlinemedia__slides"> <figure class="inlinemedia__figure js-carousel-slide"> <img src="./~/media/manual/professional/images/e/r/u/eruptive_xanthoma_high.jpg?mw=350&thn=0&sc_lang=en" alt="Eruptive" xanthoma="" (skin)="" loading="lazy" width="1000" height="758"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Eruptive Xanthoma (Skin)","Credits":"\u003cspan id=\u0022v87770757\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003ePhoto provided by Thomas Habif, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"4d02fb1a-568a-4af9-8c17-07cc7a21e490","Title":"Eruptive%20Xanthoma%20%28Skin%29","ShareUrlTitle":"eruptive-xanthoma-skin","Description":"%3Cp%3EEruptive%20xanthomas%20are%20skin%20manifestations%20of%20elevated%20triglyceride%20levels.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/e/r/u/eruptive_xanthoma_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/e/r/u/eruptive_xanthoma_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v8398990","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"758","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"Carousel-v37991882","LinkText":"Eruptive%20Xanthoma%20%28Skin%29","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Xanthoma%20Manifestations","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <figcaption class="inlinemedia__title mlr-0">Eruptive Xanthoma (Skin)</figcaption> <figcaption class="inlinemedia__description"><ul><span id="v88838295" class="anchor"></span><div class="para"> <p>Eruptive xanthomas are skin manifestations of elevated triglyceride levels.</p></div></ul></figcaption> <figcaption class="inlinemedia__copyright"><span id="v87770757" class="anchor"></span><div class="para"> <p>Photo provided by Thomas Habif, MD.</p></div></figcaption> </figure> <figure class="inlinemedia__figure js-carousel-slide"> <img src="./~/media/manual/professional/images/5/3/7/537-eruptive-xanthoma-s131-springer-high.jpg?mw=350&thn=0&sc_lang=en" alt="Eruptive" xanthoma="" loading="lazy" width="1000" height="607"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Eruptive Xanthoma","Credits":"\u003cspan id=\u0022v85655766\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003e© Springer Science+Business Media\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"77a2adc8-cfd2-4dd4-8291-38bd947fa691","Title":"Eruptive%20Xanthoma","ShareUrlTitle":"eruptive-xanthoma","Description":"%3Cp%3EPatients%20with%20severe%20elevations%20of%20TGs%20can%20have%20eruptive%20xanthomas%20over%20the%20trunk%2C%20back%2C%20elbows%2C%20buttocks%2C%20knees%2C%20hands%2C%20and%20feet.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/5/3/7/537-eruptive-xanthoma-s131-springer-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/5/3/7/537-eruptive-xanthoma-s131-springer-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v27732326","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"607","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"Carousel-v37991882","LinkText":"Eruptive%20Xanthoma","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Xanthoma%20Manifestations","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <figcaption class="inlinemedia__title mlr-0">Eruptive Xanthoma</figcaption> <figcaption class="inlinemedia__description"><ul><span id="v88838297" class="anchor"></span><div class="para"> <p>Patients with severe elevations of TGs can have eruptive xanthomas over the trunk, back, elbows, buttocks, knees, hands, and feet.</p></div></ul></figcaption> <figcaption class="inlinemedia__copyright"><span id="v85655766" class="anchor"></span><div class="para"> <p>© Springer Science+Business Media</p></div></figcaption> </figure> <figure class="inlinemedia__figure js-carousel-slide"> <img src="./~/media/manual/professional/images/6/8/x/68_xanthoma_slide_5b_springer_high.jpg?mw=350&thn=0&sc_lang=en" alt="Tuberous" xanthoma="" loading="lazy" width="715" height="1000"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Tuberous Xanthoma","Credits":"\u003cspan id=\u0022v85663387\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003e© Springer Science+Business Media\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"86c5fbea-16b0-4b47-b27e-1b3f81200281","Title":"Tuberous%20Xanthoma","ShareUrlTitle":"tuberous-xanthoma","Description":"%3Cp%3ETuberous%20xanthomas%20are%20painless%2C%20firm%20nodules%20typically%20located%20over%20extensor%20surfaces%20of%20joints.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/6/8/x/68_xanthoma_slide_5b_springer_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/6/8/x/68_xanthoma_slide_5b_springer_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v21453889","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"715","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"Carousel-v37991882","LinkText":"Tuberous%20Xanthoma","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Xanthoma%20Manifestations","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <figcaption class="inlinemedia__title mlr-0">Tuberous Xanthoma</figcaption> <figcaption class="inlinemedia__description"><ul><span id="v88838299" class="anchor"></span><div class="para"> <p>Tuberous xanthomas are painless, firm nodules typically located over extensor surfaces of joints.</p></div></ul></figcaption> <figcaption class="inlinemedia__copyright"><span id="v85663387" class="anchor"></span><div class="para"> <p>© Springer Science+Business Media</p></div></figcaption> </figure> <figure class="inlinemedia__figure js-carousel-slide"> <img src="./~/media/manual/professional/images/a/c/h/achilles-tendon-xanthomas-hypercholesterolemia-davidson-sized.jpg?mw=350&thn=0&sc_lang=en" alt="Achilles" tendon="" xanthomas="" loading="lazy" width="1000" height="750"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Achilles Tendon Xanthomas","Credits":"\u003cspan id=\u0022v85652423\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Michael H. Davidson, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"312d60f9-5296-4121-90e7-3d4e5ec6b525","Title":"Achilles%20Tendon%20Xanthomas","ShareUrlTitle":"achilles-tendon-xanthomas","Description":"%3Cp%3EAchilles%20tendon%20xanthomas%20are%20diagnostic%20of%20familial%20hypercholesterolemia.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/a/c/h/achilles-tendon-xanthomas-hypercholesterolemia-davidson-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/a/c/h/achilles-tendon-xanthomas-hypercholesterolemia-davidson-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v45392406","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"750","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"Carousel-v37991882","LinkText":"Achilles%20Tendon%20Xanthomas","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Xanthoma%20Manifestations","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <figcaption class="inlinemedia__title mlr-0">Achilles Tendon Xanthomas</figcaption> <figcaption class="inlinemedia__description"><ul><span id="v88838301" class="anchor"></span><div class="para"> <p>Achilles tendon xanthomas are diagnostic of familial hypercholesterolemia.</p></div></ul></figcaption> <figcaption class="inlinemedia__copyright"><span id="v85652423" class="anchor"></span><div class="para"> <p>Image courtesy of Michael H. Davidson, MD.</p></div></figcaption> </figure> <figure class="inlinemedia__figure js-carousel-slide"> <img src="./~/media/manual/professional/images/t/e/n/tendon-xanthomas-davidson-arrow-sized.jpg?mw=350&thn=0&sc_lang=en" alt="Tendon" xanthomas="" loading="lazy" width="1000" height="750"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Tendon Xanthomas","Credits":"\u003cspan id=\u0022v85662926\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Michael H. Davidson, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"9bdd2dc5-5498-42c7-aaf9-ca29a6553fb4","Title":"Tendon%20Xanthomas","ShareUrlTitle":"tendon-xanthomas","Description":"%3Cp%3ETendon%20xanthomas%20%28arrow%29%20are%20diagnostic%20of%20familial%20hypercholesterolemia.%20%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/t/e/n/tendon-xanthomas-davidson-arrow-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/t/e/n/tendon-xanthomas-davidson-arrow-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v45392423","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"750","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"Carousel-v37991882","LinkText":"Tendon%20Xanthomas","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Xanthoma%20Manifestations","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <figcaption class="inlinemedia__title mlr-0">Tendon Xanthomas</figcaption> <figcaption class="inlinemedia__description"><ul><span id="v88838303" class="anchor"></span><div class="para"> <p>Tendon xanthomas (arrow) are diagnostic of familial hypercholesterolemia. </p></div></ul></figcaption> <figcaption class="inlinemedia__copyright"><span id="v85662926" class="anchor"></span><div class="para"> <p>Image courtesy of Michael H. Davidson, MD.</p></div></figcaption> </figure> </div> </div> <div class="tablebox__cell slidernav__next" role="button" tabindex="0" aria-label="Next"></div> </div> <div class="tablebox slidernav__dots"> <div class="tablebox__cell slidernav__fill"></div> <div class="tablebox__cell slidernav__dotwrapper"> <div class="slidernav__dot" data-slidenavid="0" tabindex="0" role="button" aria-label="Indicator 0"></div> </div> <div class="tablebox__cell slidernav__dotwrapper"> <div class="slidernav__dot" data-slidenavid="1" tabindex="0" role="button" aria-label="Indicator 1"></div> </div> <div class="tablebox__cell slidernav__dotwrapper"> <div class="slidernav__dot" data-slidenavid="2" tabindex="0" role="button" aria-label="Indicator 2"></div> </div> <div class="tablebox__cell slidernav__dotwrapper"> <div class="slidernav__dot" data-slidenavid="3" tabindex="0" role="button" aria-label="Indicator 3"></div> </div> <div class="tablebox__cell slidernav__dotwrapper"> <div class="slidernav__dot" data-slidenavid="4" tabindex="0" role="button" aria-label="Indicator 4"></div> </div> <div class="tablebox__cell slidernav__fill"></div> </div> </div> </div> <div class="inlinemedia-component " data-ko-rebind="v45392389" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Xanthelasma of the Eyelid","Credits":"\u003cspan id=\u0022v85663938\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Michael H. Davidson, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"c366fe8b-b36f-4863-a859-f1ef186bc781","Title":"Xanthelasma of the Eyelid","ShareUrlTitle":"xanthelasma-of-the-eyelid","Description":"\u003cul\u003e\u003cspan id=\u0022v88838305\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eThis photo shows yellow-white plaques on the lateral eyelids and underneath the medial inner corner of the eye in a patient with hypercholesterolemia. Xanthelasma are not specific for familial hypercholesterolemia.\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/x/a/n/xanthelasma-davidson-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/x/a/n/xanthelasma-davidson-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v45392389","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"750","ImageHeight":"1000","IframeSrc":null,"Target":null}'> </div> <div class="inlinemedia-component " data-ko-rebind="v27763713" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Xanthelasma of the Eyelid","Credits":"\u003cspan id=\u0022v87770647\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003e© Springer Science+Business Media\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"b48c2151-ed98-4fba-aa69-b01176485e0c","Title":"Xanthelasma of the Eyelid","ShareUrlTitle":"xanthelasma-of-the-eyelid","Description":"\u003cul\u003e\u003cspan id=\u0022v88838307\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eThis photo shows yellow-white plaques on the upper medial eyelids in a patient with hypercholesterolemia. Xanthelasma are not specific for familial hypercholesterolemia.\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/5/3/8/538-xanthoma-eyelid-s132-springer-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/5/3/8/538-xanthoma-eyelid-s132-springer-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v27763713","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"667","IframeSrc":null,"Target":null}'> </div> </div> </section> <section id="v990134" class="topic__section FHead"> <h2 id="Diagnosis_v990135" class="topic__header--section" data-originaltitle="Diagnosis"> <span id="v990135" class="anchor"></span> Diagnosis of Dyslipidemia </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v990139" class="anchor"></span><div class="para"> <p>Serum lipid profile (measured total cholesterol, TG, and HDL-C and calculated LDL-C and VLDL-C)</p></div></li></ul></div><span id="v37991897" class="anchor"></span><div class="para"> <p>Dyslipidemia is diagnosed by measuring serum lipids. Routine measurements (lipid profile) include total cholesterol (TC), TGs, HDL-C, and LDL-C; these results are used to calculate LDL-C and VLDL-C.</p></div><span id="v990140" class="anchor"></span><div class="para"> <p>Dyslipidemia is often diagnosed with routine screening tests. It may also be suspected in patients with complications of dyslipidemia (eg, atherosclerotic disease). Physical findings are less common, and suggest primary dyslipidemia.</p></div><span id="v37991887" class="anchor"></span><div class="para"> <p>Primary lipid disorders are suspected when patients have </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v37991890" class="anchor"></span><div class="para"> <p>Physical signs of dyslipidemia, such as tendon xanthomas, which are pathognomonic for familial hypercholesterolemia</p></div></li><li class="topic__listitem"><span id="v37991892" class="anchor"></span><div class="para"> <p>Onset of premature atherosclerotic disease (men <span class='symbol'>&lt</span> 55 years, women <span class='symbol'>&lt</span> 60 years)</p></div></li><li class="topic__listitem"><span id="v37991894" class="anchor"></span><div class="para"> <p>Family history of premature atherosclerotic disease or severe hyperlipidemia</p></div></li><li class="topic__listitem"><span id="v37991896" class="anchor"></span><div class="para"> <p>Serum cholesterol <span class='symbol'>></span> 190 mg/dL (<span class='symbol'>></span> 4.9 mmol/L)</p></div></li></ul></div> <section id="v990141" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v990135_v990142" class="topic__header--subsection"> <span id="v990142" class="anchor"></span> Lipid profile measurement </h3> <div class="topic__content"> <span id="v990149" class="anchor"></span><div class="para"> <p>Total cholesterol (TC), triglycerides (TGs), and HDL-C are measured directly. TC and TG values reflect cholesterol and TGs in all circulating lipoproteins, including chylomicrons, VLDL, intermediate-density lipoprotein (IDL), LDL, and HDL. TC values can vary by 10% and TGs by up to 25% day-to-day even in the absence of a disorder. </p></div><span id="v80953255" class="anchor"></span><div class="para"> <p>TC and HDL-C may be measured in the nonfasting state, but most patients should have all lipids measured while fasting (usually for 12 hours) for maximum accuracy and consistency.</p></div> <a id="v55564920"></a> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--pearlsandpitfalls "> <div class="inlinebox__wrapper" id="v37991900"> <div class="inlinebox__content"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v37991900"></span> <div class="SidebarHalfPage" id="v55564921"> <h3 class="title">Pearls & Pitfalls</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v55564930" class="anchor"></span><div class="para"> <p>Total cholesterol and HDL-C can be measured in the nonfasting state, but most patients should have all lipids measured while fasting (usually for 12 hours) for maximum accuracy and consistency.</p></div></li></ul></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> <!-- Type: PearlsAndPitfalls --> </div><span id="v990150" class="anchor"></span><div class="para"> <p>Testing should be postponed if a patient has an acute illness, because TG and lipoprotein(a) levels increase and cholesterol levels decrease in inflammatory states. Also, lipid profiles can vary for about 30 days after an acute myocardial infarction (MI); however, results obtained within 24 hours after MI are usually reliable enough to guide initial lipid-lowering therapy.</p></div><span id="v990151" class="anchor"></span><div class="para"> <p>LDL-C values are most often calculated as the amount of cholesterol not contained in HDL and VLDL. VLDL is estimated by TG <span class='symbol'>÷</span> 5 because the cholesterol concentration in VLDL particles is usually one fifth of the total lipid in the particle. Thus, the Friedewald formula estimates LDL-C as follows:</p></div><span class='equation'><img src="./~/media/manual/professional/images/f/r/i/friedewald_formula.gif?thn=0&sc_lang=en" height="44" width="624" alt="equation" class="eq-img" loading="lazy"></span><span id="v9008957" class="anchor"></span><div class="para"> <p>The calculated LDL cholesterol value incorporates measures of all non-HDL and nonchylomicron cholesterol, including that in IDL and lipoprotein (a) (Lp(a)).</p></div><span id="v80953256" class="anchor"></span><div class="para"> <p>For patients who have elevated TG levels, errors in estimating VLDL-C are magnified while using the constant factor of 5. The Martin-Hopkins equation may be used to obtain a more reliable estimate of LDL-C. The constant factor of 5 is replaced with a novel factor based on a patient's non-HDL-C and TG values (<a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37991949" data-toggle="tooltip" title="Diagnosis reference" data-id="64de7b64-a704-41f2-be26-dbc1d0b01192" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">1</a><span id="64de7b64-a704-41f2-be26-dbc1d0b01192" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37991949"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis reference </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis reference" loading="lazy"> </span> </a> </span> </span>). The novel factor is an adjustable factor that is based on the patient's non-HDL-C and TG levels and is derived from a table. Both the Friedewald and Martin-Hopkins equations were developed and validated for fasting patients with serum TG levels < 400 mg/dL (< 4.5 mmol/L). </p></div><span id="v80953258" class="anchor"></span><div class="para"> <p>The Martin-Hopkins equation is as follows:</p></div><span class='equation'><img src="./~/media/manual/professional/images/m/a/r/martin-hopkins-equation.gif?thn=0&sc_lang=en" height="44" width="630" alt="equation" class="eq-img" loading="lazy"></span><span id="v21453994" class="anchor"></span><div class="para"> <p>LDL-C can also be measured directly using plasma ultracentrifugation, which separates chylomicrons and VLDL fractions from HDL-C and LDL-C, and by an immunoassay method. Direct measurement may be useful in some patients with elevated TGs, but these direct measurements are not usually necessary. </p></div> <div class="inlinemedia-component " data-ko-rebind="v80953034" data-bind="component: {name: 'inlinemedia-calculator', params: $data}" data-inline-model='{"IframeSrc":"/medical-calculators/MartinLDL.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"2fdb23a2-c0ae-411a-9e9b-9d13e4100b2d","Title":"Martin Equation for Low Density Lipoprotein (LDL-C)","ShareUrlTitle":"martin-equation-for-low-density-lipoprotein-ldl-c","Description":null,"ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical Calculator","UniqueId":null,"Placement":"sideline","IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}'> </div> <div class="inlinemedia-component " data-ko-rebind="v21453990" data-bind="component: {name: 'inlinemedia-calculator', params: $data}" data-inline-model='{"IframeSrc":"/medical-calculators/VeryLowDensityLipoprotein.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"98ed3657-d663-4369-bb10-bf55bece8504","Title":"Very Low Density Lipoprotein (VLDL)","ShareUrlTitle":"very-low-density-lipoprotein-vldl","Description":null,"ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical Calculator","UniqueId":null,"Placement":"sideline","IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}'> </div> </div> </section> <section id="v990152" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v990135_v990153" class="topic__header--subsection"> <span id="v990153" class="anchor"></span> Other tests </h3> <div class="topic__content"> <span id="v990154" class="anchor"></span><div class="para"> <p>In some patients, additional lipid tests should be done. </p></div><span id="v80953262" class="anchor"></span><div class="para"> <p>Lp(a) levels and C-reactive protein levels should be measured in patients with premature atherosclerotic cardiovascular disease, cardiovascular disease (even if they have lower risk lipid levels; see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"058cfbbb-9f9d-41e4-84af-e6b555162cf0","Title":"Cholesterol%20Levels%20and%20Cardiovascular%20Risk","ShareUrlTitle":"cholesterol-levels-and-cardiovascular-risk","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v80952898","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ECholesterol%20Levels%20and%20Cardiovascular%20Risk%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>), or high LDL-C levels refractory to drug therapy. Lp(a) levels may also be directly measured in patients with borderline-high LDL-C levels to determine whether drug therapy is warranted. </p></div><span id="v37991910" class="anchor"></span><div class="para"> <p>Measurements of LDL particle number or apoprotein B-100 (apo B) is useful in patients with elevated TGs and the <a href="./{AA3B18F4-F664-48AA-B238-17DD381248DF}.html" data-toggle="tooltip" title="Metabolic Syndrome" data-id="2e597e11-362e-4f85-98b6-2ddda5035965" data-itemid="aa3b18f4-f664-48aa-b238-17dd381248df">metabolic syndrome</a><span id="2e597e11-362e-4f85-98b6-2ddda5035965" class="d-none xref"> <span class="tooltip-container"> <a href="./{AA3B18F4-F664-48AA-B238-17DD381248DF}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Metabolic Syndrome </span> Metabolic syndrome is characterized by a large waist circumference (due to excess abdominal adipose tissue), hypertension, abnormal fasting plasma glucose or insulin resistance, and dyslipidemia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Apo B provides similar information to LDL particle number because there is one apo B molecule for each LDL particle. Apo B measurement includes all atherogenic particles, including remnants and Lp(a).</p></div><span id="v80953265" class="anchor"></span><div class="para"> <p>Apo B value reflects all non-HDL-C (in VLDL, IDL, and LDL) and is more predictive of CAD risk than LDL-C. Non-HDL-C (TC − HDL-C) is also more predictive of CAD risk than LDL-C, especially in patients with hypertriglyceridemia.</p></div> <div class="inlinemedia-component " data-ko-rebind="v21453995" data-bind="component: {name: 'inlinemedia-calculator', params: $data}" data-inline-model='{"IframeSrc":"/medical-calculators/Friedewald_SI.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"20484bf8-584c-431b-af65-3f7b7b40b17e","Title":"Friedewald Equation for Low Density Lipoprotein (LDL-C SI units)","ShareUrlTitle":"friedewald-equation-for-low-density-lipoprotein-ldl-c-si-units","Description":null,"ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical Calculator","UniqueId":null,"Placement":"sideline","IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}'> </div> <div class="inlinemedia-component " data-ko-rebind="v21453999" data-bind="component: {name: 'inlinemedia-calculator', params: $data}" data-inline-model='{"IframeSrc":"/medical-calculators/Friedewald.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"4244b658-113a-4da3-803a-bf8025a55b10","Title":"Friedewald Equation for Low Density Lipoprotein (LDL-C)","ShareUrlTitle":"friedewald-equation-for-low-density-lipoprotein-ldl-c","Description":null,"ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical Calculator","UniqueId":null,"Placement":"sideline","IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}'> </div> </div> </section> <section id="v990155" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v990135_v990156" class="topic__header--subsection"> <span id="v990156" class="anchor"></span> Secondary causes </h3> <div class="topic__content"> <span id="v990157" class="anchor"></span><div class="para"> <p>Tests for secondary causes of dyslipidemia should be done in most patients with newly diagnosed dyslipidemia and repeated when a component of the lipid profile has inexplicably changed for the worse. Such tests include measurements of</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v37991917" class="anchor"></span><div class="para"> <p>Creatinine</p></div></li><li class="topic__listitem"><span id="v37991913" class="anchor"></span><div class="para"> <p>Fasting glucose and/or glycosylated hemoglobin (HbA1C)</p></div></li><li class="topic__listitem"><span id="v37991915" class="anchor"></span><div class="para"> <p>Liver enzymes</p></div></li><li class="topic__listitem"><span id="v37991919" class="anchor"></span><div class="para"> <p>Thyroid-stimulating hormone (TSH)</p></div></li><li class="topic__listitem"><span id="v37991921" class="anchor"></span><div class="para"> <p>Urinary protein</p></div></li></ul></div> </div> </section> <section id="v37991948" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v990135_v37991949" class="topic__header--subsection"> <span id="v37991949" class="anchor"></span> Diagnosis reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v80953272" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/24240933/">Martin SS, Blaha MJ, Elshazly MB, et al</a>: Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. <i>JAMA</i> 310(19):2061-2068, 2013. doi:10.1001/jama.2013.280532</p></div></li></ul></div> </div> </section> </div> </section> <section id="v80953274" class="topic__section FHead"> <h2 id="" class="topic__header--section" data-originaltitle="Screening"> <span id="v80953275" class="anchor"></span> Screening for Dyslipidemia </h2> <div class="topic__content"> <span id="v80953277" class="anchor"></span><div class="para"> <p>Screening is done using a fasting lipid profile (TC, TGs, HDL-C, and calculated LDL-C). Medical society guidelines vary regarding when to begin screening. Based on the risk factors, screening can begin as early as age 2 in children with family history of heart disease or familial hypercholesterolemia.</p></div><span id="v80953278" class="anchor"></span><div class="para"> <p> Lipid measurement should be accompanied by assessment for other cardiovascular risk factors, including</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v80953281" class="anchor"></span><div class="para"> <p>Cigarette use</p></div></li><li class="topic__listitem"><span id="v80953283" class="anchor"></span><div class="para"> <p> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html" data-toggle="tooltip" title="Diabetes Mellitus (DM)" data-id="0d5544c6-c984-4e12-958f-d05c0e2f8f0b" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">Diabetes mellitus</a><span id="0d5544c6-c984-4e12-958f-d05c0e2f8f0b" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetes Mellitus (DM) </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v80953286" class="anchor"></span><div class="para"> <p>Family history of <a href="./{B08A09F4-F747-4FA0-985E-90465F8128C5}.html" data-toggle="tooltip" title="Overview of Coronary Artery Disease" data-id="837432f6-6686-4f4a-a87d-250e6278e022" data-itemid="b08a09f4-f747-4fa0-985e-90465f8128c5">CAD</a><span id="837432f6-6686-4f4a-a87d-250e6278e022" class="d-none xref"> <span class="tooltip-container"> <a href="./{B08A09F4-F747-4FA0-985E-90465F8128C5}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Coronary Artery Disease </span> Coronary artery disease (CAD) involves impairment of blood flow through the coronary arteries, most commonly by atheromas. Clinical presentations include silent ischemia, angina pectoris, acute... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/a/n/g/angioplasty_stent_01_high_blausen.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Coronary Artery Disease" loading="lazy"> </span> </a> </span> </span> in a male first-degree relative before age 55 years or a female first-degree relative before age 65 years</p></div></li><li class="topic__listitem"><span id="v80953289" class="anchor"></span><div class="para"> <p> <a href="./{B9A25E4F-9BEA-42DE-8EE8-16E867ADC0B5}.html" data-toggle="tooltip" title="Hypertension" data-id="6e67ac7c-42d5-4a98-9e0b-5efae4f937c2" data-itemid="b9a25e4f-9bea-42de-8ee8-16e867adc0b5">Hypertension</a><span id="6e67ac7c-42d5-4a98-9e0b-5efae4f937c2" class="d-none xref"> <span class="tooltip-container"> <a href="./{B9A25E4F-9BEA-42DE-8EE8-16E867ADC0B5}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypertension </span> Hypertension is sustained elevation of resting systolic blood pressure (≥ 130 mm Hg), diastolic blood pressure (≥ 80 mm Hg), or both. Hypertension with no known cause (primary; formerly, essential... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/5/1/5/515-left-ventricular-hypertrophy-on-ekg-s108-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Hypertension" loading="lazy"> </span> </a> </span> </span></p></div></li></ul></div> <section id="v80953291" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v80953292" class="anchor"></span> Screening in children </h3> <div class="topic__content"> <span id="v80953293" class="anchor"></span><div class="para"> <p>Most physicians recommend screening per the 2012 National Heart Lung and Blood Institute Guidelines (<a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v80953310" data-toggle="tooltip" title="Screening references" data-id="c659df61-4c68-43d5-8783-164516b628e3" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">1</a><span id="c659df61-4c68-43d5-8783-164516b628e3" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v80953310"> <span class="tooltip-content"> <span class="tooltip-heading"> Screening references </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Screening references" loading="lazy"> </span> </a> </span> </span>) as follows</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v80953297" class="anchor"></span><div class="para"> <p>Children with risk factors (eg, <a href="./{477D3E24-6B2B-4BC2-8649-F49FE2C8845D}.html" data-toggle="tooltip" title="Diabetes Mellitus in Children and Adolescents" data-id="f9f6820a-912d-4068-bdeb-0ceb3d2ec7f9" data-itemid="477d3e24-6b2b-4bc2-8649-f49fe2c8845d">diabetes</a><span id="f9f6820a-912d-4068-bdeb-0ceb3d2ec7f9" class="d-none xref"> <span class="tooltip-container"> <a href="./{477D3E24-6B2B-4BC2-8649-F49FE2C8845D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetes Mellitus in Children and Adolescents </span> Diabetes mellitus involves absence of insulin secretion (type 1) or peripheral insulin resistance (type 2), causing hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{AD4BA0A0-3F58-4599-BE90-43726D1C342F}.html" data-toggle="tooltip" title="Hypertension in Children" data-id="df7f6696-95c0-46f5-b264-fa3e7dfbab0a" data-itemid="ad4ba0a0-3f58-4599-be90-43726d1c342f">hypertension</a><span id="df7f6696-95c0-46f5-b264-fa3e7dfbab0a" class="d-none xref"> <span class="tooltip-container"> <a href="./{AD4BA0A0-3F58-4599-BE90-43726D1C342F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypertension in Children </span> Hypertension is sustained elevation of resting systolic blood pressure, diastolic blood pressure, or both; the pressures considered abnormal in children vary based on age up to age 13. Hypertension... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, family history of severe hyperlipidemia or premature CAD): Fasting lipid profile once at age 2 to 8</p></div></li><li class="topic__listitem"><span id="v80953301" class="anchor"></span><div class="para"> <p>Children with no risk factors: Non-fasting or fasting lipid profile once before puberty (usually age 9 to 11) and once more at age 17 to 21</p></div></li></ul></div> </div> </section> <section id="v80953302" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v80953303" class="anchor"></span> Screening in adults </h3> <div class="topic__content"> <span id="v80953304" class="anchor"></span><div class="para"> <p>Adults should be screened at age 20 (<a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v80953310" data-toggle="tooltip" title="Screening references" data-id="223f8371-4b92-425b-a85d-caefbb31d91b" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">2, 3</a><span id="223f8371-4b92-425b-a85d-caefbb31d91b" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v80953310"> <span class="tooltip-content"> <span class="tooltip-heading"> Screening references </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Screening references" loading="lazy"> </span> </a> </span> </span>) and every 5 years thereafter. </p></div><span id="v80953306" class="anchor"></span><div class="para"> <p>An age to discontinue screening has not been established, but evidence supports screening of patients into their 80s, especially if they have atherosclerotic cardiovascular disease (<a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v80953310" data-toggle="tooltip" title="Screening references" data-id="6fecedb4-fa91-4c37-b57c-507220d62fa1" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">4</a><span id="6fecedb4-fa91-4c37-b57c-507220d62fa1" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v80953310"> <span class="tooltip-content"> <span class="tooltip-heading"> Screening references </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Screening references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v80953308" class="anchor"></span><div class="para"> <p>Patients with an extensive family history of heart disease—heart attack, stroke, or coronary artery disease before age 55 (in men) or age 65 (in women) without known risk factors, such as high LDL, smoking, diabetes, or obesity, or known family history of high Lp(a)—should also be screened by measuring Lp(a) levels.</p></div> </div> </section> <section id="v80953309" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v80953310" class="anchor"></span> Screening references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v80953313" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.nhlbi.nih.gov/files/docs/guidelines/peds_guidelines_full.pdf">Expert Panel on Integrated Guidelines</a> for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. 2011.</p></div></li><li class="topic__listitem"><span id="v80953317" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700825/">Goff DC Jr, Lloyd-Jones DM, Bennett G, et al</a>: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. <i>J Am Coll Cardiol</i> 63:2935–2959, 2014. doi: 10.1016/j.jacc.2013.11.005</p></div></li><li class="topic__listitem"><span id="v80953320" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625">Grundy SM, Stone NJ, Bailey AL, et al</a>: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. <i>Circulation</i> 139: e1082–e1143, 2019. doi: 10.1161/CIR.0000000000000625</p></div></li><li class="topic__listitem"><span id="v80953323" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31780523/">Kleipool EE, Dorresteijn JA, Smulders YM, et al</a>: Treatment of hypercholesterolaemia in older adults calls for a patient-centred approach. <i>Heart</i> 106(4):261-266, 2020. doi:10.1136/heartjnl-2019-315600</p></div></li></ul></div> </div> </section> </div> </section> <section id="v990175" class="topic__section FHead" itemprop="possibleTreatment" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Treatment_v990176" class="topic__header--section" data-originaltitle="Treatment"> <span id="v990176" class="anchor"></span> Treatment of Dyslipidemia </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v990183" class="anchor"></span><div class="para"> <p>Lifestyle changes (eg, exercise, dietary modification)</p></div></li><li class="topic__listitem"><span id="v990185" class="anchor"></span><div class="para"> <p>For high LDL-C, statins, bile acid sequestrants, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ezetimibe</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bempedoic acid</span>, and PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors</p></div></li><li class="topic__listitem"><span id="v990187" class="anchor"></span><div class="para"> <p>For high TG, fibrates, omega-3 fatty acids, and sometimes other measures</p></div></li></ul></div> <section id="v990188" class="topic__section GHead"> <span></span> <h3 id="Treatment_v990176_v990189" class="topic__header--subsection"> <span id="v990189" class="anchor"></span> General principles </h3> <div class="topic__content"> <span id="v990190" class="anchor"></span><div class="para"> <p>The main goal for dyslipidemia treatment is prevention of atherosclerotic cardiovascular disease (ASCVD), including <a href="./{77C0CDF2-C352-414E-BD93-B44680DB73E6}.html" data-toggle="tooltip" title="Overview of Acute Coronary Syndromes (ACS)" data-id="e937ba0b-7faa-422d-b8ab-c0b537a1eeb9" data-itemid="77c0cdf2-c352-414e-bd93-b44680db73e6">acute coronary syndromes</a><span id="e937ba0b-7faa-422d-b8ab-c0b537a1eeb9" class="d-none xref"> <span class="tooltip-container"> <a href="./{77C0CDF2-C352-414E-BD93-B44680DB73E6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Acute Coronary Syndromes (ACS) </span> Acute coronary syndromes result from acute obstruction of a coronary artery. Consequences depend on degree and location of obstruction and range from unstable angina to non–ST-segment elevation... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{E61C2983-3440-4F96-AA2E-B108231A4E5D}.html" data-toggle="tooltip" title="Overview of Stroke" data-id="92bfc457-49e1-4060-8764-701af4519b8f" data-itemid="e61c2983-3440-4f96-aa2e-b108231a4e5d">stroke</a><span id="92bfc457-49e1-4060-8764-701af4519b8f" class="d-none xref"> <span class="tooltip-container"> <a href="./{E61C2983-3440-4F96-AA2E-B108231A4E5D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Stroke </span> Strokes are a heterogeneous group of disorders involving sudden, focal interruption of cerebral blood flow that causes neurologic deficit. Strokes can be Ischemic (80%), typically resulting... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/u/b/subacute-mca-infarct-ctisus-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Stroke" loading="lazy"> </span> </a> </span> </span>, <a href="./{945BC64F-CCBA-460A-A635-E01C4655FEEE}.html" data-toggle="tooltip" title="Transient Ischemic Attack (TIA)" data-id="73ca6a73-18fe-459c-9e5e-55a094a2ad18" data-itemid="945bc64f-ccba-460a-a635-e01c4655feee">transient ischemic attack</a><span id="73ca6a73-18fe-459c-9e5e-55a094a2ad18" class="d-none xref"> <span class="tooltip-container"> <a href="./{945BC64F-CCBA-460A-A635-E01C4655FEEE}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Transient Ischemic Attack (TIA) </span> A transient ischemic attack (TIA) is focal brain ischemia that causes sudden, transient neurologic deficits and is not accompanied by permanent brain infarction (eg, negative results on diffusion-weighted... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, or <a href="./{9B1A6686-21BF-44A1-932E-124AB567A473}.html" data-toggle="tooltip" title="Peripheral Arterial Disease" data-id="d8bf3d00-4ed7-4b73-99e6-e3211a51a74f" data-itemid="9b1a6686-21bf-44a1-932e-124ab567a473">peripheral arterial disease</a><span id="d8bf3d00-4ed7-4b73-99e6-e3211a51a74f" class="d-none xref"> <span class="tooltip-container"> <a href="./{9B1A6686-21BF-44A1-932E-124AB567A473}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Peripheral Arterial Disease </span> Peripheral arterial disease (PAD) is atherosclerosis of the extremities (virtually always lower) causing ischemia. Mild PAD may be asymptomatic or cause intermittent claudication; severe PAD... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/7/m1750188-cyanosis-peripheral-vascular-disease-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Peripheral Arterial Disease" loading="lazy"> </span> </a> </span> </span> presumed caused by <a href="./{2E89ECA0-4144-42F5-A042-99D82FF08250}.html" data-toggle="tooltip" title="Atherosclerosis" data-id="d01c533f-d3b0-4170-b36e-13b3af56f545" data-itemid="2e89eca0-4144-42f5-a042-99d82ff08250">atherosclerosis</a><span id="d01c533f-d3b0-4170-b36e-13b3af56f545" class="d-none xref"> <span class="tooltip-container"> <a href="./{2E89ECA0-4144-42F5-A042-99D82FF08250}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Atherosclerosis </span> Atherosclerosis is characterized by patchy intimal plaques (atheromas) that encroach on the lumen of medium-sized and large arteries. The plaques contain lipids, inflammatory cells, smooth muscle... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/7/m1750135-atherosclerotic-plaque-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Atherosclerosis" loading="lazy"> </span> </a> </span> </span>. Treatment is indicated for all patients with ASCVD (secondary prevention) and for some without (primary prevention). </p></div><span id="v990449" class="anchor"></span><div class="para"> <p>Treatment of children is controversial because there is no evidence that lowering lipid levels in childhood effectively prevents heart disease in adulthood. Moreover, the safety and effectiveness of long-term lipid-lowering treatment in children are unknown. Nevertheless, the American Academy of Pediatrics (AAP) recommends treatment for some <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v21454122" data-toggle="tooltip" title="Elevated LDL-C in children" data-id="220b2914-b567-47bc-9a67-a8077a7cbcf7" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">children who have elevated LDL-C</a><span id="220b2914-b567-47bc-9a67-a8077a7cbcf7" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v21454122"> <span class="tooltip-content"> <span class="tooltip-heading"> Elevated LDL-C in children </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Elevated LDL-C in children" loading="lazy"> </span> </a> </span> </span> levels. Children with heterozygous familial hypercholesterolemia should be treated beginning at age 8 to 10 years. Children with homozygous familial hypercholesterolemia require diet, medications, and often LDL apheresis to prevent premature death; treatment is begun when the diagnosis is made.</p></div><span id="v990451" class="anchor"></span><div class="para"> <p>Treatment options depend on the specific lipid abnormality, although different lipid abnormalities often coexist. In some patients, a single abnormality may require several therapies; in others, a single treatment may be adequate for several abnormalities. Treatment should always include treatment of <a href="./{B9A25E4F-9BEA-42DE-8EE8-16E867ADC0B5}.html#v932322" data-toggle="tooltip" title="Treatment" data-id="36269966-a49c-4b79-b8f0-d9b9e8508d13" data-itemid="b9a25e4f-9bea-42de-8ee8-16e867adc0b5">hypertension</a><span id="36269966-a49c-4b79-b8f0-d9b9e8508d13" class="d-none xref"> <span class="tooltip-container"> <a href="./{B9A25E4F-9BEA-42DE-8EE8-16E867ADC0B5}.html#v932322"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment </span> Hypertension is sustained elevation of resting systolic blood pressure (≥ 130 mm Hg), diastolic blood pressure (≥ 80 mm Hg), or both. Hypertension with no known cause (primary; formerly, essential... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/5/1/5/515-left-ventricular-hypertrophy-on-ekg-s108-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment" loading="lazy"> </span> </a> </span> </span> and <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html#v988395" data-toggle="tooltip" title="Treatment" data-id="96a84303-6a05-4c36-846e-39747ce661cd" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">diabetes</a><span id="96a84303-6a05-4c36-846e-39747ce661cd" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html#v988395"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and <a href="./{559556CB-4832-446E-944B-416328EBE12B}.html" data-toggle="tooltip" title="Smoking Cessation" data-id="e71131a4-f77a-4092-99d8-65166b5628ff" data-itemid="559556cb-4832-446e-944b-416328ebe12b">smoking cessation</a><span id="e71131a4-f77a-4092-99d8-65166b5628ff" class="d-none xref"> <span class="tooltip-container"> <a href="./{559556CB-4832-446E-944B-416328EBE12B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Smoking Cessation </span> Most people who smoke want to quit and have tried doing so with limited success. Effective interventions include cessation counseling and pharmacologic treatment, such as varenicline, bupropion... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Treatment should also include daily low-dose <span class="genericDrug" data-showrollover="false">aspirin</span> in patients age 40 to 79 years with a low risk of bleeding and with a 10-year risk of myocardial infarction or death due to CAD of <span class='symbol'>≥</span> 20%. In general, treatment options for men and women are the same.</p></div> <div class="inlinemedia-component " data-ko-rebind="v45392360" data-bind="component: {name: 'inlinemedia-calculator', params: $data}" data-inline-model='{"IframeSrc":"/medical-calculators/CVRiskRevised2018.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"4858d1c4-e027-433d-a284-ebe26a577767","Title":"Cardiovascular Risk Assessment (10-year, Revised Pooled Cohort Equations 2018)","ShareUrlTitle":"cardiovascular-risk-assessment-10-year-revised-pooled-cohort-equations-2018","Description":null,"ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical Calculator","UniqueId":null,"Placement":"sideline","IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}'> </div> </div> </section> <section id="v991023" class="topic__section GHead"> <span></span> <h3 id="Treatment_v990176_v991024" class="topic__header--subsection"> <span id="v991024" class="anchor"></span> Elevated LDL-C treatment </h3> <div class="topic__content"> <span id="v991260" class="anchor"></span><div class="para"> <p>For all individuals, the prevention of ASCVD requires an emphasis on a heart-healthy lifestyle, particularly diet and exercise. Other options to lower LDL-C in all age groups include medications, dietary supplements, and procedural interventions. Many of these options are also effective for treating other lipid abnormalities. </p></div><span id="v21454008" class="anchor"></span><div class="para"> <p><b>Dietary changes</b> help to maintain ideal body weight and provide other benefits. These changes include </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v45392846" class="anchor"></span><div class="para"> <p>Decreasing intake of saturated fats and cholesterol</p></div></li><li class="topic__listitem"><span id="v45392848" class="anchor"></span><div class="para"> <p>Increasing the proportion of dietary fiber and complex carbohydrates</p></div></li></ul></div><span id="v45392851" class="anchor"></span><div class="para"> <p>Referral to a dietitian is often useful. </p></div><span id="v37991962" class="anchor"></span><div class="para"> <p><b>Exercise</b> lowers LDL-C in some people and also helps maintain ideal body weight. </p></div><span id="v37991963" class="anchor"></span><div class="para"> <p>Dietary changes and exercise should be used whenever feasible, but American Heart Association (AHA)/American College of Cardiology (ACC) guidelines recommend also using drug therapy for certain groups of patients after discussion of the risks and benefits of statin therapy (<a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011" data-toggle="tooltip" title="Treatment references" data-id="2554ce9d-0a0f-41d2-8b19-81c14b5640dd" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">1</a><span id="2554ce9d-0a0f-41d2-8b19-81c14b5640dd" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v991026" class="anchor"></span><div class="para"> <p>For <b>drug therapy in adults,</b> the AHA/ACC Guidelines recommend treatment with a statin for 4 groups of patients, comprised of those with any of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v991029" class="anchor"></span><div class="para"> <p>Clinical ASCVD</p></div></li><li class="topic__listitem"><span id="v991031" class="anchor"></span><div class="para"> <p>LDL-C ≥ 190 mg/dL (≥ 4.9 mmol/L)</p></div></li><li class="topic__listitem"><span id="v991033" class="anchor"></span><div class="para"> <p><span class='symbol'>Age 40 to 75 years, with diabetes and LDL-C 70 to 189 mg/dL (1.8 to 4.9 mmol/L)</span></p></div></li><li class="topic__listitem"><span id="v21454011" class="anchor"></span><div class="para"> <p>Age 40 to 75 years, with LDL-C 70 to 189 mg/dL (1.8 to 4.9 mmol/L), and an estimated 10-year risk of ASCVD ≥ 7.5%</p></div></li></ul></div><span id="v21454012" class="anchor"></span><div class="para"> <p><b>Risk of ASCVD</b> is estimated using the pooled cohort risk assessment equations. This risk <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"IframeSrc":"/medical-calculators/CVRiskRevised2018.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"4858d1c4-e027-433d-a284-ebe26a577767","Title":"Cardiovascular%20Risk%20Assessment%20%2810-year%2C%20Revised%20Pooled%20Cohort%20Equations%202018%29","ShareUrlTitle":"cardiovascular-risk-assessment-10-year-revised-pooled-cohort-equations-2018","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical%20Calculator","UniqueId":null,"Placement":null,"IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3Ecalculator%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Clinical%20Calculator","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span> is based on sex, age, race, total and HDL-C, systolic and diastolic blood pressure, diabetes and smoking status, and use of antihypertensives or statins. </p></div><span id="v80953328" class="anchor"></span><div class="para"> <p>Increased lifetime risk (identified using the AHA/ACC risk calculator) is relevant because 10-year risk may be low in younger patients, in whom longer-term risk should be taken into account.</p></div><span id="v80953329" class="anchor"></span><div class="para"> <p>When considering whether to give a statin, clinicians may also take into account other factors, including </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v80953332" class="anchor"></span><div class="para"> <p>LDL-C ≥ 160 mg/dL (4.1 mmol/L)</p></div></li><li class="topic__listitem"><span id="v80953334" class="anchor"></span><div class="para"> <p>Family history of premature ASCVD (ie, age of onset < 55 years in a male first-degree relative, or < 65 years in a female first-degree relative)</p></div></li><li class="topic__listitem"><span id="v80953336" class="anchor"></span><div class="para"> <p>High-sensitivity C-reactive protein ≥ 2 mg/L (≥ 19 nmol/L)</p></div></li><li class="topic__listitem"><span id="v80953338" class="anchor"></span><div class="para"> <p>Coronary artery calcium score ≥ 300 Agatston units (or ≥ 75th percentile for the patient's demographic)</p></div></li><li class="topic__listitem"><span id="v80953340" class="anchor"></span><div class="para"> <p>Ankle-brachial index < 0.9</p></div></li><li class="topic__listitem"><span id="v80953342" class="anchor"></span><div class="para"> <p>Increased lifetime risk</p></div></li></ul></div><span id="v991266" class="anchor"></span><div class="para"> <p><b>Statins</b> are the treatment of choice for LDL-C reduction because evidence has demonstrated that they reduce cardiovascular morbidity and mortality (<a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011" data-toggle="tooltip" title="Treatment references" data-id="f536da66-a9a0-4c13-8ff9-d5f4160fc7fe" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">2</a><span id="f536da66-a9a0-4c13-8ff9-d5f4160fc7fe" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). Other classes of lipid-lowering drugs are not the first choice for treating elevated LDL-C because they have not demonstrated equivalent efficacy for decreasing ASCVD. </p></div><span id="v80953344" class="anchor"></span><div class="para"> <p>Statins inhibit hydroxymethylglutaryl CoA reductase, a key enzyme in cholesterol synthesis, leading to up-regulation of LDL receptors and increased LDL clearance. They reduce LDL-C by up to 60% and produce small increases in HDL-C and modest decreases in TGs. Statins also appear to decrease intra-arterial inflammation, systemic inflammation, or both by stimulating production of endothelial nitric oxide and may have other beneficial effects.</p></div><span id="v45392852" class="anchor"></span><div class="para"> <p>Statin therapy is classified as high-, moderate-, or low-intensity and is given based on treatment group and age (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"25aa7f27-d15c-4405-b26f-e168117d5f61","Title":"Statins%20For%20ASCVD%20Prevention","ShareUrlTitle":"statins-for-ascvd-prevention","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55564932","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EStatins%20for%20ASCVD%20Prevention%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). The choice of statin depends on the patient's co-morbidities, other drugs, risk factors for adverse events, statin intolerance, cost, and patient preference. </p></div><span id="v21454015" class="anchor"></span><div class="para"> <p>Adverse effects with statins are uncommon but include liver enzyme elevations and myositis or <a href="./{3181CE47-B4AB-4B2E-9B9C-7ABDFD245FEB}.html" data-toggle="tooltip" title="Rhabdomyolysis" data-id="b63067b3-250b-48c3-801f-387d78803c9e" data-itemid="3181ce47-b4ab-4b2e-9b9c-7abdfd245feb">rhabdomyolysis</a><span id="b63067b3-250b-48c3-801f-387d78803c9e" class="d-none xref"> <span class="tooltip-container"> <a href="./{3181CE47-B4AB-4B2E-9B9C-7ABDFD245FEB}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Rhabdomyolysis </span> Rhabdomyolysis is a clinical syndrome involving the breakdown of skeletal muscle tissue. Symptoms and signs include muscle weakness, myalgias, and reddish-brown urine, although this triad is... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Liver enzyme elevations are uncommon, and serious liver toxicity is extremely rare. Symptoms or severe adverse effects involving muscle occur in up to 10% of patients taking statins and may be dose-dependent. Muscle symptoms can occur without muscle enzyme (eg, creatine kinase) elevation. Adverse effects are more common among older patients, patients with several disorders, and patients taking several drugs. In some patients, changing from one statin to another or lowering the dose (after temporarily discontinuing the drug) relieves the problem. Muscle toxicity seems to be most common when some of the statins are used with drugs that inhibit cytochrome P3A4 (eg, macrolide antibiotics, azole antifungals, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cyclosporine</span>) and with fibrates, especially <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>gemfibrozil</span>. Statins are contraindicated during pregnancy and lactation.</p></div><span id="v45392855" class="anchor"></span><div class="para"> <p>In patients with ASCVD, risk reduction increases with decreasing LDL-C levels. Thus, initial treatment is a statin at maximally tolerated dose with the goal of lowering LDL-C by > 50% (high-intensity therapy). For very high-risk patients with ASCVD (eg, those with a recent <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html" data-toggle="tooltip" title="Acute Myocardial Infarction (MI)" data-id="c5767cb2-5ff3-43e2-8d79-f9cdc49d6f10" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">myocardial infarction</a><span id="c5767cb2-5ff3-43e2-8d79-f9cdc49d6f10" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Myocardial Infarction (MI) </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Myocardial Infarction (MI)" loading="lazy"> </span> </a> </span> </span> or <a href="./{F5554F32-C171-4894-9A7D-5BC591853560}.html" data-toggle="tooltip" title="Unstable Angina" data-id="7a115ad8-ec4b-443a-8e8d-1bbf5f3ffdcc" data-itemid="f5554f32-c171-4894-9a7d-5bc591853560">unstable angina</a><span id="7a115ad8-ec4b-443a-8e8d-1bbf5f3ffdcc" class="d-none xref"> <span class="tooltip-container"> <a href="./{F5554F32-C171-4894-9A7D-5BC591853560}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Unstable Angina </span> Unstable angina results from acute obstruction of a coronary artery without myocardial infarction. Symptoms include chest discomfort with or without dyspnea, nausea, and diaphoresis. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> or with high-risk comorbidities such as <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html" data-toggle="tooltip" title="Diabetes Mellitus (DM)" data-id="dfa16102-fdc7-4a14-af29-0745f6b791dc" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">diabetes</a><span id="dfa16102-fdc7-4a14-af29-0745f6b791dc" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetes Mellitus (DM) </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>), a LDL-C level > 70 mg/dL (> 1.2 mmol/L) despite maximal statin therapy should prompt the addition of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ezetimibe</span> or a PCSK9 inhibitor (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>evolocumab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alirocumab</span>). These therapies have been proven to reduce major adverse cardiovascular events in conjunction with statin therapy in large clinical outcome trials (<a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011" data-toggle="tooltip" title="Treatment references" data-id="a875dec6-59e7-46ba-b500-245d65af7e86" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">3</a><span id="a875dec6-59e7-46ba-b500-245d65af7e86" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>, <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011" data-toggle="tooltip" title="Treatment references" data-id="44b87409-d214-44fa-8af3-3f02f6353a0c" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">4</a><span id="44b87409-d214-44fa-8af3-3f02f6353a0c" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v80953346" class="anchor"></span><div class="para"> <p><b>Non-statin medications</b> also have a place in lowering LDL-C (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"e9ee36de-b7c3-4624-b0ca-3907bba2fe85","Title":"Non-Statin%20Lipid%E2%80%93Lowering%20Drugs%2A","ShareUrlTitle":"non-statin-lipidlowering-drugs","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v80953053","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ENon-Statin%20Lipid%E2%80%93Lowering%20Drugs%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). The 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies provides guidance to clinicians on the role of non-statin therapy in both primary and secondary prevention of ASCVD (<a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011" data-toggle="tooltip" title="Treatment references" data-id="ee526971-b3b9-414a-814b-4bb328e7fc47" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">5</a><span id="ee526971-b3b9-414a-814b-4bb328e7fc47" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). Statins are generally first-line medications, but in patients with statin intolerance, or those who are not able to achieve target LDL-C levels despite statin use, non-statin medications are used.</p></div> <span id="v55564931"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v21454021"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"25aa7f27-d15c-4405-b26f-e168117d5f61","Title":"Statins%20For%20ASCVD%20Prevention","ShareUrlTitle":"statins-for-ascvd-prevention","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55564932","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Statins%20For%20ASCVD%20Prevention","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="25aa7f27-d15c-4405-b26f-e168117d5f61"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '25aa7f27-d15c-4405-b26f-e168117d5f61' }, async: true, success: function (data) { $('#25aa7f27-d15c-4405-b26f-e168117d5f61').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> <span id="v80953052"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v80953054"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"e9ee36de-b7c3-4624-b0ca-3907bba2fe85","Title":"Non-Statin%20Lipid%E2%80%93Lowering%20Drugs%2A","ShareUrlTitle":"non-statin-lipidlowering-drugs","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v80953053","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Non-Statin%20Lipid%E2%80%93Lowering%20Drugs%2A","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="e9ee36de-b7c3-4624-b0ca-3907bba2fe85"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'e9ee36de-b7c3-4624-b0ca-3907bba2fe85' }, async: true, success: function (data) { $('#e9ee36de-b7c3-4624-b0ca-3907bba2fe85').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v54800687" class="anchor"></span><div class="para"> <p>The <b><span class="genericDrug" data-showrollover="false">adenosine</span> triphosphate citrate lyase inhibitor,</b> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bempedoic acid</span> impairs cholesterol synthesis in the liver and increases LDL receptors. It lowers LDL-C by 15 to 17% (<a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011" data-toggle="tooltip" title="Treatment references" data-id="cc960524-c190-458b-98da-32413a72b8e8" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">6, 7</a><span id="cc960524-c190-458b-98da-32413a72b8e8" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bempedoic acid</span> is especially useful in patients with statin-associated muscle adverse effects because it does not cause muscle pain or weakness. It can be used as monotherapy or as an add-on to other lipid-lowering therapy. Risks include hyperuricemia and tendon rupture.</p></div><span id="v991269" class="anchor"></span><div class="para"> <p><b>Bile acid sequestrants</b> (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cholestyramine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>colestipol</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>colesevelam</span>) block intestinal bile acid reabsorption, forcing up-regulation of hepatic LDL receptors to recruit circulating cholesterol for bile synthesis. They have been shown to reduce cardiovascular mortality. Bile acid sequestrants are usually used with statins or with <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v991306" data-toggle="tooltip" title="Low HDL-C" data-id="1659b703-5a2d-4316-840a-739a9a1d71da" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">nicotinic acid</a><span id="1659b703-5a2d-4316-840a-739a9a1d71da" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v991306"> <span class="tooltip-content"> <span class="tooltip-heading"> Low HDL-C </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Low HDL-C" loading="lazy"> </span> </a> </span> </span> to augment LDL-C reduction. They are the drugs of choice for women who are or are planning to become pregnant. Statins are contraindicated in pregnancy because they maybe teratogenic due to the interruption of cholesterol synthesis, which is essential in fetal development. Bile acid sequestrants are safe, but their use is limited by adverse effects of bloating, nausea, cramping, and constipation. They may also increase TGs, so their use is contraindicated in patients with hypertriglyceridemia. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Cholestyramine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>colestipol</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>colesevelam</span> (but to a lesser degree), interfere with absorption of other drugs—notably thiazides, beta-blockers, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>digoxin</span>, and thyroxine—an effect that can be decreased by administration at least 4 hours before or 1 hour after other drugs. Bile acid sequestrants should be given with meals to increase their efficacy.</p></div><span id="v991275" class="anchor"></span><div class="para"> <p>The <b>cholesterol absorption inhibitor</b> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ezetimibe</span> inhibits intestinal absorption of cholesterol and phytosterol. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ezetimibe</span> usually lowers LDL-C by 15 to 20% and causes small increases in HDL-C and a mild decrease in triglycerides. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ezetimibe</span> can be used as monotherapy in patients intolerant to statins or added to statins for patients taking maximum statin doses with persistent LDL-C elevation. Adverse effects are infrequent.</p></div><span id="v21454120" class="anchor"></span><div class="para"> <p><b>PCSK9 monoclonal antibodies</b> (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alirocumab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>evolocumab</span>) are available as subcutaneous injections given once or twice per month. These drugs keep PCSK9 from attaching to LDL receptors, leading to improved function of these receptors. LDL-C is lowered by 40 to 70%. Cardiovascular outcomes trials with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>evolocumab</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alirocumab</span> showed a decrease in cardiovascular events in patients with prior atherosclerotic cardiovascular disease (<a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011" data-toggle="tooltip" title="Treatment references" data-id="ea5bbd79-fae5-4e27-96ed-e968bbf9f8e9" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">3</a><span id="ea5bbd79-fae5-4e27-96ed-e968bbf9f8e9" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v80953351" class="anchor"></span><div class="para"> <p><b>SiRNA targeting PCSK9 </b>is given as a subcutaneous injection every 6 months. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Inclisiran</span> inhibits PCSK9 production in the liver, thereby prolonging activity of LDL receptors and lowering LDL-C levels. Although LDL-C is lowered, cardiovascular outcome trials with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>inclisiran</span> are ongoing. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Inclisiran</span> can be used as an adjunct to diet and maximally tolerated statin therapy for patients with ASCVD or heterozygous familial hypercholesterolemia.</p></div><span id="v991277" class="anchor"></span><div class="para"> <p><b>Dietary supplements</b> that lower LDL-C levels include fiber supplements and commercially available margarines and other products containing plant sterols (sitosterol, campesterol) or stanols. Fiber supplements decrease cholesterol levels in multiple ways, including decreased absorption and increased excretion. Oat-based fiber supplements can decrease total cholesterol by up to 18%. Plant sterols and stanols decrease cholesterol absorption by displacing cholesterol from intestinal micelles and can reduce LDL-C by up to 10% without affecting HDL-C or TGs.</p></div><span id="v80953352" class="anchor"></span><div class="para"> <p><b>Cholesterylester transfer protein inhibitors </b>are a class of drugs that are under investigation and that may simultaneously raise HDL-C and lower LDL-C. Cholesterylester transfer protein (CETP) is a plasma glycoprotein produced in the liver and adipose tissue that circulates in the blood bound primarily to HDL, which mediates the transfer of cholesteryl esters from HDL to ApoB containing particles.</p></div> <section id="v80953353" class="topic__section HHead"> <h3 class="topic__header--subsection"> <span id="v80953354" class="anchor"></span> Medications for homozygous familial hypercholesterolemia </h3> <div class="topic__content"> <span id="v80953355" class="anchor"></span><div class="para"> <p>Medications for homozygous familial hypercholesterolemia include PCSK9 inhibitors, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>lomitapide</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>evinacumab</span>. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lomitapide</span> is an inhibitor of microsomal triglyceride transfer protein that interferes with the secretion of TG-rich lipoproteins in the liver and intestine. Dose is begun low and gradually titrated up about every 2 weeks. Patients must follow a diet with less than 20% of calories from fat. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lomitapide</span> can cause gastrointestinal adverse effects (eg, diarrhea, increased hepatic fat, elevated liver enzymes). <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Evinacumab</span> is a recombinant human monoclonal antibody that binds to and inhibits angiopoietin-like protein 3, an inhibitor of LPL and endothelial lipase. It can decrease LDL-C (by 47%), TG, and HDL-C. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Evinacumab</span> is given by intravenous infusion once monthly. It can cause gout, influenza-like illness, and infusion reactions.</p></div> </div> </section> <section id="v80953356" class="topic__section HHead"> <h3 class="topic__header--subsection"> <span id="v80953357" class="anchor"></span> Procedural approaches </h3> <div class="topic__content"> <span id="v80953358" class="anchor"></span><div class="para"> <p>Procedural approaches are reserved for patients with severe hyperlipidemia (LDL-C <span class='symbol'>></span> 300 mg/dL [> 7.74 mmol/L]) and no vascular disease. LDL apheresis may be done in patients with LDL-C > 200 mg/dL (> 5.16 mmol/L) and vascular disease that is refractory to conventional therapy, such as occurs with familial hypercholesterolemia. Options include LDL apheresis (in which LDL is removed by extracorporeal plasma exchange) and, rarely, ileal bypass (to block reabsorption of bile acids) and liver transplantation (which transplants LDL receptors). LDL apheresis is the procedure of choice in most instances when maximally tolerated therapy fails to lower LDL-C adequately. Apheresis is also the usual therapy in patients with the homozygous form of familial hypercholesterolemia who have limited or no response to drug therapy.</p></div> </div> </section> </div> </section> <section id="v21454121" class="topic__section GHead"> <span></span> <h3 id="Treatment_v990176_v21454122" class="topic__header--subsection"> <span id="v21454122" class="anchor"></span> Elevated LDL-C in children </h3> <div class="topic__content"> <span id="v21454125" class="anchor"></span><div class="para"> <p>Childhood risk factors besides family history and <a href="./{477D3E24-6B2B-4BC2-8649-F49FE2C8845D}.html" data-toggle="tooltip" title="Diabetes Mellitus in Children and Adolescents" data-id="1855575e-e0ad-4991-8c3a-1843a8d4fc7a" data-itemid="477d3e24-6b2b-4bc2-8649-f49fe2c8845d">diabetes</a><span id="1855575e-e0ad-4991-8c3a-1843a8d4fc7a" class="d-none xref"> <span class="tooltip-container"> <a href="./{477D3E24-6B2B-4BC2-8649-F49FE2C8845D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetes Mellitus in Children and Adolescents </span> Diabetes mellitus involves absence of insulin secretion (type 1) or peripheral insulin resistance (type 2), causing hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> include cigarette smoking, <a href="./{AD4BA0A0-3F58-4599-BE90-43726D1C342F}.html" data-toggle="tooltip" title="Hypertension in Children" data-id="acb5fb85-8cb4-4bb0-9145-666f1918cef0" data-itemid="ad4ba0a0-3f58-4599-be90-43726d1c342f">hypertension</a><span id="acb5fb85-8cb4-4bb0-9145-666f1918cef0" class="d-none xref"> <span class="tooltip-container"> <a href="./{AD4BA0A0-3F58-4599-BE90-43726D1C342F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypertension in Children </span> Hypertension is sustained elevation of resting systolic blood pressure, diastolic blood pressure, or both; the pressures considered abnormal in children vary based on age up to age 13. Hypertension... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, low HDL-C (<span class='symbol'>&lt</span> 35 mg/dL [< 0.9 mmol/L]), obesity, and physical inactivity.</p></div><span id="v21454126" class="anchor"></span><div class="para"> <p>The American Heart Association recommends dietary treatment for children with LDL-C <span class='symbol'>></span> 110 mg/dL (> 2.8 mmol/L) (<a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011" data-toggle="tooltip" title="Treatment references" data-id="897bb573-a7ac-4e9f-8f89-2dcfae236b39" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">8</a><span id="897bb573-a7ac-4e9f-8f89-2dcfae236b39" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v37991999" class="anchor"></span><div class="para"> <p>Drug therapy is recommended for children <span class='symbol'>></span> 8 years and with either of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v21454129" class="anchor"></span><div class="para"> <p>Poor response to dietary therapy, LDL-C <span class='symbol'>≥</span> 190 mg/dL (<span class='symbol'>≥</span> 4.9 mmol/L), and no family history of premature cardiovascular disease</p></div></li><li class="topic__listitem"><span id="v21454131" class="anchor"></span><div class="para"> <p>LDL-C <span class='symbol'>≥</span> 160 mg/dL (<span class='symbol'>≥</span> 4.13 mmol/L) and a family history of premature cardiovascular disease or <span class='symbol'>≥</span> 2 risk factors for premature cardiovascular disease</p></div></li></ul></div><span id="v21454132" class="anchor"></span><div class="para"> <p>Medications used in children include many of the statins. Children with familial hypercholesterolemia may require a second drug to achieve LDL-C reduction of at least 50%.</p></div> </div> </section> <section id="v991284" class="topic__section GHead"> <span></span> <h3 id="Treatment_v990176_v991285" class="topic__header--subsection"> <span id="v991285" class="anchor"></span> Elevated triglycerides </h3> <div class="topic__content"> <span id="v991288" class="anchor"></span><div class="para"> <p>Although it is unclear whether elevated TGs independently contribute to cardiovascular disease, they are associated with multiple metabolic abnormalities that contribute to coronary artery disease (eg, <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html" data-toggle="tooltip" title="Diabetes Mellitus (DM)" data-id="73f232e1-7c1c-49a9-84cb-e4d18a51525a" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">diabetes</a><span id="73f232e1-7c1c-49a9-84cb-e4d18a51525a" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetes Mellitus (DM) </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{AA3B18F4-F664-48AA-B238-17DD381248DF}.html" data-toggle="tooltip" title="Metabolic Syndrome" data-id="8eb1d4ec-5ff8-4fd4-a2fc-dcc684a623dc" data-itemid="aa3b18f4-f664-48aa-b238-17dd381248df">metabolic syndrome</a><span id="8eb1d4ec-5ff8-4fd4-a2fc-dcc684a623dc" class="d-none xref"> <span class="tooltip-container"> <a href="./{AA3B18F4-F664-48AA-B238-17DD381248DF}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Metabolic Syndrome </span> Metabolic syndrome is characterized by a large waist circumference (due to excess abdominal adipose tissue), hypertension, abnormal fasting plasma glucose or insulin resistance, and dyslipidemia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Consensus is emerging that lowering elevated TGs is beneficial. No target goals exist, but levels <span class='symbol'>&lt</span> 150 mg/dL (<span class='symbol'>&lt</span> 1.7 mmol/L) are generally considered desirable. No guidelines specifically address treatment of elevated TGs in children.</p></div><span id="v991290" class="anchor"></span><div class="para"> <p>The <b>overall treatment strategy</b> is to first implement lifestyle changes, including exercise, weight loss, and avoidance of concentrated dietary sugar and alcohol. Intake of 2 to 4 servings/week of marine fish high in omega-3 fatty acids may be effective, but the amount of omega-3 fatty acids is often lower than needed; supplemental doses may be helpful. In patients with diabetes, glucose levels should be tightly controlled. If these measures are ineffective, lipid-lowering drugs should be considered. Patients with very high TG levels (> 1,000 mg/dL [> 11 mmol/L]) may need to begin drug therapy at diagnosis to more quickly reduce the risk of <a href="./{7E47F9C7-92B2-4285-9AB0-BCB4AA41145C}.html" data-toggle="tooltip" title="Acute Pancreatitis" data-id="7b57d61e-114d-4007-9b5b-8617337a7fe4" data-itemid="7e47f9c7-92b2-4285-9ab0-bcb4aa41145c">acute pancreatitis</a><span id="7b57d61e-114d-4007-9b5b-8617337a7fe4" class="d-none xref"> <span class="tooltip-container"> <a href="./{7E47F9C7-92B2-4285-9AB0-BCB4AA41145C}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Pancreatitis </span> Acute pancreatitis is acute inflammation of the pancreas (and, sometimes, adjacent tissues). The most common triggers are gallstones and alcohol intake. The severity of acute pancreatitis is... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/v/p/pv-pancreatits-walled-off-necrosis-arrows-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Pancreatitis" loading="lazy"> </span> </a> </span> </span>.</p></div><span id="v991291" class="anchor"></span><div class="para"> <p><b>Fibrates</b> reduce TGs by about 50%. They appear to stimulate endothelial lipoprotein lipase (LPL), leading to increased fatty acid oxidation in the liver and muscle and decreased hepatic VLDL synthesis. They also increase HDL-C by up to 20%. Fibrates can cause gastrointestinal adverse effects, including dyspepsia, abdominal pain, and elevated liver enzymes. They uncommonly cause <a href="./{D157BECC-0D45-4991-8E8A-3FF369C3BDD2}.html" data-toggle="tooltip" title="Cholelithiasis" data-id="26a91a9a-6d7f-4b66-94b2-056d77bb1226" data-itemid="d157becc-0d45-4991-8e8a-3ff369c3bdd2">cholelithiasis</a><span id="26a91a9a-6d7f-4b66-94b2-056d77bb1226" class="d-none xref"> <span class="tooltip-container"> <a href="./{D157BECC-0D45-4991-8E8A-3FF369C3BDD2}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Cholelithiasis </span> Cholelithiasis is the presence of one or more calculi (gallstones) in the gallbladder. Gallstones tend to be asymptomatic. The most common symptom is biliary colic; gallstones do not cause dyspepsia... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/5/3/6/536-abdominal-imaging-gallstones-s130-springer-arrows-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Cholelithiasis" loading="lazy"> </span> </a> </span> </span>. Fibrates may potentiate muscle toxicity when used with statins and potentiate the effects of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span>.</p></div><span id="v991294" class="anchor"></span><div class="para"> <p><b>Statins</b> can be used in patients with TGs <span class='symbol'>&lt</span> 500 mg/dL (<span class='symbol'>&lt</span> 5.65 mmol/L) if LDL-C elevations are also present; statins may reduce both LDL-C and TGs through reduction of VLDL. If only TGs are elevated, fibrates are the drug of choice.</p></div><span id="v991296" class="anchor"></span><div class="para"> <p><b>Omega-3 fatty acids</b> in high doses (1 to 6 g a day of eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) can be effective in reducing TGs. The omega-3 fatty acids EPA and DHA are the active ingredients in marine <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fish oil</span> or omega-3 capsules. Adverse effects include eructation and diarrhea. These effects may be decreased by giving the <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fish oil</span> capsules with meals in divided doses (eg, twice a day or 3 times a day). Omega-3 fatty acids can be a useful adjunct to other therapies. Prescription omega-3 fatty acid preparations are indicated for TG levels > 500 mg/dL (<span class='symbol'>></span> 5.65 mmol/L).</p></div><span id="v37992000" class="anchor"></span><div class="para"> <p>The <b>Apo CIII inhibitor</b> (an antisense inhibitor of apo CIII), volanesorsen, is available in some countries. It lowers triglyceride levels in patients with severely elevated TG levels, including people with lipoprotein lipase deficiency. It is given as a weekly injection.</p></div> </div> </section> <section id="v991301" class="topic__section GHead"> <span></span> <h3 id="Treatment_v990176_v991302" class="topic__header--subsection"> <span id="v991302" class="anchor"></span> Low HDL-C </h3> <div class="topic__content"> <span id="v991304" class="anchor"></span><div class="para"> <p>Although higher HDL-C levels predict lower cardiovascular risk, it is not clear whether treatments to increase HDL-C levels decrease risk of death. Guidelines in the Third Report of the NCEP Expert Panel define low HDL-C as <span class='symbol'>&lt</span> 40 mg/dL [<span class='symbol'>&lt</span> 1.04 mmol/L]; the guidelines do not specify an HDL-C target level and recommend interventions to raise HDL-C only after LDL-C targets have been reached (<a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011" data-toggle="tooltip" title="Treatment references" data-id="25630378-d0ba-47be-998c-e3ed71563148" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">9</a><span id="25630378-d0ba-47be-998c-e3ed71563148" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v37992011"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). Treatments for LDL-C and TG reduction often increase HDL-C, and the 3 objectives can sometimes be achieved simultaneously. </p></div><span id="v37992002" class="anchor"></span><div class="para"> <p>No guidelines specifically address treatment of low HDL-C in children.</p></div> <a id="v55565201"></a> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--pearlsandpitfalls "> <div class="inlinebox__wrapper" id="v21454135"> <div class="inlinebox__content"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v21454135"></span> <div class="SidebarHalfPage" id="v55565202"> <h3 class="title">Pearls & Pitfalls</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v55565211" class="anchor"></span><div class="para"> <p>Although higher HDL-C levels predict lower cardiovascular risk, it is not clear whether treatments to increase HDL-C levels decrease risk of cardiovascular events or death.</p></div></li></ul></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> <!-- Type: PearlsAndPitfalls --> </div><span id="v991305" class="anchor"></span><div class="para"> <p>Treatment includes <b>lifestyle changes</b> such as an increase in exercise and weight loss. Alcohol raises HDL-C but is not routinely recommended as a therapy because of its many other adverse effects. Drugs may be successful in raising levels when lifestyle changes alone are insufficient, but it is uncertain whether raising HDL-C levels reduces mortality. </p></div><span id="v991306" class="anchor"></span><div class="para"> <p><b>Nicotinic acid (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>niacin</span>)</b> is the most effective drug for increasing HDL-C. Its mechanism of action is unknown, but it appears to both increase HDL-C production and inhibit HDL-C clearance; it may also mobilize cholesterol from macrophages. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Niacin</span> also decreases TGs and, in doses of 1500 to 2000 mg a day, reduces LDL-C. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Niacin</span> causes flushing, pruritus, and nausea; premedication with low-dose <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>aspirin</span> may prevent these adverse effects. Extended-release preparations cause flushing less often. However, most over-the-counter slow-release preparations are not recommended; an exception is polygel controlled-release <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>niacin</span>. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Niacin</span> can cause liver enzyme elevations and occasionally liver failure, <span class="genericDrug" data-showrollover="false">insulin</span> resistance, and hyperuricemia and gout. It may also <a href="./{4AB8034A-CCAB-4E1E-AE47-0377DB2B0278}.html" data-toggle="tooltip" title="Hyperhomocysteinemia" data-id="fab75259-23f6-49e0-a84a-5d4ed14abeba" data-itemid="4ab8034a-ccab-4e1e-ae47-0377db2b0278">increase homocysteine levels</a><span id="fab75259-23f6-49e0-a84a-5d4ed14abeba" class="d-none xref"> <span class="tooltip-container"> <a href="./{4AB8034A-CCAB-4E1E-AE47-0377DB2B0278}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hyperhomocysteinemia </span> Hyperhomocysteinemia may predispose to arterial and venous thrombosis. (See also Overview of Thrombotic Disorders.) Hyperhomocysteinemia may predispose to arterial thrombosis and venous thromboembolism... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. The combination of high doses of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>niacin</span> with statins may increase the risk of myopathy. In patients with average LDL-C and below-average HDL-C levels, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>niacin</span> combined with statin treatment may be effective in preventing cardiovascular disorders. In patients treated with statins to lower LDL-C to < 70 mg/dL (< 1.8 mmol/L), <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>niacin</span> does not appear to have added benefit and may cause increased adverse effects, including <a href="./{BDE969BB-FBF1-4748-95F9-C1ED7B1BB4FA}.html" data-toggle="tooltip" title="Ischemic Stroke" data-id="1cd0f3b3-efff-4f19-a857-8f2e14e91ef8" data-itemid="bde969bb-fbf1-4748-95f9-c1ed7b1bb4fa">ischemic stroke</a><span id="1cd0f3b3-efff-4f19-a857-8f2e14e91ef8" class="d-none xref"> <span class="tooltip-container"> <a href="./{BDE969BB-FBF1-4748-95F9-C1ED7B1BB4FA}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Ischemic Stroke </span> Ischemic stroke is sudden neurologic deficits that result from focal cerebral ischemia associated with permanent brain infarction (eg, positive results on diffusion-weighted MRI). Common causes... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/h/y/p/hypoxic-ischemic-brain-injury-edema-ctisus-modified.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Ischemic Stroke" loading="lazy"> </span> </a> </span> </span>.</p></div><span id="v991309" class="anchor"></span><div class="para"> <p><b>Fibrates</b> increase HDL-C. Fibrates may decrease cardiovascular risk in patients with TGs > 200 mg/dL (> 2.26 mmol/L) and HDL-C < 40 mg/dL (<span class='symbol'>&lt</span> 1.04 mmol/L). </p></div> </div> </section> <section id="v991311" class="topic__section GHead"> <span></span> <h3 id="Treatment_v990176_v991312" class="topic__header--subsection"> <span id="v991312" class="anchor"></span> Elevated Lp(a) </h3> <div class="topic__content"> <span id="v80953365" class="anchor"></span><div class="para"> <p>The usual approach in patients with elevated Lp(a) is to lower LDL-C aggressively. LDL apheresis has been used to lower Lp(a) in patients with high Lp(a) levels and progressive vascular disease. </p></div><span id="v991315" class="anchor"></span><div class="para"> <p>The upper limit of normal for Lp(a) is about 30 mg/dL (75 nmol/L), but values in African Americans tend to be higher. Few data exist to guide the treatment of elevated Lp(a) or to establish treatment efficacy. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Niacin</span> is the only drug that directly decreases Lp(a); it can lower Lp(a) by > 20% at higher doses. There are several RNA-based therapies that lower Lp(a) levels in clinical development. </p></div> </div> </section> <section id="v991316" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="Treatment_v990176_v991317" class="topic__header--subsection"> <span itemprop="name" id="v991317" class="anchor"></span> Treatment in patients with comorbidities </h3> <div class="topic__content"> <span id="v991322" class="anchor"></span><div class="para"> <p>Treatment of diabetic dyslipidemia should always involve lifestyle changes and statins to reduce LDL-C. To decrease the risk of pancreatitis, fibrates can be used to decrease TGs when levels are > 500 mg/dL (<span class='symbol'>></span> 5.65 mmol/L). <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Metformin</span> lowers TGs, which may be a reason to choose it over other oral antihyperglycemic drugs when treating diabetes. Some thiazolidinediones (TZDs) increase both HDL-C and LDL-C. Some TZDs also decrease TGs. These antihyperglycemic drugs should not be chosen over lipid-lowering drugs to treat lipid abnormalities in patients with diabetes but may be useful adjuncts. Patients with very high TG levels and less than optimally controlled diabetes may have a better response to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>insulin</span> than to oral antihyperglycemic drugs.</p></div><span id="v991327" class="anchor"></span><div class="para"> <p>Treatment of dyslipidemia in patients with <a href="./{AED9B0F6-7F08-4F38-8383-CB92A7292346}.html" data-toggle="tooltip" title="Hypothyroidism" data-id="6945a67e-bf56-474c-8680-d1fff54578c0" data-itemid="aed9b0f6-7f08-4f38-8383-cb92a7292346">hypothyroidism</a><span id="6945a67e-bf56-474c-8680-d1fff54578c0" class="d-none xref"> <span class="tooltip-container"> <a href="./{AED9B0F6-7F08-4F38-8383-CB92A7292346}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypothyroidism </span> Hypothyroidism is thyroid hormone deficiency. Symptoms include cold intolerance, fatigue, and weight gain. Signs may include a typical facial appearance, hoarse slow speech, and dry skin. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/y/x/myxedema_in_hypothyroidism_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Hypothyroidism" loading="lazy"> </span> </a> </span> </span>, <a href="./{291C26B0-7C10-48A8-8057-7D2D9EE60EE6}.html" data-toggle="tooltip" title="Chronic Kidney Disease" data-id="ae4253a1-9901-4617-baf3-cd2ecfa7cd3c" data-itemid="291c26b0-7c10-48a8-8057-7d2d9ee60ee6">chronic kidney disease</a><span id="ae4253a1-9901-4617-baf3-cd2ecfa7cd3c" class="d-none xref"> <span class="tooltip-container"> <a href="./{291C26B0-7C10-48A8-8057-7D2D9EE60EE6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chronic Kidney Disease </span> Chronic kidney disease (CKD) is long-standing, progressive deterioration of renal function. Symptoms develop slowly and in advanced stages include anorexia, nausea, vomiting, stomatitis, dysgeusia... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/3/3/633-uremic-frost-springer-high-with-arrow-cropped.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Chronic Kidney Disease" loading="lazy"> </span> </a> </span> </span>, liver disease, or a combination of these disorders involves treating the underlying disorders primarily and lipid abnormalities secondarily. Abnormal lipid levels in patients with low-normal thyroid function (high-normal TSH levels) improve with hormone replacement. Reducing the dosage of or stopping drugs that cause lipid abnormalities should be considered.</p></div> </div> </section> <section id="v991329" class="topic__section GHead"> <span></span> <h3 id="Treatment_v990176_v991330" class="topic__header--subsection"> <span id="v991330" class="anchor"></span> Monitoring treatment </h3> <div class="topic__content"> <span id="v991331" class="anchor"></span><div class="para"> <p>Lipid levels should be monitored periodically after starting treatment. No data support specific monitoring intervals, but measuring lipid levels 2 to 3 months after starting or changing therapies and once or twice yearly after lipid levels are stabilized is common practice.</p></div><span id="v991332" class="anchor"></span><div class="para"> <p>Liver and severe muscle toxicity with statin use occurs in 0.5 to 2% of all users. Routine monitoring of liver enzyme levels is not necessary, and routine measurement of creatine kinase (CK) is not useful to predict the onset of <a href="./{3181CE47-B4AB-4B2E-9B9C-7ABDFD245FEB}.html" data-toggle="tooltip" title="Rhabdomyolysis" data-id="146c170f-e50f-41bc-b42f-588df3f3dab7" data-itemid="3181ce47-b4ab-4b2e-9b9c-7abdfd245feb">rhabdomyolysis</a><span id="146c170f-e50f-41bc-b42f-588df3f3dab7" class="d-none xref"> <span class="tooltip-container"> <a href="./{3181CE47-B4AB-4B2E-9B9C-7ABDFD245FEB}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Rhabdomyolysis </span> Rhabdomyolysis is a clinical syndrome involving the breakdown of skeletal muscle tissue. Symptoms and signs include muscle weakness, myalgias, and reddish-brown urine, although this triad is... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Muscle enzyme levels need not be checked regularly unless patients develop myalgias or other muscle symptoms. If statin-induced muscle damage is suspected, statin use is stopped and CK may be measured. When muscle symptoms subside, a lower dose or a different statin can be tried. If symptoms do not subside within 1 to 2 weeks of stopping the statin, another cause should be sought for the muscle symptoms (eg, <a href="./{BE5DA85E-EFF0-4CF0-88A5-945340C143E8}.html" data-toggle="tooltip" title="Polymyalgia Rheumatica" data-id="e34cefe9-8696-4f35-858d-2708254e8275" data-itemid="be5da85e-eff0-4cf0-88a5-945340c143e8">polymyalgia rheumatica</a><span id="e34cefe9-8696-4f35-858d-2708254e8275" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE5DA85E-EFF0-4CF0-88A5-945340C143E8}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Polymyalgia Rheumatica </span> Polymyalgia rheumatica is a syndrome closely associated with giant cell arteritis (temporal arteritis). It affects adults > 55. It typically causes severe pain and stiffness in proximal muscles... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div> </div> </section> <section id="v37992010" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="Treatment_v990176_v37992011" class="topic__header--subsection"> <span itemprop="name" id="v37992011" class="anchor"></span> Treatment references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v45392877" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625">Grundy SM, Stone NJ, Bailey AL, et al</a>: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. <i>Circulation</i> 139: e1082–e1143, 2019. doi: 10.1161/CIR.0000000000000625</p></div></li><li class="topic__listitem"><span id="v80953368" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35997723/">US Preventive Services Task Force, Mangione CM, Barry MJ, et al</a>: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. <i>JAMA</i> 328(8):746-753, 2022. doi:10.1001/jama.2022.13044</p></div></li><li class="topic__listitem"><span id="v37992018" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/28304224">Sabatine MS, Giugliano RP, Keech AC, et al</a>: <span class="genericDrug" data-showrollover="false">Evolocumab</span> and clinical outcomes in patients with cardiovascular disease. <i>N Engl J Med</i> 376:1713–1722, 2017. 15</p></div></li><li class="topic__listitem"><span id="v45392881" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/30403574">Schwartz GG, Steg PG, Szarek M, et al</a>: <span class="genericDrug" data-showrollover="false">Alirocumab</span> and cardiovascular outcomes after acute coronary syndrome. <i>New Engl J Med</i> 379:2097–2107, 2018. doi: 10.1056/NEJMoa1801174.</p></div></li><li class="topic__listitem"><span id="v80953373" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/36031461/">Writing Committee, Lloyd-Jones DM, Morris PB, et al</a>:. 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee [published correction appears in <i>J Am Coll Cardiol</i> 2023 Jan 3;81(1):104]. <i>J Am Coll Cardiol</i> 80(14):1366-1418, 2022. doi:10.1016/j.jacc.2022.07.006</p></div></li><li class="topic__listitem"><span id="v80953376" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31714986/">Goldberg AC, Leiter LA, Stroes ESG, et al</a>. Effect of <span class="genericDrug" data-showrollover="false">Bempedoic Acid</span> vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial [published correction appears in JAMA. 2020 Jan 21;323(3):282]. <i>JAMA</i> 2019;322(18):1780-1788. doi:10.1001/jama.2019.16585</p></div></li><li class="topic__listitem"><span id="v80953380" class="anchor"></span><div class="para"> <p>7. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/30865796/">Ray KK, Bays HE, Catapano AL, et al</a>. Safety and Efficacy of <span class="genericDrug" data-showrollover="false">Bempedoic Acid</span> to Reduce LDL Cholesterol. <i>N Engl J Med</i> 2019;380(11):1022-1032. doi:10.1056/NEJMoa1803917</p></div></li><li class="topic__listitem"><span id="v80953384" class="anchor"></span><div class="para"> <p>8. <a rel="nofollow" target="_blank" href="https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000618">de Ferranti SD, Steinberger J, Ameduri R, et al</a>: Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association. <i>Circulation</i> 139(13):e603-e634, 2019. doi:10.1161/CIR.0000000000000618</p></div></li><li class="topic__listitem"><span id="v80953387" class="anchor"></span><div class="para"> <p>9. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/12485966/">National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)</a>: Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. <i>Circulation</i> 106(25):3143-3421, 2002.</p></div></li></ul></div> </div> </section> </div> </section> <section id="v9009046" class="topic__section topic__section--keypoints FHead"> <h2 id="KeyPoints_v9009047" class="topic__header--section"> <span id="v9009047" class="anchor"></span> Key Points <span class="topic__keypoints--icon"></span> </h2> <div class="topic__content--keypoints"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v9009050" class="anchor"></span><div class="para"> <p>Elevated lipid levels are a risk factor for atherosclerosis and thus can lead to symptomatic coronary artery disease and peripheral arterial disease.</p></div></li><li class="topic__listitem"><span id="v9009052" class="anchor"></span><div class="para"> <p>Causes of dyslipidemia include a sedentary lifestyle with excessive dietary intake of calories, saturated fat, cholesterol, and trans fats and/or genetic (familial) abnormalities of lipid metabolism.</p></div></li><li class="topic__listitem"><span id="v9009054" class="anchor"></span><div class="para"> <p>Diagnose using serum lipid profile (measured total cholesterol, triglycerides, and high-density lipoprotein [HDL] cholesterol and calculated low-density lipoprotein [LDL] cholesterol and very low-density lipoprotein [VLDL] cholesterol).</p></div></li><li class="topic__listitem"><span id="v9009056" class="anchor"></span><div class="para"> <p>Screening tests should be done at age 9 to 11 years and again at age 17 to 21 years (age 2 to 8 if there is a strong family history of severe hyperlipidemia or premature coronary artery disease or other risk factors); adults are screened every 5 years beginning at age 20.</p></div></li><li class="topic__listitem"><span id="v9009058" class="anchor"></span><div class="para"> <p>Treatment with a statin is indicated to reduce risk of atherosclerotic cardiovascular disease for all patients in 4 major risk groups as defined by the American College of Cardiology/American Heart Association and for those without who have certain other combinations of risk factors and elevated lipid levels.</p></div></li><li class="topic__listitem"><span id="v21454145" class="anchor"></span><div class="para"> <p>Optimize adherence, lifestyle changes, and statin usage before adding a non-statin drug; if a patient has an LDL-C level > 70 mg/dL (> 1.8 mmol/L) with high risk atherosclerotic cardiovascular disease, adding <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ezetimibe</span> or PSCK9 inhibitor is reasonable.</p></div></li><li class="topic__listitem"><span id="v9009060" class="anchor"></span><div class="para"> <p>Other treatment depends on the specific lipid abnormality but should always include lifestyle changes, treatment of hypertension and diabetes, smoking cessation, and in some patients with increased risk of myocardial infarction or death due to coronary artery disease, daily low-dose <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>aspirin</span>.</p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="272.4;272.0;272.1;272.2;272.3">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '272.4;272.0;272.1;272.2;272.3',
 title: 'Dyslipidemia',
 itemGuid: '47789936-4b59-4aec-9810-c84b2beaeb1b'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{B0CE355F-3128-4E55-9D50-B5509467809F}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Overview of Lipid Metabolism</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{274069A0-1251-4943-A548-DC12C2DF7A33}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Elevated High-Density Lipoprotein Cholesterol (HDL-C) Levels</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="8797690b-e0ee-4de4-b8db-afedbc6fc8e4_mobile" usemap="#8797690b-e0ee-4de4-b8db-afedbc6fc8e4_mobile" width="326" height="90">
 <map name="8797690b-e0ee-4de4-b8db-afedbc6fc8e4_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="8797690b-e0ee-4de4-b8db-afedbc6fc8e4_tablet" usemap="#8797690b-e0ee-4de4-b8db-afedbc6fc8e4_tablet" width="326" height="90">
 <map name="8797690b-e0ee-4de4-b8db-afedbc6fc8e4_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="8797690b-e0ee-4de4-b8db-afedbc6fc8e4_desktop" usemap="#8797690b-e0ee-4de4-b8db-afedbc6fc8e4_desktop" width="326" height="90">
 <map name="8797690b-e0ee-4de4-b8db-afedbc6fc8e4_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd03
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="477899364B594AEC9810C84B2BEAEB1B">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v80952898'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v80952899"></span> <div class="TableFullPage" id="v80952898"> <h3 class="title">Cholesterol Levels and Cardiovascular Risk</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v80952908" class="anchor"></span><div class="para"> <p>Cardiovascular Risk</p></div></th><th style='text-align:left' scope='col'><span id="v80952910" class="anchor"></span><div class="para"> <p>Total Cholesterol</p></div></th><th style='text-align:left' scope='col'><span id="v80952912" class="anchor"></span><div class="para"> <p>LDL-C</p></div></th><th style='text-align:left' scope='col'><span id="v80952914" class="anchor"></span><div class="para"> <p>HDL-C</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v80952929" class="anchor"></span><div class="para"> <p>Higher risk</p></div></td><td><span id="v80952931" class="anchor"></span><div class="para"> <p>≥ 6.2 mmol/L (240 mg/dL)</p></div></td><td><span id="v80952933" class="anchor"></span><div class="para"> <p>≥ 4.1 mmol/L (160 mg/dL)</p></div></td><td><span id="v80952935" class="anchor"></span><div class="para"> <p>Male: < 1.0 mmol/l (40></p></div><span id="v80952936" class="anchor"></span><div class="para"> <p>Female: < 1.3 mmol/l (50></p></div></td></tr><tr class="even"><td><span id="v80952939" class="anchor"></span><div class="para"> <p>At- risk</p></div></td><td><span id="v80952941" class="anchor"></span><div class="para"> <p>5.2-6.2 mmol/L (200-239 mg/dL)</p></div></td><td><span id="v80952943" class="anchor"></span><div class="para"> <p>2.6-4.1 mmol/L (100-159 mg/dL)</p></div></td><td><span id="v80952945" class="anchor"></span><div class="para"> <p>Male: 1.0-1.5 mmol/L (40-59 mg/dL)</p></div><span id="v80952946" class="anchor"></span><div class="para"> <p>Female: 1.3-1.5 mmol/L (50-59 mg/dL)</p></div></td></tr><tr class="odd"><td><span id="v80952949" class="anchor"></span><div class="para"> <p>Lower risk</p></div></td><td><span id="v80952951" class="anchor"></span><div class="para"> <p>< 5.2 mmol/l (200></p></div></td><td><span id="v80952953" class="anchor"></span><div class="para"> <p>< 2.6 mmol/l (100></p></div></td><td><span id="v80952955" class="anchor"></span><div class="para"> <p>≥ 1.6 mmol/L (60 mg/dL )</p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v80952918" class="anchor"></span><div class="para"> <p>HDL <span class='symbol'>=</span> high-density lipoprotein; LDL <span class='symbol'>=</span> low-density lipoprotein.</p></div></td></tr><tr><td colspan="4"><span id="v80952921" class="anchor"></span><div class="para"> <p>Data from <a rel="nofollow" target="_blank" href="https://www.sciencedirect.com/science/article/abs/pii/B9780128012383653333">Carmena R</a>: Primary Mixed Dyslipidemias, Editor(s): Ilpo Huhtaniemi, Luciano Martini, Encyclopedia of Endocrine Diseases (Second Edition), Academic Press, 2019, Pages 314-319, ISBN 9780128122006, https://doi.org/10.1016/B978-0-12-801238-3.65333-3, <a rel="nofollow" target="_blank" href="https://www.nhlbi.nih.gov/health-topics/high-blood-cholesterol">National Heart Lung and Blood Institute</a>: What is Blood Cholesterol? Updated March 24, 2022, https://www.nhlbi.nih.gov/health-topics/high-blood-cholesterol; <a rel="nofollow" target="_blank" href="https://www.heart.org/en/health-topics/cholesterol">American Heart Association</a>: Cholesterol, https://www.heart.org/en/health-topics/cholesterol; <a rel="nofollow" target="_blank" href="https://www.cdc.gov/cholesterol">Centers for Disease Control and Prevention</a>: Cholesterol. Reviewed March 20, 2023, https://www.cdc.gov/cholesterol.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v55564567'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v45392470"></span> <div class="TableFullPage" id="v55564567"> <h3 class="title">Genetic (Primary) Dyslipidemias</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564580" class="anchor"></span><div class="para"> <p>Disorder</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564583" class="anchor"></span><div class="para"> <p>Genetic Defect/Mechanism</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564586" class="anchor"></span><div class="para"> <p>Inheritance</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564589" class="anchor"></span><div class="para"> <p>Prevalence</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564592" class="anchor"></span><div class="para"> <p>Clinical Features</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564595" class="anchor"></span><div class="para"> <p>Treatment</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v55564603" class="anchor"></span><div class="para"> <p>Apo C-II deficiency [a]</p></div></td><td><span id="v55564605" class="anchor"></span><div class="para"> <p>Apo C-II (causing functional LPL deficiency)</p></div></td><td><span id="v55564607" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564609" class="anchor"></span><div class="para"> <p><span class='symbol'><></span> 1/1 million</p></div></td><td><span id="v55564611" class="anchor"></span><div class="para"> <p>Pancreatitis (in some adults), metabolic syndrome (often present)</p></div><span id="v55564612" class="anchor"></span><div class="para"> <p>TG: <span class='symbol'>></span> 750 mg/dL (<span class='symbol'>></span> 8.5 mmol/L)</p></div></td><td><span id="v55564614" class="anchor"></span><div class="para"> <p>Diet: Severe fat restriction with fat-soluble vitamin supplementation and medium-chain TG supplementation</p></div></td></tr><tr class="even"><td><span id="v55564617" class="anchor"></span><div class="para"> <p>Cerebrotendinous xanthomatosis [b]</p></div></td><td><span id="v55564619" class="anchor"></span><div class="para"> <p>Hepatic mitochondrial 27-hydroxylase defect</p></div><span id="v55564620" class="anchor"></span><div class="para"> <p>Blockage of bile acid synthesis and conversion of cholesterol to cholestanol, which accumulates</p></div></td><td><span id="v55564622" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564624" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v55564626" class="anchor"></span><div class="para"> <p>Cataracts, premature CAD, neuropathy, ataxia</p></div></td><td><span id="v55564628" class="anchor"></span><div class="para"> <p>Chenodeoxycholic acid</p></div></td></tr><tr class="odd"><td><span id="v55564631" class="anchor"></span><div class="para"> <p> <a href="./{A47AB568-C9DF-449C-AB9B-745B0082030B}.html" data-toggle="tooltip" title="Cholesteryl Ester Storage Disease and Wolman Disease" data-id="7c99e13f-2914-4265-9304-e417f857f6c0" data-itemid="a47ab568-c9df-449c-ab9b-745b0082030b">Cholesteryl ester storage disease</a><span id="7c99e13f-2914-4265-9304-e417f857f6c0" class="d-none xref"> <span class="tooltip-container"> <a href="./{A47AB568-C9DF-449C-AB9B-745B0082030B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Cholesteryl Ester Storage Disease and Wolman Disease </span> Cholesteryl ester storage disease and Wolman disease are sphingolipidoses, an inherited disorder of metabolism, caused by lysosomal acid lipase deficiency resulting in hyperlipidemia and hepatomegaly... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and <a href="./{A47AB568-C9DF-449C-AB9B-745B0082030B}.html" data-toggle="tooltip" title="Cholesteryl Ester Storage Disease and Wolman Disease" data-id="4188af43-fc95-4200-8d53-173362bd16ee" data-itemid="a47ab568-c9df-449c-ab9b-745b0082030b">Wolman disease</a><span id="4188af43-fc95-4200-8d53-173362bd16ee" class="d-none xref"> <span class="tooltip-container"> <a href="./{A47AB568-C9DF-449C-AB9B-745B0082030B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Cholesteryl Ester Storage Disease and Wolman Disease </span> Cholesteryl ester storage disease and Wolman disease are sphingolipidoses, an inherited disorder of metabolism, caused by lysosomal acid lipase deficiency resulting in hyperlipidemia and hepatomegaly... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> [c]</p></div></td><td><span id="v55564635" class="anchor"></span><div class="para"> <p>Lysosomal acid lipase deficiency</p></div></td><td><span id="v55564637" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564639" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v55564641" class="anchor"></span><div class="para"> <p>Premature CAD</p></div><span id="v55564642" class="anchor"></span><div class="para"> <p>Accumulation of cholesteryl esters and TG in lysosomes in the liver, spleen, and lymph nodes</p></div><span id="v55564643" class="anchor"></span><div class="para"> <p>Cirrhosis</p></div></td><td><span id="v55564645" class="anchor"></span><div class="para"> <p>Possibly statins</p></div><span id="v55564646" class="anchor"></span><div class="para"> <p>Enzyme replacement </p></div></td></tr><tr class="even"><td><span id="v55564649" class="anchor"></span><div class="para"> <p>Familial apo AI deficiency/mutations [d]</p></div></td><td><span id="v55564651" class="anchor"></span><div class="para"> <p>Apo AI</p></div></td><td><span id="v55564653" class="anchor"></span><div class="para"> <p>Unknown</p></div></td><td><span id="v55564655" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v55564657" class="anchor"></span><div class="para"> <p>Corneal opacities, xanthomas, premature CAD (in some people)</p></div><span id="v55564658" class="anchor"></span><div class="para"> <p>HDL: 15–30 mg/dL (0.39–0.78 mmol/L)</p></div></td><td><span id="v55564660" class="anchor"></span><div class="para"> <p>Nonspecific</p></div></td></tr><tr class="odd"><td><span id="v55564663" class="anchor"></span><div class="para"> <p>Familial combined hyperlipidemia [e]</p></div></td><td><span id="v55564665" class="anchor"></span><div class="para"> <p>Unknown, possibly multiple defects and mechanisms</p></div></td><td><span id="v55564667" class="anchor"></span><div class="para"> <p>Dominant</p></div></td><td><span id="v55564669" class="anchor"></span><div class="para"> <p>1/50 to 1/100</p></div></td><td><span id="v55564671" class="anchor"></span><div class="para"> <p>Premature CAD, responsible for about 15% of MIs in people <span class='symbol'><></span> 60 years</p></div><span id="v55564672" class="anchor"></span><div class="para"> <p> Apo B: Disproportionately elevated</p></div><span id="v55564673" class="anchor"></span><div class="para"> <p>TC: 250–500 mg/dL (6.5–13.0 mmol/L)</p></div><span id="v55564674" class="anchor"></span><div class="para"> <p>TG: 250–750 mg/dL (2.8–8.5 mmol/L)</p></div></td><td><span id="v55564676" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564677" class="anchor"></span><div class="para"> <p>Weight loss</p></div><span id="v55564678" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div></td></tr><tr class="even"><td><span id="v55564681" class="anchor"></span><div class="para"> <p>Familial defective apo B-100 [f]</p></div></td><td><span id="v55564683" class="anchor"></span><div class="para"> <p>Apo B (LDL receptor–binding region defect)</p></div><span id="v55564684" class="anchor"></span><div class="para"> <p>Diminished LDL clearance</p></div></td><td><span id="v55564686" class="anchor"></span><div class="para"> <p>Dominant</p></div></td><td><span id="v55564688" class="anchor"></span><div class="para"> <p>1/700</p></div></td><td><span id="v55564690" class="anchor"></span><div class="para"> <p>Xanthomas, arcus corneae, premature CAD</p></div><span id="v55564691" class="anchor"></span><div class="para"> <p>TC: 250–500 mg/dL (6.5–13 mmol/L)</p></div></td><td><span id="v55564693" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564694" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div></td></tr><tr class="odd"><td><span id="v55564697" class="anchor"></span><div class="para"> <p>Familial dysbetalipoproteinemia [g]</p></div></td><td><span id="v55564699" class="anchor"></span><div class="para"> <p>Apo E (usually e2/e2 homozygotes)</p></div><span id="v55564700" class="anchor"></span><div class="para"> <p>Diminished chylomicron and VLDL clearance</p></div></td><td><span id="v55564702" class="anchor"></span><div class="para"> <p>Recessive (more common) or dominant (less common)</p></div></td><td><span id="v55564704" class="anchor"></span><div class="para"> <p>1/5000</p></div><span id="v55564705" class="anchor"></span><div class="para"> <p></div></td><td><span id="v55564707" class="anchor"></span><div class="para"> <p>Xanthomas (especially tuberous and palmar), yellow palmar creases, premature CAD</p></div><span id="v55564708" class="anchor"></span><div class="para"> <p>TC: 250–500 mg/dL (6.5–13.0 mmol/L)</p></div><span id="v55564709" class="anchor"></span><div class="para"> <p>TG: 250–500 mg/dL (2.8–5.6 mmol/L)</p></div></td><td><span id="v55564711" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564712" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div></td></tr><tr class="even"><td><span id="v55564715" class="anchor"></span><div class="para"> <p>Familial HDL deficiency </p></div></td><td><span id="v55564717" class="anchor"></span><div class="para"> <p><i>ABCA1</i> gene</p></div></td><td><span id="v55564720" class="anchor"></span><div class="para"> <p>Dominant</p></div></td><td><span id="v55564722" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v55564724" class="anchor"></span><div class="para"> <p>Premature CAD</p></div></td><td><span id="v55564726" class="anchor"></span><div class="para"> <p>Low-fat diet</p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v55564729" class="anchor"></span><div class="para"> <p>Familial hypercholesterolemia [h]</p></div></td><td rowspan="2"><span id="v55564731" class="anchor"></span><div class="para"> <p>LDL receptor defect</p></div><span id="v55564732" class="anchor"></span><div class="para"> <p>Diminished LDL clearance</p></div></td><td rowspan="2"><span id="v55564734" class="anchor"></span><div class="para"> <p>Codominant</p></div></td><td><span id="v55564736" class="anchor"></span><div class="para"> <p>—</p></div></td><td><span id="v55564738" class="anchor"></span><div class="para"> <p>—</p></div></td><td rowspan="2"><span id="v55564740" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564741" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div><span id="v55564742" class="anchor"></span><div class="para"> <p>LDL apheresis (for homozygotes and heterozygotes with severe disease)</p></div><span id="v55564743" class="anchor"></span><div class="para"> <p>Liver transplantation (for homozygotes)</p></div></td></tr><tr class="even"><td><span id="v55564746" class="anchor"></span><div class="para"> <p>Heterozygotes: 1/200</p></div></td><td><span id="v55564748" class="anchor"></span><div class="para"> <p>Tendon xanthomas, arcus corneae, premature CAD (ages 30–50), responsible for about 5% of MIs in people <span class='symbol'><></span> 60 years</p></div><span id="v55564749" class="anchor"></span><div class="para"> <p>TC: 250–500 mg/dL (6.5–13 mmol/L)</p></div></td></tr><tr class="odd"><td><span id="v55564752" class="anchor"></span><div class="para"> <p></div></td><td><span id="v55564754" class="anchor"></span><div class="para"> <p></div></td><td><span id="v55564756" class="anchor"></span><div class="para"> <p></div></td><td><span id="v55564758" class="anchor"></span><div class="para"> <p>Homozygotes: 1/250,000–1/1 million (increased among French Canadian, Christian Lebanese, and South African populations)</p></div></td><td><span id="v55564760" class="anchor"></span><div class="para"> <p>Planar and tendon xanthomas and tuberous xanthomas, premature CAD (before age 18)</p></div><span id="v55564761" class="anchor"></span><div class="para"> <p>TC <span class='symbol'>></span> 500 mg/dL (<span class='symbol'>></span> 13 mmol/L)</p></div></td><td><span id="v55564763" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v55564766" class="anchor"></span><div class="para"> <p>Familial hypertriglyceridemia [g]</p></div></td><td><span id="v55564768" class="anchor"></span><div class="para"> <p>Unknown, possibly multiple defects and mechanisms</p></div></td><td><span id="v55564771" class="anchor"></span><div class="para"> <p>Dominant</p></div></td><td><span id="v55564773" class="anchor"></span><div class="para"> <p>1/500</p></div></td><td><span id="v55564775" class="anchor"></span><div class="para"> <p>Usually no symptoms or findings; occasionally hyperuricemia, sometimes early atherosclerosis</p></div><span id="v55564776" class="anchor"></span><div class="para"> <p>TG: 200–500 mg/dL (2.3–5.6 mmol/L), possibly higher depending on diet and alcohol use</p></div></td><td><span id="v55564778" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564779" class="anchor"></span><div class="para"> <p>Weight loss</p></div><span id="v55564780" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div></td></tr><tr class="odd"><td><span id="v55564783" class="anchor"></span><div class="para"> <p>Familial LCAT deficiency [i]</p></div></td><td><span id="v55564785" class="anchor"></span><div class="para"> <p><i>LCAT</i> gene</p></div></td><td><span id="v55564788" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564790" class="anchor"></span><div class="para"> <p>Extremely rare</p></div></td><td><span id="v55564792" class="anchor"></span><div class="para"> <p>Corneal opacities, anemia, chronic kidney disease</p></div><span id="v55564793" class="anchor"></span><div class="para"> <p>HDL: <span class='symbol'><></span> 10 mg/dL (< 0.26="" mmol/l)=""></p></div></td><td><span id="v55564795" class="anchor"></span><div class="para"> <p>Fat restriction</p></div><span id="v55564796" class="anchor"></span><div class="para"> <p>Renal transplantation</p></div></td></tr><tr class="even"><td><span id="v55564799" class="anchor"></span><div class="para"> <p>Fisheye disease (partial LCAT deficiency)</p></div></td><td><span id="v55564801" class="anchor"></span><div class="para"> <p><i>LCAT</i> gene</p></div></td><td><span id="v55564804" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564806" class="anchor"></span><div class="para"> <p>Extremely rare</p></div></td><td><span id="v55564808" class="anchor"></span><div class="para"> <p>Corneal opacities</p></div><span id="v55564809" class="anchor"></span><div class="para"> <p>HDL: <span class='symbol'><></span> 10 mg/dL (< 0.26=""></p></div></td><td><span id="v55564811" class="anchor"></span><div class="para"> <p>Nonspecific</p></div></td></tr><tr class="odd"><td><span id="v55564814" class="anchor"></span><div class="para"> <p>Hepatic lipase deficiency</p></div></td><td><span id="v55564816" class="anchor"></span><div class="para"> <p>Hepatic lipase</p></div></td><td><span id="v55564818" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564820" class="anchor"></span><div class="para"> <p>Extremely rare</p></div></td><td><span id="v55564822" class="anchor"></span><div class="para"> <p>Premature CAD</p></div><span id="v55564823" class="anchor"></span><div class="para"> <p>TC: 250–1500 mg/dL (6.5–39 mmol/L)</p></div><span id="v55564824" class="anchor"></span><div class="para"> <p>TG: 395–8200 mg/dL (4.5–93 mmol/L)</p></div><span id="v55564825" class="anchor"></span><div class="para"> <p>HDL: Variable</p></div></td><td><span id="v55564827" class="anchor"></span><div class="para"> <p>Empiric: Diet, lipid-lowering drugs</p></div></td></tr><tr class="even"><td><span id="v55564830" class="anchor"></span><div class="para"> <p>LPL deficiency [j]</p></div></td><td><span id="v55564832" class="anchor"></span><div class="para"> <p>Endothelial LPL defect</p></div><span id="v55564833" class="anchor"></span><div class="para"> <p>Diminished chylomicron clearance</p></div></td><td><span id="v55564835" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564837" class="anchor"></span><div class="para"> <p>Rare but present worldwide</p></div></td><td><span id="v55564839" class="anchor"></span><div class="para"> <p>Failure to thrive (in infants), eruptive xanthomas, hepatosplenomegaly, pancreatitis</p></div><span id="v55564840" class="anchor"></span><div class="para"> <p>TG: <span class='symbol'>></span> 750 mg/dL (<span class='symbol'>></span> 8.5 mmol/L)</p></div></td><td><span id="v55564842" class="anchor"></span><div class="para"> <p>Diet: Severe fat restriction with fat-soluble vitamin supplementation and medium-chain TG supplementation</p></div><span id="v55564843" class="anchor"></span><div class="para"> <p>Gene therapy (approved in European Union)</p></div></td></tr><tr class="odd"><td><span id="v55564846" class="anchor"></span><div class="para"> <p>PCSK9 gain of function mutations</p></div></td><td><span id="v55564848" class="anchor"></span><div class="para"> <p>Increased degradation of LDL receptors</p></div></td><td><span id="v55564850" class="anchor"></span><div class="para"> <p>Dominant</p></div></td><td><span id="v55564852" class="anchor"></span><div class="para"> <p>Unknown</p></div></td><td><span id="v55564854" class="anchor"></span><div class="para"> <p>Similar to familial hypercholesterolemia</p></div></td><td><span id="v55564856" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564857" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div></td></tr><tr class="even"><td><span id="v55564860" class="anchor"></span><div class="para"> <p>Polygenic hypercholesterolemia</p></div></td><td><span id="v55564862" class="anchor"></span><div class="para"> <p>Unknown, possibly multiple defects and mechanisms</p></div></td><td><span id="v55564864" class="anchor"></span><div class="para"> <p>Variable</p></div></td><td><span id="v55564866" class="anchor"></span><div class="para"> <p>Common</p></div></td><td><span id="v55564868" class="anchor"></span><div class="para"> <p>Premature CAD</p></div><span id="v55564869" class="anchor"></span><div class="para"> <p>TC: 250–350 mg/dL (6.5–9.0 mmol/L)</p></div></td><td><span id="v55564871" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564872" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div></td></tr><tr class="odd"><td><span id="v55564875" class="anchor"></span><div class="para"> <p>Primary hypoalphalipoproteinemia (familial or nonfamilial)</p></div></td><td><span id="v55564877" class="anchor"></span><div class="para"> <p>Unknown, possibly apo A-I, C-III, or A-IV</p></div></td><td><span id="v55564879" class="anchor"></span><div class="para"> <p>Dominant</p></div></td><td><span id="v55564881" class="anchor"></span><div class="para"> <p>About 5%</p></div></td><td><span id="v55564883" class="anchor"></span><div class="para"> <p>Premature CAD</p></div><span id="v55564884" class="anchor"></span><div class="para"> <p>HDL: 15–35 mg/dL (0.39–0.91 mmol/L)</p></div></td><td><span id="v55564886" class="anchor"></span><div class="para"> <p>Exercise</p></div><span id="v55564887" class="anchor"></span><div class="para"> <p>LDL-lowering drugs</p></div></td></tr><tr class="even"><td><span id="v55564890" class="anchor"></span><div class="para"> <p>Sitosterolemia</p></div></td><td><span id="v55564892" class="anchor"></span><div class="para"> <p><i>ABCG5</i> and <i>ABCG8</i> genes </p></div></td><td><span id="v55564896" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564898" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v55564900" class="anchor"></span><div class="para"> <p>Tendon xanthomas, premature CAD</p></div></td><td><span id="v55564902" class="anchor"></span><div class="para"> <p>Fat restriction</p></div><span id="v55564903" class="anchor"></span><div class="para"> <p>Bile acid sequestrants</p></div><span id="v55564904" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ezetimibe</span></p></div></td></tr><tr class="odd"><td><span id="v55564907" class="anchor"></span><div class="para"> <p>Tangier disease</p></div></td><td><span id="v55564909" class="anchor"></span><div class="para"> <p><i>ABCA1</i> gene</p></div></td><td><span id="v55564912" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564914" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v55564916" class="anchor"></span><div class="para"> <p>Premature CAD (in some people), peripheral neuropathy, hemolytic anemia, corneal opacities, hepatosplenomegaly, orange tonsils</p></div><span id="v55564917" class="anchor"></span><div class="para"> <p>HDL: <span class='symbol'><></span>5 mg/dL (< 0.13="" mmol/l)=""></p></div></td><td><span id="v55564919" class="anchor"></span><div class="para"> <p>Low-fat diet</p></div></td></tr></tbody> <tfoot><tr><td colspan="6"><span id="x000188" class="anchor"></span><div class="para"> <p>[a] Prevalence data from <a rel="nofollow" target="_blank" href="https://link.springer.com/referenceworkentry/10.1007/978-3-540-29676-8_137">Hoffmann, M.M., März, W</a>. (2009). Apo C-II Deficiency. In: Lang, F. (eds) <i>Encyclopedia of Molecular Mechanisms of Disease.</i> Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-29676-8_137</p></div></td></tr><tr><td colspan="6"><span id="x000192" class="anchor"></span><div class="para"> <p>[b] Prevalece data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/25424010/">Nie S, Chen G, Cao X, Zhang Y</a>. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. <i>Orphanet J Rare Dis</i> 2014;9:179. Published 2014 Nov 26. doi:10.1186/s13023-014-0179-4</p></div></td></tr><tr><td colspan="6"><span id="x000193" class="anchor"></span><div class="para"> <p>[c] Prevalence data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/28786388/">Pericleous M, Kelly C, Wang T, Livingstone C, Ala A</a>. Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol Hepatol. 2017;2(9):670-679. doi:10.1016/S2468-1253(17)30052-3</p></div></td></tr><tr><td colspan="6"><span id="x000194" class="anchor"></span><div class="para"> <p>[d] Data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/30333156/">Geller AS, Polisecki EY, Diffenderfer MR, et al</a>. Genetic and secondary causes of severe HDL deficiency and cardiovascular disease. <i>J Lipid Res</i> 2018;59(12):2421-2435. doi:10.1194/jlr.M088203</p></div></td></tr><tr><td colspan="6"><span id="x000195" class="anchor"></span><div class="para"> <p>[e] Prevalence data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34478023/">Taghizadeh E, Farahani N, Mardani R, Taheri F, Taghizadeh H, Gheibihayat SM</a>. Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update. <i>Biochem Genet</i> 2022;60(2):453-481. doi:10.1007/s10528-021-10130-2</p></div></td></tr><tr><td colspan="6"><span id="x000196" class="anchor"></span><div class="para"> <p>[f] Prevalence data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/1466657/">Tybjaerg-Hansen A, Humphries SE</a>. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease. <i>Atherosclerosis</i> 1992;96(2-3):91-107. doi:10.1016/0021-9150(92)90056-m</p></div></td></tr><tr><td colspan="6"><span id="x000197" class="anchor"></span><div class="para"> <p>[g] Data from <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/books/NBK395571/">Shah AS, Wilson DP</a>. Genetic Disorders Causing Hypertriglyceridemia in Children and Adolescents. [Updated 2023 Feb 22]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK395571/</p></div></td></tr><tr><td colspan="6"><span id="x000198" class="anchor"></span><div class="para"> <p>[h] Data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34327446/">Jackson CL, Ahmad Z, Das SR, Khera A</a>. The evaluation and management of patients with LDL-C ≥ 190 ​mg/dL in a large health care system. <i>Am J Prev Cardiol</i> 2020;1:100002. Published 2020 May 1. doi:10.1016/j.ajpc.2020.100002</p></div></td></tr><tr><td colspan="6"><span id="x000199" class="anchor"></span><div class="para"> <p>[i] Data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34256778/">Mehta R, Elias-Lopez D, Martagon AJ, et al</a>. LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred. <i>Lipids Health Dis</i> 2021;20(1):70. Published 2021 Jul 13. doi:10.1186/s12944-021-01498-6</p></div></td></tr><tr><td colspan="6"><span id="x000191" class="anchor"></span><div class="para"> <p>[j] Data from <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/books/NBK560795/">Balasubramanian S, Aggarwal P, Sharma S</a>: Lipoprotein Lipase Deficiency. [Updated 2022 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560795/</p></div></td></tr><tr><td colspan="6"><span id="v55564599" class="anchor"></span><div class="para"> <p>ABCA1 <span class='symbol'>= </span>ATP-binding cassette transporter A1; ABCG5 and 8 <span class='symbol'>=</span> ATP-binding cassette subfamily G members 5 and 8; apo <span class='symbol'>=</span> apoprotein; CAD <span class='symbol'>=</span> coronary artery disease; HDL <span class='symbol'>=</span> high-density lipoprotein; LCAT <span class='symbol'>=</span><span class="genericDrug" data-showrollover="false">lecithin</span>-cholesterol acyltransferase; LDL <span class='symbol'>=</span> low-density lipoprotein; LPL <span class='symbol'>=</span> lipoprotein lipase; MI = myocardial infarction; PCSK9 = proprotein convertase subtilisin-like/kexin type 9; TC <span class='symbol'>=</span> total cholesterol; TG <span class='symbol'>=</span> triglyceride; VLDL <span class='symbol'>=</span> very-low-density lipoprotein.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v55564502'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v989709"></span> <div class="TableHalfPage" id="v55564502"> <h3 class="title">Lipoprotein Patterns (Fredrickson Phenotypes)</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564512" class="anchor"></span><div class="para"> <p>Phenotype</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564515" class="anchor"></span><div class="para"> <p>Elevated Lipoprotein(s)</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564518" class="anchor"></span><div class="para"> <p>Elevated Lipids</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v55564526" class="anchor"></span><div class="para"> <p>I</p></div></td><td><span id="v55564528" class="anchor"></span><div class="para"> <p>Chylomicrons</p></div></td><td><span id="v55564530" class="anchor"></span><div class="para"> <p>TGs</p></div></td></tr><tr class="even"><td><span id="v55564533" class="anchor"></span><div class="para"> <p>IIa*</p></div></td><td><span id="v55564535" class="anchor"></span><div class="para"> <p>LDL</p></div></td><td><span id="v55564537" class="anchor"></span><div class="para"> <p>Cholesterol</p></div></td></tr><tr class="odd"><td><span id="v55564540" class="anchor"></span><div class="para"> <p>IIb*</p></div></td><td><span id="v55564542" class="anchor"></span><div class="para"> <p>LDL and VLDL</p></div></td><td><span id="v55564544" class="anchor"></span><div class="para"> <p>TGs and cholesterol</p></div></td></tr><tr class="even"><td><span id="v55564547" class="anchor"></span><div class="para"> <p>III</p></div></td><td><span id="v55564549" class="anchor"></span><div class="para"> <p>VLDL and chylomicron remnants</p></div></td><td><span id="v55564551" class="anchor"></span><div class="para"> <p>TGs and cholesterol</p></div></td></tr><tr class="odd"><td><span id="v55564554" class="anchor"></span><div class="para"> <p>IV</p></div></td><td><span id="v55564556" class="anchor"></span><div class="para"> <p>VLDL</p></div></td><td><span id="v55564558" class="anchor"></span><div class="para"> <p>TGs</p></div></td></tr><tr class="even"><td><span id="v55564561" class="anchor"></span><div class="para"> <p>V</p></div></td><td><span id="v55564563" class="anchor"></span><div class="para"> <p>Chylomicrons and VLDL</p></div></td><td><span id="v55564565" class="anchor"></span><div class="para"> <p>TGs and cholesterol</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="x000183" class="anchor"></span><div class="para"> <p>* The names of some primary disorders reflect an old nomenclature in which lipoproteins were detected and distinguished by how they separated into alpha (HDL) and beta (LDL) bands on electrophoretic gels.</p></div></td></tr><tr><td colspan="3"><span id="v55564522" class="anchor"></span><div class="para"> <p>LDL <span class='symbol'>=</span> low-density lipoprotein; TGs <span class='symbol'>=</span> triglycerides; VLDL <span class='symbol'>=</span> very-low-density lipoprotein.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v80953053'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v80953054"></span> <div class="TableFullPage" id="v80953053"> <h3 class="title">Non-Statin Lipid–Lowering Drugs*</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v80953062" class="anchor"></span><div class="para"> <p>Drugs</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v80953065" class="anchor"></span><div class="para"> <p>Comments</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953077" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Adenosine</span> triphosphate citrate lyase inhibitor</p></div></p></td><td><span id="v80953080" class="anchor"></span><div class="para"> <p>Lowers LDL-C</p></div></td></tr><tr class="even"><td><span id="v80953083" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bempedoic acid</span></p></div></td><td><span id="v80953085" class="anchor"></span><div class="para"> <p>Risk of hyperuricemia, tendon rupture</p></div><span id="v80953086" class="anchor"></span><div class="para"> <p>Especially useful in patients with statin-associated muscle adverse effects as the enzyme required to activate this drug is absent in the muscle</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953090" class="anchor"></span><div class="para"> <p>Bile acid sequestrants</p></div></p></td><td><span id="v80953092" class="anchor"></span><div class="para"> <p>Lower LDL-C (primary), slightly increase HDL-C (secondary), may increase TGs</p></div></td></tr><tr class="even"><td><span id="v80953095" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Cholestyramine</span></p></div></td><td><span id="v80953097" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd"><td><span id="v80953100" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Colesevelam</span></p></div></td><td><span id="v80953102" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v80953105" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Colestipol</span></p></div></td><td><span id="v80953107" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953111" class="anchor"></span><div class="para"> <p>Cholesterol absorption inhibitor</p></div></p></td><td><span id="v80953113" class="anchor"></span><div class="para"> <p>Lowers LDL-C (primary), minimally increases HDL-C</p></div></td></tr><tr class="even"><td><span id="v80953116" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ezetimibe</span></p></div></td><td><span id="v80953118" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953122" class="anchor"></span><div class="para"> <p>Drugs for homozygous familial hypercholesteremia</p></div></p></td><td><span id="v80953124" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v80953127" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Evinacumab</span></p></div></td><td><span id="v80953129" class="anchor"></span><div class="para"> <p>Given as an intravenous infusion over 60 minutes</p></div><span id="v80953130" class="anchor"></span><div class="para"> <p>Adverse reactions in clinical trials include nasopharyngitis, influenza-like illness, and infusion reaction</p></div></td></tr><tr class="odd"><td><span id="v80953133" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lomitapide</span></p></div></td><td><span id="v80953135" class="anchor"></span><div class="para"> <p>Risk of hepatotoxicity</p></div><span id="v80953136" class="anchor"></span><div class="para"> <p>Increase dose gradually (about every 2 weeks)</p></div><span id="v80953137" class="anchor"></span><div class="para"> <p>Measure transaminase levels before increasing dosage</p></div></td></tr><tr class="even" tablehead2=""><td><p class="tableHead2"><span id="v80953141" class="anchor"></span><div class="para"> <p>Fibrates</p></div></p></td><td><span id="v80953143" class="anchor"></span><div class="para"> <p>Lower TGs and VLDL, increase HDL-C, may increase LDL-C (in patients with high TGs)</p></div></td></tr><tr class="odd"><td><span id="v80953146" class="anchor"></span><div class="para"> <p>Bezafibrate</p></div></td><td><span id="v80953148" class="anchor"></span><div class="para"> <p>Decreased dose required in renal insufficiency</p></div><span id="v80953149" class="anchor"></span><div class="para"> <p>Not available in US</p></div></td></tr><tr class="even"><td><span id="v80953152" class="anchor"></span><div class="para"> <p>Ciprofibrate</p></div></td><td><span id="v80953154" class="anchor"></span><div class="para"> <p>Not available in US</p></div></td></tr><tr class="odd"><td><span id="v80953157" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fenofibrate</span></p></div></td><td><span id="v80953159" class="anchor"></span><div class="para"> <p>Decreased dose required in renal insufficiency</p></div><span id="v80953160" class="anchor"></span><div class="para"> <p>May be safest fibrate for use with statins</p></div></td></tr><tr class="even"><td><span id="v80953163" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Gemfibrozil</span></p></div></td><td><span id="v80953165" class="anchor"></span><div class="para"> <p>Decreased dose required in renal insufficiency</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953169" class="anchor"></span><div class="para"> <p>Nicotinic acid (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>niacin</span>)</p></div></p></td><td><span id="v80953171" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v80953174" class="anchor"></span><div class="para"> <p></div></td><td><span id="v80953176" class="anchor"></span><div class="para"> <p>Increases HDL-C; lowers TGs (low doses), LDL-C (higher doses), and Lp(a) (secondary)</p></div><span id="v80953177" class="anchor"></span><div class="para"> <p>Frequent adverse effects: Flushing, impaired glucose tolerance, increased uric acid</p></div><span id="v80953178" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Aspirin</span> and administration with food minimize flushing</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953183" class="anchor"></span><div class="para"> <p>PCSK9 monoclonal antibodies</p></div></p></td><td><span id="v80953185" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v80953188" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Alirocumab</span></p></div></td><td><span id="v80953190" class="anchor"></span><div class="para"> <p>For patients with familial hypercholesterolemia and for other high-risk patients</p></div></td></tr><tr class="odd"><td><span id="v80953193" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Evolocumab</span></p></div></td><td><span id="v80953195" class="anchor"></span><div class="para"> <p>For patients with familial hypercholesterolemia and for other high-risk patients</p></div></td></tr><tr class="even" tablehead2=""><td><p class="tableHead2"><span id="v80953199" class="anchor"></span><div class="para"> <p>Prescription omega-3 fatty acids</p></div></p></td><td><span id="v80953201" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="odd"><td><span id="v80953204" class="anchor"></span><div class="para"> <p>Eicosapentaenoic acid ethyl ester (EPA) + Docosahexaenoic acid (DHA)</p></div></td><td><span id="v80953206" class="anchor"></span><div class="para"> <p>Lowers TGs</p></div><span id="v80953207" class="anchor"></span><div class="para"> <p>Increases LDL-C</p></div></td></tr><tr class="even"><td><span id="v80953210" class="anchor"></span><div class="para"> <p>Eicosapentaenoic acid ethyl ester (EPA) only</p></div></td><td><span id="v80953212" class="anchor"></span><div class="para"> <p>Lowers TGs only</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953216" class="anchor"></span><div class="para"> <p>SiRNA targeting PCSK9</p></div></p><span id="v80953217" class="anchor"></span><div class="para"> <p></div></td><td><span id="v80953219" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v80953222" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Inclisiran</span></p></div></td><td><span id="v80953224" class="anchor"></span><div class="para"> <p>For patients with familial hypercholesterolemia and for other high-risk patients</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v80953069" class="anchor"></span><div class="para"> <p>* Many of these drugs are also available in combination with a statin.</p></div></td></tr><tr><td colspan="2"><span id="v80953072" class="anchor"></span><div class="para"> <p>HDL <span class='symbol'>=</span> high-density lipoprotein; HDL-C <span class='symbol'>=</span> HDL cholesterol; LDL <span class='symbol'>=</span> low-density lipoprotein; LDL-C <span class='symbol'>=</span> LDL cholesterol; Lp(a) <span class='symbol'>=</span> lipoprotein (a); PCSK9 = proprotein convertase subtilisin-like/kexin type 9; SiRNA = small interfering ribonucleic acid; TG <span class='symbol'>=</span> triglyceride; VLDL = very low-density lipoprotein.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v55564932'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v21454021"></span> <div class="TableFullPage" id="v55564932"> <h3 class="title">Statins For ASCVD Prevention</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v55564942" class="anchor"></span><div class="para"> <p>Classification</p></div></th><th style='text-align:left' scope='col'><span id="v55564944" class="anchor"></span><div class="para"> <p>Effects*</p></div></th><th style='text-align:left' scope='col'><span id="v55564946" class="anchor"></span><div class="para"> <p>Recommended For</p></div></th><th style='text-align:left' scope='col'><span id="v55564948" class="anchor"></span><div class="para"> <p>Examples†</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v55564966" class="anchor"></span><div class="para"> <p>High-intensity</p></div></td><td><span id="v55564968" class="anchor"></span><div class="para"> <p>Lowers LDL-C ≥ 50%</p></div></td><td><span id="v55564970" class="anchor"></span><div class="para"> <p>Clinical ASCVD, age ≤ 75 years</p></div><span id="v55564971" class="anchor"></span><div class="para"> <p>LDL-C ≥ 190 mg/dL (4.9 mmol/L)</p></div><span id="v55564973" class="anchor"></span><div class="para"> <p>Age 40 to 75 years, 10-year ASCVD risk ≥ 7.5%</p></div><span id="v55564972" class="anchor"></span><div class="para"> <p>Diabetes and 10-year ASCVD risk ≥ 7.5%</p></div></td><td><span id="v55564976" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atorvastatin</span> 40-80 mg</p></div><span id="v55564977" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rosuvastatin</span> 20-40 mg</p></div></td></tr><tr class="even"><td><span id="v55564980" class="anchor"></span><div class="para"> <p>Moderate-intensity</p></div></td><td><span id="v55564982" class="anchor"></span><div class="para"> <p>Lowers LDL-C 30 to <></p></div></td><td><span id="v55564984" class="anchor"></span><div class="para"> <p>Clinical ASCVD, age > 75 years</p></div><span id="v55564987" class="anchor"></span><div class="para"> <p>Age 40 to 75 years, 10-year ASCVD risk 5 to <></p></div><span id="v55564986" class="anchor"></span><div class="para"> <p>Age 40 to 75 years, 10-year ASCVD risk ≥ 7.5% (if unable to tolerate high-intensity statin)</p></div><span id="v55564985" class="anchor"></span><div class="para"> <p>Diabetes and 10-year ASCVD risk <></p></div></td><td><span id="v55564989" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atorvastatin</span> 10-20 mg</p></div><span id="v55564990" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fluvastatin</span> XL 80 mg</p></div><span id="v55564991" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lovastatin</span> 40 mg</p></div><span id="v55564992" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pitavastatin</span> 2-4 mg</p></div><span id="v55564993" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pravastatin</span> 40-80 mg</p></div><span id="v55564994" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rosuvastatin</span> 5-10 mg</p></div><span id="v55564995" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Simvastatin</span> 20-40 mg</p></div></td></tr><tr class="odd"><td><span id="v55564998" class="anchor"></span><div class="para"> <p>Low-intensity</p></div></td><td><span id="v55565000" class="anchor"></span><div class="para"> <p>Lowers LDL-C <></p></div></td><td><span id="v55565002" class="anchor"></span><div class="para"> <p>Patients who cannot tolerate high or moderate intensity treatment </p></div></td><td><span id="v55565004" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fluvastatin</span> 20-40 mg</p></div><span id="v55565005" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lovastatin</span> 20 mg</p></div><span id="v55565006" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pitavastatin</span> 1 mg</p></div><span id="v55565007" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pravastatin</span> 10-20 mg</p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v55564952" class="anchor"></span><div class="para"> <p>* Individual response may vary.</p></div></td></tr><tr><td colspan="4"><span id="v55564955" class="anchor"></span><div class="para"> <p>† All doses are oral and given once daily.</p></div></td></tr><tr><td colspan="4"><span id="v55564958" class="anchor"></span><div class="para"> <p>ASCVD = atherosclerotic cardiovascular disease; LDL-C = low density lipoprotein cholesterol.</p></div></td></tr><tr><td colspan="4"><span id="v55564961" class="anchor"></span><div class="para"> <p>Adapted from Stone NJ, Robinson J, Lichtenstein AH, et al: 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. <i>Circulation</i> 129:S1–S45, 2014.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v80952898'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v80952899"></span> <div class="TableFullPage" id="v80952898"> <h3 class="title">Cholesterol Levels and Cardiovascular Risk</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v80952908" class="anchor"></span><div class="para"> <p>Cardiovascular Risk</p></div></th><th style='text-align:left' scope='col'><span id="v80952910" class="anchor"></span><div class="para"> <p>Total Cholesterol</p></div></th><th style='text-align:left' scope='col'><span id="v80952912" class="anchor"></span><div class="para"> <p>LDL-C</p></div></th><th style='text-align:left' scope='col'><span id="v80952914" class="anchor"></span><div class="para"> <p>HDL-C</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v80952929" class="anchor"></span><div class="para"> <p>Higher risk</p></div></td><td><span id="v80952931" class="anchor"></span><div class="para"> <p>≥ 6.2 mmol/L (240 mg/dL)</p></div></td><td><span id="v80952933" class="anchor"></span><div class="para"> <p>≥ 4.1 mmol/L (160 mg/dL)</p></div></td><td><span id="v80952935" class="anchor"></span><div class="para"> <p>Male: < 1.0="" mmol/l="" (40=""></p></div><span id="v80952936" class="anchor"></span><div class="para"> <p>Female: < 1.3="" mmol/l="" (50=""></p></div></td></tr><tr class="even"><td><span id="v80952939" class="anchor"></span><div class="para"> <p>At- risk</p></div></td><td><span id="v80952941" class="anchor"></span><div class="para"> <p>5.2-6.2 mmol/L (200-239 mg/dL)</p></div></td><td><span id="v80952943" class="anchor"></span><div class="para"> <p>2.6-4.1 mmol/L (100-159 mg/dL)</p></div></td><td><span id="v80952945" class="anchor"></span><div class="para"> <p>Male: 1.0-1.5 mmol/L (40-59 mg/dL)</p></div><span id="v80952946" class="anchor"></span><div class="para"> <p>Female: 1.3-1.5 mmol/L (50-59 mg/dL)</p></div></td></tr><tr class="odd"><td><span id="v80952949" class="anchor"></span><div class="para"> <p>Lower risk</p></div></td><td><span id="v80952951" class="anchor"></span><div class="para"> <p>< 5.2="" mmol/l="" (200=""></p></div></td><td><span id="v80952953" class="anchor"></span><div class="para"> <p>< 2.6="" mmol/l="" (100=""></p></div></td><td><span id="v80952955" class="anchor"></span><div class="para"> <p>≥ 1.6 mmol/L (60 mg/dL )</p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v80952918" class="anchor"></span><div class="para"> <p>HDL <span class='symbol'>=</span> high-density lipoprotein; LDL <span class='symbol'>=</span> low-density lipoprotein.</p></div></td></tr><tr><td colspan="4"><span id="v80952921" class="anchor"></span><div class="para"> <p>Data from <a rel="nofollow" target="_blank" href="https://www.sciencedirect.com/science/article/abs/pii/B9780128012383653333">Carmena R</a>: Primary Mixed Dyslipidemias, Editor(s): Ilpo Huhtaniemi, Luciano Martini, Encyclopedia of Endocrine Diseases (Second Edition), Academic Press, 2019, Pages 314-319, ISBN 9780128122006, https://doi.org/10.1016/B978-0-12-801238-3.65333-3, <a rel="nofollow" target="_blank" href="https://www.nhlbi.nih.gov/health-topics/high-blood-cholesterol">National Heart Lung and Blood Institute</a>: What is Blood Cholesterol? Updated March 24, 2022, https://www.nhlbi.nih.gov/health-topics/high-blood-cholesterol; <a rel="nofollow" target="_blank" href="https://www.heart.org/en/health-topics/cholesterol">American Heart Association</a>: Cholesterol, https://www.heart.org/en/health-topics/cholesterol; <a rel="nofollow" target="_blank" href="https://www.cdc.gov/cholesterol">Centers for Disease Control and Prevention</a>: Cholesterol. Reviewed March 20, 2023, https://www.cdc.gov/cholesterol.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55564502'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v989709"></span> <div class="TableHalfPage" id="v55564502"> <h3 class="title">Lipoprotein Patterns (Fredrickson Phenotypes)</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564512" class="anchor"></span><div class="para"> <p>Phenotype</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564515" class="anchor"></span><div class="para"> <p>Elevated Lipoprotein(s)</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564518" class="anchor"></span><div class="para"> <p>Elevated Lipids</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v55564526" class="anchor"></span><div class="para"> <p>I</p></div></td><td><span id="v55564528" class="anchor"></span><div class="para"> <p>Chylomicrons</p></div></td><td><span id="v55564530" class="anchor"></span><div class="para"> <p>TGs</p></div></td></tr><tr class="even"><td><span id="v55564533" class="anchor"></span><div class="para"> <p>IIa*</p></div></td><td><span id="v55564535" class="anchor"></span><div class="para"> <p>LDL</p></div></td><td><span id="v55564537" class="anchor"></span><div class="para"> <p>Cholesterol</p></div></td></tr><tr class="odd"><td><span id="v55564540" class="anchor"></span><div class="para"> <p>IIb*</p></div></td><td><span id="v55564542" class="anchor"></span><div class="para"> <p>LDL and VLDL</p></div></td><td><span id="v55564544" class="anchor"></span><div class="para"> <p>TGs and cholesterol</p></div></td></tr><tr class="even"><td><span id="v55564547" class="anchor"></span><div class="para"> <p>III</p></div></td><td><span id="v55564549" class="anchor"></span><div class="para"> <p>VLDL and chylomicron remnants</p></div></td><td><span id="v55564551" class="anchor"></span><div class="para"> <p>TGs and cholesterol</p></div></td></tr><tr class="odd"><td><span id="v55564554" class="anchor"></span><div class="para"> <p>IV</p></div></td><td><span id="v55564556" class="anchor"></span><div class="para"> <p>VLDL</p></div></td><td><span id="v55564558" class="anchor"></span><div class="para"> <p>TGs</p></div></td></tr><tr class="even"><td><span id="v55564561" class="anchor"></span><div class="para"> <p>V</p></div></td><td><span id="v55564563" class="anchor"></span><div class="para"> <p>Chylomicrons and VLDL</p></div></td><td><span id="v55564565" class="anchor"></span><div class="para"> <p>TGs and cholesterol</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="x000183" class="anchor"></span><div class="para"> <p>* The names of some primary disorders reflect an old nomenclature in which lipoproteins were detected and distinguished by how they separated into alpha (HDL) and beta (LDL) bands on electrophoretic gels.</p></div></td></tr><tr><td colspan="3"><span id="v55564522" class="anchor"></span><div class="para"> <p>LDL <span class='symbol'>=</span> low-density lipoprotein; TGs <span class='symbol'>=</span> triglycerides; VLDL <span class='symbol'>=</span> very-low-density lipoprotein.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55564567'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v45392470"></span> <div class="TableFullPage" id="v55564567"> <h3 class="title">Genetic (Primary) Dyslipidemias</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564580" class="anchor"></span><div class="para"> <p>Disorder</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564583" class="anchor"></span><div class="para"> <p>Genetic Defect/Mechanism</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564586" class="anchor"></span><div class="para"> <p>Inheritance</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564589" class="anchor"></span><div class="para"> <p>Prevalence</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564592" class="anchor"></span><div class="para"> <p>Clinical Features</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55564595" class="anchor"></span><div class="para"> <p>Treatment</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v55564603" class="anchor"></span><div class="para"> <p>Apo C-II deficiency [a]</p></div></td><td><span id="v55564605" class="anchor"></span><div class="para"> <p>Apo C-II (causing functional LPL deficiency)</p></div></td><td><span id="v55564607" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564609" class="anchor"></span><div class="para"> <p><span class='symbol'><></span> 1/1 million</p></div></td><td><span id="v55564611" class="anchor"></span><div class="para"> <p>Pancreatitis (in some adults), metabolic syndrome (often present)</p></div><span id="v55564612" class="anchor"></span><div class="para"> <p>TG: <span class='symbol'>></span> 750 mg/dL (<span class='symbol'>></span> 8.5 mmol/L)</p></div></td><td><span id="v55564614" class="anchor"></span><div class="para"> <p>Diet: Severe fat restriction with fat-soluble vitamin supplementation and medium-chain TG supplementation</p></div></td></tr><tr class="even"><td><span id="v55564617" class="anchor"></span><div class="para"> <p>Cerebrotendinous xanthomatosis [b]</p></div></td><td><span id="v55564619" class="anchor"></span><div class="para"> <p>Hepatic mitochondrial 27-hydroxylase defect</p></div><span id="v55564620" class="anchor"></span><div class="para"> <p>Blockage of bile acid synthesis and conversion of cholesterol to cholestanol, which accumulates</p></div></td><td><span id="v55564622" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564624" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v55564626" class="anchor"></span><div class="para"> <p>Cataracts, premature CAD, neuropathy, ataxia</p></div></td><td><span id="v55564628" class="anchor"></span><div class="para"> <p>Chenodeoxycholic acid</p></div></td></tr><tr class="odd"><td><span id="v55564631" class="anchor"></span><div class="para"> <p> <a href="./{A47AB568-C9DF-449C-AB9B-745B0082030B}.html" data-toggle="tooltip" title="Cholesteryl Ester Storage Disease and Wolman Disease" data-id="7c99e13f-2914-4265-9304-e417f857f6c0" data-itemid="a47ab568-c9df-449c-ab9b-745b0082030b">Cholesteryl ester storage disease</a><span id="7c99e13f-2914-4265-9304-e417f857f6c0" class="d-none xref"> <span class="tooltip-container"> <a href="./{A47AB568-C9DF-449C-AB9B-745B0082030B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Cholesteryl Ester Storage Disease and Wolman Disease </span> Cholesteryl ester storage disease and Wolman disease are sphingolipidoses, an inherited disorder of metabolism, caused by lysosomal acid lipase deficiency resulting in hyperlipidemia and hepatomegaly... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and <a href="./{A47AB568-C9DF-449C-AB9B-745B0082030B}.html" data-toggle="tooltip" title="Cholesteryl Ester Storage Disease and Wolman Disease" data-id="4188af43-fc95-4200-8d53-173362bd16ee" data-itemid="a47ab568-c9df-449c-ab9b-745b0082030b">Wolman disease</a><span id="4188af43-fc95-4200-8d53-173362bd16ee" class="d-none xref"> <span class="tooltip-container"> <a href="./{A47AB568-C9DF-449C-AB9B-745B0082030B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Cholesteryl Ester Storage Disease and Wolman Disease </span> Cholesteryl ester storage disease and Wolman disease are sphingolipidoses, an inherited disorder of metabolism, caused by lysosomal acid lipase deficiency resulting in hyperlipidemia and hepatomegaly... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> [c]</p></div></td><td><span id="v55564635" class="anchor"></span><div class="para"> <p>Lysosomal acid lipase deficiency</p></div></td><td><span id="v55564637" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564639" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v55564641" class="anchor"></span><div class="para"> <p>Premature CAD</p></div><span id="v55564642" class="anchor"></span><div class="para"> <p>Accumulation of cholesteryl esters and TG in lysosomes in the liver, spleen, and lymph nodes</p></div><span id="v55564643" class="anchor"></span><div class="para"> <p>Cirrhosis</p></div></td><td><span id="v55564645" class="anchor"></span><div class="para"> <p>Possibly statins</p></div><span id="v55564646" class="anchor"></span><div class="para"> <p>Enzyme replacement </p></div></td></tr><tr class="even"><td><span id="v55564649" class="anchor"></span><div class="para"> <p>Familial apo AI deficiency/mutations [d]</p></div></td><td><span id="v55564651" class="anchor"></span><div class="para"> <p>Apo AI</p></div></td><td><span id="v55564653" class="anchor"></span><div class="para"> <p>Unknown</p></div></td><td><span id="v55564655" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v55564657" class="anchor"></span><div class="para"> <p>Corneal opacities, xanthomas, premature CAD (in some people)</p></div><span id="v55564658" class="anchor"></span><div class="para"> <p>HDL: 15–30 mg/dL (0.39–0.78 mmol/L)</p></div></td><td><span id="v55564660" class="anchor"></span><div class="para"> <p>Nonspecific</p></div></td></tr><tr class="odd"><td><span id="v55564663" class="anchor"></span><div class="para"> <p>Familial combined hyperlipidemia [e]</p></div></td><td><span id="v55564665" class="anchor"></span><div class="para"> <p>Unknown, possibly multiple defects and mechanisms</p></div></td><td><span id="v55564667" class="anchor"></span><div class="para"> <p>Dominant</p></div></td><td><span id="v55564669" class="anchor"></span><div class="para"> <p>1/50 to 1/100</p></div></td><td><span id="v55564671" class="anchor"></span><div class="para"> <p>Premature CAD, responsible for about 15% of MIs in people <span class='symbol'><></span> 60 years</p></div><span id="v55564672" class="anchor"></span><div class="para"> <p> Apo B: Disproportionately elevated</p></div><span id="v55564673" class="anchor"></span><div class="para"> <p>TC: 250–500 mg/dL (6.5–13.0 mmol/L)</p></div><span id="v55564674" class="anchor"></span><div class="para"> <p>TG: 250–750 mg/dL (2.8–8.5 mmol/L)</p></div></td><td><span id="v55564676" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564677" class="anchor"></span><div class="para"> <p>Weight loss</p></div><span id="v55564678" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div></td></tr><tr class="even"><td><span id="v55564681" class="anchor"></span><div class="para"> <p>Familial defective apo B-100 [f]</p></div></td><td><span id="v55564683" class="anchor"></span><div class="para"> <p>Apo B (LDL receptor–binding region defect)</p></div><span id="v55564684" class="anchor"></span><div class="para"> <p>Diminished LDL clearance</p></div></td><td><span id="v55564686" class="anchor"></span><div class="para"> <p>Dominant</p></div></td><td><span id="v55564688" class="anchor"></span><div class="para"> <p>1/700</p></div></td><td><span id="v55564690" class="anchor"></span><div class="para"> <p>Xanthomas, arcus corneae, premature CAD</p></div><span id="v55564691" class="anchor"></span><div class="para"> <p>TC: 250–500 mg/dL (6.5–13 mmol/L)</p></div></td><td><span id="v55564693" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564694" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div></td></tr><tr class="odd"><td><span id="v55564697" class="anchor"></span><div class="para"> <p>Familial dysbetalipoproteinemia [g]</p></div></td><td><span id="v55564699" class="anchor"></span><div class="para"> <p>Apo E (usually e2/e2 homozygotes)</p></div><span id="v55564700" class="anchor"></span><div class="para"> <p>Diminished chylomicron and VLDL clearance</p></div></td><td><span id="v55564702" class="anchor"></span><div class="para"> <p>Recessive (more common) or dominant (less common)</p></div></td><td><span id="v55564704" class="anchor"></span><div class="para"> <p>1/5000</p></div><span id="v55564705" class="anchor"></span><div class="para"> <p></div></td><td><span id="v55564707" class="anchor"></span><div class="para"> <p>Xanthomas (especially tuberous and palmar), yellow palmar creases, premature CAD</p></div><span id="v55564708" class="anchor"></span><div class="para"> <p>TC: 250–500 mg/dL (6.5–13.0 mmol/L)</p></div><span id="v55564709" class="anchor"></span><div class="para"> <p>TG: 250–500 mg/dL (2.8–5.6 mmol/L)</p></div></td><td><span id="v55564711" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564712" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div></td></tr><tr class="even"><td><span id="v55564715" class="anchor"></span><div class="para"> <p>Familial HDL deficiency </p></div></td><td><span id="v55564717" class="anchor"></span><div class="para"> <p><i>ABCA1</i> gene</p></div></td><td><span id="v55564720" class="anchor"></span><div class="para"> <p>Dominant</p></div></td><td><span id="v55564722" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v55564724" class="anchor"></span><div class="para"> <p>Premature CAD</p></div></td><td><span id="v55564726" class="anchor"></span><div class="para"> <p>Low-fat diet</p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v55564729" class="anchor"></span><div class="para"> <p>Familial hypercholesterolemia [h]</p></div></td><td rowspan="2"><span id="v55564731" class="anchor"></span><div class="para"> <p>LDL receptor defect</p></div><span id="v55564732" class="anchor"></span><div class="para"> <p>Diminished LDL clearance</p></div></td><td rowspan="2"><span id="v55564734" class="anchor"></span><div class="para"> <p>Codominant</p></div></td><td><span id="v55564736" class="anchor"></span><div class="para"> <p>—</p></div></td><td><span id="v55564738" class="anchor"></span><div class="para"> <p>—</p></div></td><td rowspan="2"><span id="v55564740" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564741" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div><span id="v55564742" class="anchor"></span><div class="para"> <p>LDL apheresis (for homozygotes and heterozygotes with severe disease)</p></div><span id="v55564743" class="anchor"></span><div class="para"> <p>Liver transplantation (for homozygotes)</p></div></td></tr><tr class="even"><td><span id="v55564746" class="anchor"></span><div class="para"> <p>Heterozygotes: 1/200</p></div></td><td><span id="v55564748" class="anchor"></span><div class="para"> <p>Tendon xanthomas, arcus corneae, premature CAD (ages 30–50), responsible for about 5% of MIs in people <span class='symbol'><></span> 60 years</p></div><span id="v55564749" class="anchor"></span><div class="para"> <p>TC: 250–500 mg/dL (6.5–13 mmol/L)</p></div></td></tr><tr class="odd"><td><span id="v55564752" class="anchor"></span><div class="para"> <p></div></td><td><span id="v55564754" class="anchor"></span><div class="para"> <p></div></td><td><span id="v55564756" class="anchor"></span><div class="para"> <p></div></td><td><span id="v55564758" class="anchor"></span><div class="para"> <p>Homozygotes: 1/250,000–1/1 million (increased among French Canadian, Christian Lebanese, and South African populations)</p></div></td><td><span id="v55564760" class="anchor"></span><div class="para"> <p>Planar and tendon xanthomas and tuberous xanthomas, premature CAD (before age 18)</p></div><span id="v55564761" class="anchor"></span><div class="para"> <p>TC <span class='symbol'>></span> 500 mg/dL (<span class='symbol'>></span> 13 mmol/L)</p></div></td><td><span id="v55564763" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v55564766" class="anchor"></span><div class="para"> <p>Familial hypertriglyceridemia [g]</p></div></td><td><span id="v55564768" class="anchor"></span><div class="para"> <p>Unknown, possibly multiple defects and mechanisms</p></div></td><td><span id="v55564771" class="anchor"></span><div class="para"> <p>Dominant</p></div></td><td><span id="v55564773" class="anchor"></span><div class="para"> <p>1/500</p></div></td><td><span id="v55564775" class="anchor"></span><div class="para"> <p>Usually no symptoms or findings; occasionally hyperuricemia, sometimes early atherosclerosis</p></div><span id="v55564776" class="anchor"></span><div class="para"> <p>TG: 200–500 mg/dL (2.3–5.6 mmol/L), possibly higher depending on diet and alcohol use</p></div></td><td><span id="v55564778" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564779" class="anchor"></span><div class="para"> <p>Weight loss</p></div><span id="v55564780" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div></td></tr><tr class="odd"><td><span id="v55564783" class="anchor"></span><div class="para"> <p>Familial LCAT deficiency [i]</p></div></td><td><span id="v55564785" class="anchor"></span><div class="para"> <p><i>LCAT</i> gene</p></div></td><td><span id="v55564788" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564790" class="anchor"></span><div class="para"> <p>Extremely rare</p></div></td><td><span id="v55564792" class="anchor"></span><div class="para"> <p>Corneal opacities, anemia, chronic kidney disease</p></div><span id="v55564793" class="anchor"></span><div class="para"> <p>HDL: <span class='symbol'><></span> 10 mg/dL (< 0.26="" mmol/l)=""></p></div></td><td><span id="v55564795" class="anchor"></span><div class="para"> <p>Fat restriction</p></div><span id="v55564796" class="anchor"></span><div class="para"> <p>Renal transplantation</p></div></td></tr><tr class="even"><td><span id="v55564799" class="anchor"></span><div class="para"> <p>Fisheye disease (partial LCAT deficiency)</p></div></td><td><span id="v55564801" class="anchor"></span><div class="para"> <p><i>LCAT</i> gene</p></div></td><td><span id="v55564804" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564806" class="anchor"></span><div class="para"> <p>Extremely rare</p></div></td><td><span id="v55564808" class="anchor"></span><div class="para"> <p>Corneal opacities</p></div><span id="v55564809" class="anchor"></span><div class="para"> <p>HDL: <span class='symbol'><></span> 10 mg/dL (< 0.26=""></p></div></td><td><span id="v55564811" class="anchor"></span><div class="para"> <p>Nonspecific</p></div></td></tr><tr class="odd"><td><span id="v55564814" class="anchor"></span><div class="para"> <p>Hepatic lipase deficiency</p></div></td><td><span id="v55564816" class="anchor"></span><div class="para"> <p>Hepatic lipase</p></div></td><td><span id="v55564818" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564820" class="anchor"></span><div class="para"> <p>Extremely rare</p></div></td><td><span id="v55564822" class="anchor"></span><div class="para"> <p>Premature CAD</p></div><span id="v55564823" class="anchor"></span><div class="para"> <p>TC: 250–1500 mg/dL (6.5–39 mmol/L)</p></div><span id="v55564824" class="anchor"></span><div class="para"> <p>TG: 395–8200 mg/dL (4.5–93 mmol/L)</p></div><span id="v55564825" class="anchor"></span><div class="para"> <p>HDL: Variable</p></div></td><td><span id="v55564827" class="anchor"></span><div class="para"> <p>Empiric: Diet, lipid-lowering drugs</p></div></td></tr><tr class="even"><td><span id="v55564830" class="anchor"></span><div class="para"> <p>LPL deficiency [j]</p></div></td><td><span id="v55564832" class="anchor"></span><div class="para"> <p>Endothelial LPL defect</p></div><span id="v55564833" class="anchor"></span><div class="para"> <p>Diminished chylomicron clearance</p></div></td><td><span id="v55564835" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564837" class="anchor"></span><div class="para"> <p>Rare but present worldwide</p></div></td><td><span id="v55564839" class="anchor"></span><div class="para"> <p>Failure to thrive (in infants), eruptive xanthomas, hepatosplenomegaly, pancreatitis</p></div><span id="v55564840" class="anchor"></span><div class="para"> <p>TG: <span class='symbol'>></span> 750 mg/dL (<span class='symbol'>></span> 8.5 mmol/L)</p></div></td><td><span id="v55564842" class="anchor"></span><div class="para"> <p>Diet: Severe fat restriction with fat-soluble vitamin supplementation and medium-chain TG supplementation</p></div><span id="v55564843" class="anchor"></span><div class="para"> <p>Gene therapy (approved in European Union)</p></div></td></tr><tr class="odd"><td><span id="v55564846" class="anchor"></span><div class="para"> <p>PCSK9 gain of function mutations</p></div></td><td><span id="v55564848" class="anchor"></span><div class="para"> <p>Increased degradation of LDL receptors</p></div></td><td><span id="v55564850" class="anchor"></span><div class="para"> <p>Dominant</p></div></td><td><span id="v55564852" class="anchor"></span><div class="para"> <p>Unknown</p></div></td><td><span id="v55564854" class="anchor"></span><div class="para"> <p>Similar to familial hypercholesterolemia</p></div></td><td><span id="v55564856" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564857" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div></td></tr><tr class="even"><td><span id="v55564860" class="anchor"></span><div class="para"> <p>Polygenic hypercholesterolemia</p></div></td><td><span id="v55564862" class="anchor"></span><div class="para"> <p>Unknown, possibly multiple defects and mechanisms</p></div></td><td><span id="v55564864" class="anchor"></span><div class="para"> <p>Variable</p></div></td><td><span id="v55564866" class="anchor"></span><div class="para"> <p>Common</p></div></td><td><span id="v55564868" class="anchor"></span><div class="para"> <p>Premature CAD</p></div><span id="v55564869" class="anchor"></span><div class="para"> <p>TC: 250–350 mg/dL (6.5–9.0 mmol/L)</p></div></td><td><span id="v55564871" class="anchor"></span><div class="para"> <p>Diet</p></div><span id="v55564872" class="anchor"></span><div class="para"> <p>Lipid-lowering drugs</p></div></td></tr><tr class="odd"><td><span id="v55564875" class="anchor"></span><div class="para"> <p>Primary hypoalphalipoproteinemia (familial or nonfamilial)</p></div></td><td><span id="v55564877" class="anchor"></span><div class="para"> <p>Unknown, possibly apo A-I, C-III, or A-IV</p></div></td><td><span id="v55564879" class="anchor"></span><div class="para"> <p>Dominant</p></div></td><td><span id="v55564881" class="anchor"></span><div class="para"> <p>About 5%</p></div></td><td><span id="v55564883" class="anchor"></span><div class="para"> <p>Premature CAD</p></div><span id="v55564884" class="anchor"></span><div class="para"> <p>HDL: 15–35 mg/dL (0.39–0.91 mmol/L)</p></div></td><td><span id="v55564886" class="anchor"></span><div class="para"> <p>Exercise</p></div><span id="v55564887" class="anchor"></span><div class="para"> <p>LDL-lowering drugs</p></div></td></tr><tr class="even"><td><span id="v55564890" class="anchor"></span><div class="para"> <p>Sitosterolemia</p></div></td><td><span id="v55564892" class="anchor"></span><div class="para"> <p><i>ABCG5</i> and <i>ABCG8</i> genes </p></div></td><td><span id="v55564896" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564898" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v55564900" class="anchor"></span><div class="para"> <p>Tendon xanthomas, premature CAD</p></div></td><td><span id="v55564902" class="anchor"></span><div class="para"> <p>Fat restriction</p></div><span id="v55564903" class="anchor"></span><div class="para"> <p>Bile acid sequestrants</p></div><span id="v55564904" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ezetimibe</span></p></div></td></tr><tr class="odd"><td><span id="v55564907" class="anchor"></span><div class="para"> <p>Tangier disease</p></div></td><td><span id="v55564909" class="anchor"></span><div class="para"> <p><i>ABCA1</i> gene</p></div></td><td><span id="v55564912" class="anchor"></span><div class="para"> <p>Recessive</p></div></td><td><span id="v55564914" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v55564916" class="anchor"></span><div class="para"> <p>Premature CAD (in some people), peripheral neuropathy, hemolytic anemia, corneal opacities, hepatosplenomegaly, orange tonsils</p></div><span id="v55564917" class="anchor"></span><div class="para"> <p>HDL: <span class='symbol'><></span>5 mg/dL (< 0.13="" mmol/l)=""></p></div></td><td><span id="v55564919" class="anchor"></span><div class="para"> <p>Low-fat diet</p></div></td></tr></tbody> <tfoot><tr><td colspan="6"><span id="x000188" class="anchor"></span><div class="para"> <p>[a] Prevalence data from <a rel="nofollow" target="_blank" href="https://link.springer.com/referenceworkentry/10.1007/978-3-540-29676-8_137">Hoffmann, M.M., März, W</a>. (2009). Apo C-II Deficiency. In: Lang, F. (eds) <i>Encyclopedia of Molecular Mechanisms of Disease.</i> Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-29676-8_137</p></div></td></tr><tr><td colspan="6"><span id="x000192" class="anchor"></span><div class="para"> <p>[b] Prevalece data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/25424010/">Nie S, Chen G, Cao X, Zhang Y</a>. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. <i>Orphanet J Rare Dis</i> 2014;9:179. Published 2014 Nov 26. doi:10.1186/s13023-014-0179-4</p></div></td></tr><tr><td colspan="6"><span id="x000193" class="anchor"></span><div class="para"> <p>[c] Prevalence data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/28786388/">Pericleous M, Kelly C, Wang T, Livingstone C, Ala A</a>. Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol Hepatol. 2017;2(9):670-679. doi:10.1016/S2468-1253(17)30052-3</p></div></td></tr><tr><td colspan="6"><span id="x000194" class="anchor"></span><div class="para"> <p>[d] Data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/30333156/">Geller AS, Polisecki EY, Diffenderfer MR, et al</a>. Genetic and secondary causes of severe HDL deficiency and cardiovascular disease. <i>J Lipid Res</i> 2018;59(12):2421-2435. doi:10.1194/jlr.M088203</p></div></td></tr><tr><td colspan="6"><span id="x000195" class="anchor"></span><div class="para"> <p>[e] Prevalence data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34478023/">Taghizadeh E, Farahani N, Mardani R, Taheri F, Taghizadeh H, Gheibihayat SM</a>. Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update. <i>Biochem Genet</i> 2022;60(2):453-481. doi:10.1007/s10528-021-10130-2</p></div></td></tr><tr><td colspan="6"><span id="x000196" class="anchor"></span><div class="para"> <p>[f] Prevalence data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/1466657/">Tybjaerg-Hansen A, Humphries SE</a>. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease. <i>Atherosclerosis</i> 1992;96(2-3):91-107. doi:10.1016/0021-9150(92)90056-m</p></div></td></tr><tr><td colspan="6"><span id="x000197" class="anchor"></span><div class="para"> <p>[g] Data from <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/books/NBK395571/">Shah AS, Wilson DP</a>. Genetic Disorders Causing Hypertriglyceridemia in Children and Adolescents. [Updated 2023 Feb 22]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK395571/</p></div></td></tr><tr><td colspan="6"><span id="x000198" class="anchor"></span><div class="para"> <p>[h] Data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34327446/">Jackson CL, Ahmad Z, Das SR, Khera A</a>. The evaluation and management of patients with LDL-C ≥ 190 ​mg/dL in a large health care system. <i>Am J Prev Cardiol</i> 2020;1:100002. Published 2020 May 1. doi:10.1016/j.ajpc.2020.100002</p></div></td></tr><tr><td colspan="6"><span id="x000199" class="anchor"></span><div class="para"> <p>[i] Data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34256778/">Mehta R, Elias-Lopez D, Martagon AJ, et al</a>. LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred. <i>Lipids Health Dis</i> 2021;20(1):70. Published 2021 Jul 13. doi:10.1186/s12944-021-01498-6</p></div></td></tr><tr><td colspan="6"><span id="x000191" class="anchor"></span><div class="para"> <p>[j] Data from <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/books/NBK560795/">Balasubramanian S, Aggarwal P, Sharma S</a>: Lipoprotein Lipase Deficiency. [Updated 2022 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560795/</p></div></td></tr><tr><td colspan="6"><span id="v55564599" class="anchor"></span><div class="para"> <p>ABCA1 <span class='symbol'>= </span>ATP-binding cassette transporter A1; ABCG5 and 8 <span class='symbol'>=</span> ATP-binding cassette subfamily G members 5 and 8; apo <span class='symbol'>=</span> apoprotein; CAD <span class='symbol'>=</span> coronary artery disease; HDL <span class='symbol'>=</span> high-density lipoprotein; LCAT <span class='symbol'>=</span><span class="genericDrug" data-showrollover="false">lecithin</span>-cholesterol acyltransferase; LDL <span class='symbol'>=</span> low-density lipoprotein; LPL <span class='symbol'>=</span> lipoprotein lipase; MI = myocardial infarction; PCSK9 = proprotein convertase subtilisin-like/kexin type 9; TC <span class='symbol'>=</span> total cholesterol; TG <span class='symbol'>=</span> triglyceride; VLDL <span class='symbol'>=</span> very-low-density lipoprotein.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v80952898'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v80952899"></span> <div class="TableFullPage" id="v80952898"> <h3 class="title">Cholesterol Levels and Cardiovascular Risk</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v80952908" class="anchor"></span><div class="para"> <p>Cardiovascular Risk</p></div></th><th style='text-align:left' scope='col'><span id="v80952910" class="anchor"></span><div class="para"> <p>Total Cholesterol</p></div></th><th style='text-align:left' scope='col'><span id="v80952912" class="anchor"></span><div class="para"> <p>LDL-C</p></div></th><th style='text-align:left' scope='col'><span id="v80952914" class="anchor"></span><div class="para"> <p>HDL-C</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v80952929" class="anchor"></span><div class="para"> <p>Higher risk</p></div></td><td><span id="v80952931" class="anchor"></span><div class="para"> <p>≥ 6.2 mmol/L (240 mg/dL)</p></div></td><td><span id="v80952933" class="anchor"></span><div class="para"> <p>≥ 4.1 mmol/L (160 mg/dL)</p></div></td><td><span id="v80952935" class="anchor"></span><div class="para"> <p>Male: < 1.0="" mmol/l="" (40=""></p></div><span id="v80952936" class="anchor"></span><div class="para"> <p>Female: < 1.3="" mmol/l="" (50=""></p></div></td></tr><tr class="even"><td><span id="v80952939" class="anchor"></span><div class="para"> <p>At- risk</p></div></td><td><span id="v80952941" class="anchor"></span><div class="para"> <p>5.2-6.2 mmol/L (200-239 mg/dL)</p></div></td><td><span id="v80952943" class="anchor"></span><div class="para"> <p>2.6-4.1 mmol/L (100-159 mg/dL)</p></div></td><td><span id="v80952945" class="anchor"></span><div class="para"> <p>Male: 1.0-1.5 mmol/L (40-59 mg/dL)</p></div><span id="v80952946" class="anchor"></span><div class="para"> <p>Female: 1.3-1.5 mmol/L (50-59 mg/dL)</p></div></td></tr><tr class="odd"><td><span id="v80952949" class="anchor"></span><div class="para"> <p>Lower risk</p></div></td><td><span id="v80952951" class="anchor"></span><div class="para"> <p>< 5.2="" mmol/l="" (200=""></p></div></td><td><span id="v80952953" class="anchor"></span><div class="para"> <p>< 2.6="" mmol/l="" (100=""></p></div></td><td><span id="v80952955" class="anchor"></span><div class="para"> <p>≥ 1.6 mmol/L (60 mg/dL )</p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v80952918" class="anchor"></span><div class="para"> <p>HDL <span class='symbol'>=</span> high-density lipoprotein; LDL <span class='symbol'>=</span> low-density lipoprotein.</p></div></td></tr><tr><td colspan="4"><span id="v80952921" class="anchor"></span><div class="para"> <p>Data from <a rel="nofollow" target="_blank" href="https://www.sciencedirect.com/science/article/abs/pii/B9780128012383653333">Carmena R</a>: Primary Mixed Dyslipidemias, Editor(s): Ilpo Huhtaniemi, Luciano Martini, Encyclopedia of Endocrine Diseases (Second Edition), Academic Press, 2019, Pages 314-319, ISBN 9780128122006, https://doi.org/10.1016/B978-0-12-801238-3.65333-3, <a rel="nofollow" target="_blank" href="https://www.nhlbi.nih.gov/health-topics/high-blood-cholesterol">National Heart Lung and Blood Institute</a>: What is Blood Cholesterol? Updated March 24, 2022, https://www.nhlbi.nih.gov/health-topics/high-blood-cholesterol; <a rel="nofollow" target="_blank" href="https://www.heart.org/en/health-topics/cholesterol">American Heart Association</a>: Cholesterol, https://www.heart.org/en/health-topics/cholesterol; <a rel="nofollow" target="_blank" href="https://www.cdc.gov/cholesterol">Centers for Disease Control and Prevention</a>: Cholesterol. Reviewed March 20, 2023, https://www.cdc.gov/cholesterol.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55564932'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v21454021"></span> <div class="TableFullPage" id="v55564932"> <h3 class="title">Statins For ASCVD Prevention</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v55564942" class="anchor"></span><div class="para"> <p>Classification</p></div></th><th style='text-align:left' scope='col'><span id="v55564944" class="anchor"></span><div class="para"> <p>Effects*</p></div></th><th style='text-align:left' scope='col'><span id="v55564946" class="anchor"></span><div class="para"> <p>Recommended For</p></div></th><th style='text-align:left' scope='col'><span id="v55564948" class="anchor"></span><div class="para"> <p>Examples†</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v55564966" class="anchor"></span><div class="para"> <p>High-intensity</p></div></td><td><span id="v55564968" class="anchor"></span><div class="para"> <p>Lowers LDL-C ≥ 50%</p></div></td><td><span id="v55564970" class="anchor"></span><div class="para"> <p>Clinical ASCVD, age ≤ 75 years</p></div><span id="v55564971" class="anchor"></span><div class="para"> <p>LDL-C ≥ 190 mg/dL (4.9 mmol/L)</p></div><span id="v55564973" class="anchor"></span><div class="para"> <p>Age 40 to 75 years, 10-year ASCVD risk ≥ 7.5%</p></div><span id="v55564972" class="anchor"></span><div class="para"> <p>Diabetes and 10-year ASCVD risk ≥ 7.5%</p></div></td><td><span id="v55564976" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atorvastatin</span> 40-80 mg</p></div><span id="v55564977" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rosuvastatin</span> 20-40 mg</p></div></td></tr><tr class="even"><td><span id="v55564980" class="anchor"></span><div class="para"> <p>Moderate-intensity</p></div></td><td><span id="v55564982" class="anchor"></span><div class="para"> <p>Lowers LDL-C 30 to <></p></div></td><td><span id="v55564984" class="anchor"></span><div class="para"> <p>Clinical ASCVD, age > 75 years</p></div><span id="v55564987" class="anchor"></span><div class="para"> <p>Age 40 to 75 years, 10-year ASCVD risk 5 to <></p></div><span id="v55564986" class="anchor"></span><div class="para"> <p>Age 40 to 75 years, 10-year ASCVD risk ≥ 7.5% (if unable to tolerate high-intensity statin)</p></div><span id="v55564985" class="anchor"></span><div class="para"> <p>Diabetes and 10-year ASCVD risk <></p></div></td><td><span id="v55564989" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atorvastatin</span> 10-20 mg</p></div><span id="v55564990" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fluvastatin</span> XL 80 mg</p></div><span id="v55564991" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lovastatin</span> 40 mg</p></div><span id="v55564992" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pitavastatin</span> 2-4 mg</p></div><span id="v55564993" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pravastatin</span> 40-80 mg</p></div><span id="v55564994" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rosuvastatin</span> 5-10 mg</p></div><span id="v55564995" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Simvastatin</span> 20-40 mg</p></div></td></tr><tr class="odd"><td><span id="v55564998" class="anchor"></span><div class="para"> <p>Low-intensity</p></div></td><td><span id="v55565000" class="anchor"></span><div class="para"> <p>Lowers LDL-C <></p></div></td><td><span id="v55565002" class="anchor"></span><div class="para"> <p>Patients who cannot tolerate high or moderate intensity treatment </p></div></td><td><span id="v55565004" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fluvastatin</span> 20-40 mg</p></div><span id="v55565005" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lovastatin</span> 20 mg</p></div><span id="v55565006" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pitavastatin</span> 1 mg</p></div><span id="v55565007" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pravastatin</span> 10-20 mg</p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v55564952" class="anchor"></span><div class="para"> <p>* Individual response may vary.</p></div></td></tr><tr><td colspan="4"><span id="v55564955" class="anchor"></span><div class="para"> <p>† All doses are oral and given once daily.</p></div></td></tr><tr><td colspan="4"><span id="v55564958" class="anchor"></span><div class="para"> <p>ASCVD = atherosclerotic cardiovascular disease; LDL-C = low density lipoprotein cholesterol.</p></div></td></tr><tr><td colspan="4"><span id="v55564961" class="anchor"></span><div class="para"> <p>Adapted from Stone NJ, Robinson J, Lichtenstein AH, et al: 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. <i>Circulation</i> 129:S1–S45, 2014.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v80953053'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v80953054"></span> <div class="TableFullPage" id="v80953053"> <h3 class="title">Non-Statin Lipid–Lowering Drugs*</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v80953062" class="anchor"></span><div class="para"> <p>Drugs</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v80953065" class="anchor"></span><div class="para"> <p>Comments</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953077" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Adenosine</span> triphosphate citrate lyase inhibitor</p></div></p></td><td><span id="v80953080" class="anchor"></span><div class="para"> <p>Lowers LDL-C</p></div></td></tr><tr class="even"><td><span id="v80953083" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bempedoic acid</span></p></div></td><td><span id="v80953085" class="anchor"></span><div class="para"> <p>Risk of hyperuricemia, tendon rupture</p></div><span id="v80953086" class="anchor"></span><div class="para"> <p>Especially useful in patients with statin-associated muscle adverse effects as the enzyme required to activate this drug is absent in the muscle</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953090" class="anchor"></span><div class="para"> <p>Bile acid sequestrants</p></div></p></td><td><span id="v80953092" class="anchor"></span><div class="para"> <p>Lower LDL-C (primary), slightly increase HDL-C (secondary), may increase TGs</p></div></td></tr><tr class="even"><td><span id="v80953095" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Cholestyramine</span></p></div></td><td><span id="v80953097" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd"><td><span id="v80953100" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Colesevelam</span></p></div></td><td><span id="v80953102" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v80953105" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Colestipol</span></p></div></td><td><span id="v80953107" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953111" class="anchor"></span><div class="para"> <p>Cholesterol absorption inhibitor</p></div></p></td><td><span id="v80953113" class="anchor"></span><div class="para"> <p>Lowers LDL-C (primary), minimally increases HDL-C</p></div></td></tr><tr class="even"><td><span id="v80953116" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ezetimibe</span></p></div></td><td><span id="v80953118" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953122" class="anchor"></span><div class="para"> <p>Drugs for homozygous familial hypercholesteremia</p></div></p></td><td><span id="v80953124" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v80953127" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Evinacumab</span></p></div></td><td><span id="v80953129" class="anchor"></span><div class="para"> <p>Given as an intravenous infusion over 60 minutes</p></div><span id="v80953130" class="anchor"></span><div class="para"> <p>Adverse reactions in clinical trials include nasopharyngitis, influenza-like illness, and infusion reaction</p></div></td></tr><tr class="odd"><td><span id="v80953133" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lomitapide</span></p></div></td><td><span id="v80953135" class="anchor"></span><div class="para"> <p>Risk of hepatotoxicity</p></div><span id="v80953136" class="anchor"></span><div class="para"> <p>Increase dose gradually (about every 2 weeks)</p></div><span id="v80953137" class="anchor"></span><div class="para"> <p>Measure transaminase levels before increasing dosage</p></div></td></tr><tr class="even" tablehead2=""><td><p class="tableHead2"><span id="v80953141" class="anchor"></span><div class="para"> <p>Fibrates</p></div></p></td><td><span id="v80953143" class="anchor"></span><div class="para"> <p>Lower TGs and VLDL, increase HDL-C, may increase LDL-C (in patients with high TGs)</p></div></td></tr><tr class="odd"><td><span id="v80953146" class="anchor"></span><div class="para"> <p>Bezafibrate</p></div></td><td><span id="v80953148" class="anchor"></span><div class="para"> <p>Decreased dose required in renal insufficiency</p></div><span id="v80953149" class="anchor"></span><div class="para"> <p>Not available in US</p></div></td></tr><tr class="even"><td><span id="v80953152" class="anchor"></span><div class="para"> <p>Ciprofibrate</p></div></td><td><span id="v80953154" class="anchor"></span><div class="para"> <p>Not available in US</p></div></td></tr><tr class="odd"><td><span id="v80953157" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fenofibrate</span></p></div></td><td><span id="v80953159" class="anchor"></span><div class="para"> <p>Decreased dose required in renal insufficiency</p></div><span id="v80953160" class="anchor"></span><div class="para"> <p>May be safest fibrate for use with statins</p></div></td></tr><tr class="even"><td><span id="v80953163" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Gemfibrozil</span></p></div></td><td><span id="v80953165" class="anchor"></span><div class="para"> <p>Decreased dose required in renal insufficiency</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953169" class="anchor"></span><div class="para"> <p>Nicotinic acid (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>niacin</span>)</p></div></p></td><td><span id="v80953171" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v80953174" class="anchor"></span><div class="para"> <p></div></td><td><span id="v80953176" class="anchor"></span><div class="para"> <p>Increases HDL-C; lowers TGs (low doses), LDL-C (higher doses), and Lp(a) (secondary)</p></div><span id="v80953177" class="anchor"></span><div class="para"> <p>Frequent adverse effects: Flushing, impaired glucose tolerance, increased uric acid</p></div><span id="v80953178" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Aspirin</span> and administration with food minimize flushing</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953183" class="anchor"></span><div class="para"> <p>PCSK9 monoclonal antibodies</p></div></p></td><td><span id="v80953185" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v80953188" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Alirocumab</span></p></div></td><td><span id="v80953190" class="anchor"></span><div class="para"> <p>For patients with familial hypercholesterolemia and for other high-risk patients</p></div></td></tr><tr class="odd"><td><span id="v80953193" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Evolocumab</span></p></div></td><td><span id="v80953195" class="anchor"></span><div class="para"> <p>For patients with familial hypercholesterolemia and for other high-risk patients</p></div></td></tr><tr class="even" tablehead2=""><td><p class="tableHead2"><span id="v80953199" class="anchor"></span><div class="para"> <p>Prescription omega-3 fatty acids</p></div></p></td><td><span id="v80953201" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="odd"><td><span id="v80953204" class="anchor"></span><div class="para"> <p>Eicosapentaenoic acid ethyl ester (EPA) + Docosahexaenoic acid (DHA)</p></div></td><td><span id="v80953206" class="anchor"></span><div class="para"> <p>Lowers TGs</p></div><span id="v80953207" class="anchor"></span><div class="para"> <p>Increases LDL-C</p></div></td></tr><tr class="even"><td><span id="v80953210" class="anchor"></span><div class="para"> <p>Eicosapentaenoic acid ethyl ester (EPA) only</p></div></td><td><span id="v80953212" class="anchor"></span><div class="para"> <p>Lowers TGs only</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v80953216" class="anchor"></span><div class="para"> <p>SiRNA targeting PCSK9</p></div></p><span id="v80953217" class="anchor"></span><div class="para"> <p></div></td><td><span id="v80953219" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v80953222" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Inclisiran</span></p></div></td><td><span id="v80953224" class="anchor"></span><div class="para"> <p>For patients with familial hypercholesterolemia and for other high-risk patients</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v80953069" class="anchor"></span><div class="para"> <p>* Many of these drugs are also available in combination with a statin.</p></div></td></tr><tr><td colspan="2"><span id="v80953072" class="anchor"></span><div class="para"> <p>HDL <span class='symbol'>=</span> high-density lipoprotein; HDL-C <span class='symbol'>=</span> HDL cholesterol; LDL <span class='symbol'>=</span> low-density lipoprotein; LDL-C <span class='symbol'>=</span> LDL cholesterol; Lp(a) <span class='symbol'>=</span> lipoprotein (a); PCSK9 = proprotein convertase subtilisin-like/kexin type 9; SiRNA = small interfering ribonucleic acid; TG <span class='symbol'>=</span> triglyceride; VLDL = very low-density lipoprotein.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>